WO2020004218A1 - Absorbent article, and package - Google Patents

Absorbent article, and package Download PDF

Info

Publication number
WO2020004218A1
WO2020004218A1 PCT/JP2019/024485 JP2019024485W WO2020004218A1 WO 2020004218 A1 WO2020004218 A1 WO 2020004218A1 JP 2019024485 W JP2019024485 W JP 2019024485W WO 2020004218 A1 WO2020004218 A1 WO 2020004218A1
Authority
WO
WIPO (PCT)
Prior art keywords
wearer
inspection
side member
excrement
sheet
Prior art date
Application number
PCT/JP2019/024485
Other languages
French (fr)
Japanese (ja)
Inventor
裕哉 鈴木
佐々木 徹
Original Assignee
ユニ・チャーム株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2018125605A external-priority patent/JP6920252B2/en
Priority claimed from JP2018125581A external-priority patent/JP6905959B2/en
Application filed by ユニ・チャーム株式会社 filed Critical ユニ・チャーム株式会社
Priority to CN201980042377.4A priority Critical patent/CN112334102B/en
Publication of WO2020004218A1 publication Critical patent/WO2020004218A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/42Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators with wetness indicator or alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/512Topsheet, i.e. the permeable cover or layer facing the skin characterised by its apertures, e.g. perforations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/513Topsheet, i.e. the permeable cover or layer facing the skin characterised by its function or properties, e.g. stretchability, breathability, rewet, visual effect; having areas of different permeability

Definitions

  • the present invention relates to an absorbent article and a package.
  • FIG. 1 of Patent Document 1 discloses an absorbent article having an inspection member for inspecting a wearer's health condition.
  • the inspection member has a sensor arranged on the skin side of the absorbent article. By detecting the target component contained in the excrement by the sensor, the health condition of the wearer can be confirmed.
  • the senor is exposed on the skin side. For this reason, when the absorbent article is worn, the sensor directly touches the wearer's skin, so that the wearer's feel to the absorbent article may be deteriorated. Further, the sensor includes an indicator for detecting the target component. Therefore, when the absorbent article is worn, the indicator contained in the sensor touches the wearer's skin, and the indicator may damage the wearer's skin.
  • the present invention has been made in order to solve the above-described problems, and it is an object of the present invention to provide an absorbent article and a package that are easy to suppress deterioration of the touch of a wearer and that are easy to suppress damage to the skin by an indicator. provide.
  • the absorbent article according to the present disclosure is a surface-side member that includes at least a test member for testing a wearer's health condition and a liquid-permeable top sheet, and that is disposed closer to the skin than the test member. And a back-side member that includes at least a liquid-impermeable back sheet and is disposed closer to the skin than the inspection member.
  • the inspection member has a contact portion that contacts the excrement that has passed through the surface-side member, and a display portion that displays the wearer's health condition using an indicator according to a target component included in the excrement.
  • the front side member covers at least a part of the display unit. The front side member is peelable from the back side member so that the display unit can be visually recognized.
  • the package according to the present disclosure includes an absorbent article, a packaging sheet for individually packaging the absorbent article, and an inspection unit for inspecting a wearer's health condition.
  • the inspection unit displays a health condition of the wearer according to a target component included in the excrement of the wearer.
  • the inspection unit is fixed to the packaging sheet or is a part of the packaging sheet.
  • FIG. 2 is a sectional view taken along line F2-F2 shown in FIG. It is the top view which looked at the absorptive article concerning a 1st embodiment from the skin side.
  • It is sectional drawing of the absorbent article which concerns on 2nd Embodiment. It is sectional drawing of the absorbent article which concerns on 3rd Embodiment.
  • It is a perspective view of a package concerning a 4th embodiment. It is an expansion perspective view of an inspection part concerning a 4th embodiment.
  • FIG. 8 is a sectional view taken along line F8-F8 shown in FIG. 7. It is an expansion perspective view of an inspection part concerning a 5th embodiment.
  • FIG. 13 is a sectional view taken along line F13-F13 shown in FIG. It is a perspective view of an inspection part concerning an 8th embodiment. It is a perspective view of an inspection part concerning a 9th embodiment. It is a perspective view of the package concerning a 10th embodiment. It is a perspective view of a package concerning an eleventh embodiment.
  • An absorbent article is a surface-side member that includes at least a test member for testing a wearer's health condition and a liquid-permeable top sheet, and that is disposed closer to the skin than the test member. And a back-side member that includes at least a liquid-impermeable back sheet and is disposed closer to the skin than the inspection member.
  • the inspection member has a contact portion that contacts the excrement that has passed through the surface-side member, and a display portion that displays the wearer's health condition using an indicator according to a target component included in the excrement.
  • the front side member covers at least a part of the display unit. The front side member is peelable from the back side member so that the display unit can be visually recognized.
  • the inspection member displays the target component contained in the excrement.
  • the wearer's health condition is displayed accordingly. Because the front-side member covers at least a part of the display unit, the wearer removes the absorbent article from the body, and then peels off the front-side member from the back-side member to expose the display unit.
  • the display unit is easily visible. The wearer can confirm the health condition by visually recognizing the exposed display unit.
  • the front-side member is disposed closer to the skin than the inspection member, and covers at least a part of a display unit that displays the health condition of the wearer with an indicator.
  • an opening is formed in the front surface member so as to overlap the contact portion in a thickness direction.
  • the amount of excrement required for the inspection reaches the contact portion as compared with the case where the excrement passes through the opening. May take some time, or some excrement may not reach the contact area. Therefore, by forming an opening that overlaps with the contact portion on the surface side member, the excrement immediately reaches the contact portion when passing through the opening, so that the amount of excrement required for the inspection easily reaches quickly.
  • the excrement required for the examination can reach the contact portion in a short time, and the examination accuracy can be improved while shortening the examination time.
  • the front-side member is constituted by a plurality of sheets including the top sheet.
  • the opening is formed only in some of the plurality of sheets. Since the remaining sheet covers the opening (and the contact portion) among the plurality of sheets, the inspection member is not exposed. Thus, it is possible to reliably prevent the inspection member from touching the wearer's skin while improving the inspection accuracy.
  • the contact section and the display section are arranged at different positions.
  • the display unit does not overlap the opening in the thickness direction. Since the display unit containing the indicator reacting according to the target component does not overlap with the opening, the display unit does not directly contact the wearer's skin, so that damage to the skin due to the indicator can be suppressed.
  • the front-side member includes a liquid-impermeable sheet disposed on a non-skin side than the top sheet.
  • the opening is formed at least in the liquid impermeable sheet. Even if the front side member has the liquid impermeable sheet, the excrement can pass through the liquid impermeable sheet through the opening. Thereby, the excrement can reach the inspection member, and the health condition of the wearer can be displayed on the display unit.
  • the indicator contained in the inspection member may be dissolved in the excrement reaching the inspection member. Since the liquid impermeable sheet does not allow excrement to pass through except for the opening, the excrement can be prevented from returning to the top sheet. Therefore, damage to the wearer's skin due to the indicator contained in the excrement can be suppressed.
  • the opening is a through-hole that penetrates the surface-side member.
  • the excrement reaches the contact portion through the gap between the fibers constituting the surface-side member, compared to when the excrement passes through the opening, the amount of excrement required for the test reaches the contact portion. May take a long time or some excrement may not reach the contact part. Therefore, since the through-hole is formed in the front surface side member, the excrement can pass through the through-hole and immediately reach the contact portion, so that the amount of excrement necessary for the inspection can easily reach quickly. The excrement required for the inspection can reach the contact portion in a short time, and the inspection accuracy can be improved.
  • the back side member includes a hydrophilic sheet having a higher hydrophilicity or a higher fiber density than the liquid-permeable sheet included in the front side member.
  • the inspection member is disposed on the hydrophilic sheet. Since the liquid-permeable sheet disposed on the back-side member has a higher hydrophilicity or fiber density than the liquid-permeable sheet included in the front-side member, the excrement can be prevented from returning to the top sheet. For this reason, the influence of the indicator contained in the excrement on the wearer's skin can be suppressed.
  • a package includes an absorbent article, a packaging sheet for individually packaging the absorbent article, and an inspection unit for inspecting a wearer's health condition.
  • the inspection unit displays a health condition of the wearer according to a target component included in the excrement of the wearer.
  • the inspection unit is fixed to the packaging sheet or is a part of the packaging sheet.
  • the inspection unit is a separate member from the absorbent article, the wearer's skin is not damaged by the indicator when the absorbent article is worn.
  • the wearer contacts the excrement and the contact portion by bringing the inspection section (contact portion) into contact with the excrement from the surface of the packaging sheet opposite to the surface on which the contact portion is arranged. Without this, the excrement can be brought into contact with the contact portion. For this reason, a wearer can inspect a health condition hygienically.
  • the inspection unit has a contact unit that contacts the excrement to display the health condition.
  • the contact portion overlaps the packaging sheet in a thickness direction.
  • the wearer contacts the excrement from the surface of the packaging sheet opposite to the surface on which the contact portion is disposed, and contacts the inspection portion (contact portion), so that the excrement and the contact portion are not contacted.
  • Excrement can be brought into contact. For this reason, a wearer can inspect a health condition hygienically.
  • the inspection unit has a contact unit that contacts the excrement to display the health condition.
  • the inspection unit is disposed so as to straddle an edge of the packaging sheet.
  • the inspection unit has an extension that extends from the edge to the outside of the packaging sheet when the packaging body is opened.
  • the contact part is arranged on the extension part. Since the extension portion extends to the outside of the packaging sheet, the wearer grips the packaging sheet and contacts the contact portion arranged on the extension portion with the excrement, so that the wearer has some Can keep the distance. Therefore, the wearer can make the excrement contact the contact portion without touching the excrement and the contact portion. Therefore, the wearer can inspect the health condition hygienically.
  • the inspection section is a lead tape that is peeled off from the packaging sheet to open the packaging body. Since the lead tape is used as the inspection unit, it is not necessary to add a new member to the package as the inspection unit.
  • the inspection unit includes a display unit that includes an indicator and displays the health condition of the wearer with the indicator according to a target component included in the excrement. At least a part of the display section is covered with a water-repellent section having water repellency. Even if the wearer touches the display section, the wearer can be prevented from directly touching the indicator by touching the portion covered with the water repellent section having water repellency. Thereby, even if the indicator can damage the skin, the safety of the wearer can be improved.
  • coloration by the indicator indicating the health condition can be visually recognized. Even if the display section is covered with the water-repellent section, the wearer can visually recognize the coloring by the indicator. Therefore, the health condition indicated by the display unit can be easily grasped while enhancing the safety of the wearer.
  • the inspection unit has a contact unit that contacts the excrement to display the health condition.
  • Part of the contact portion is covered with a water-repellent portion having water repellency. Even if the wearer comes into contact with the contact part unintentionally, by touching the part covered with the water-repellent part having water repellency, the target component attached to the wearer's finger etc. Can be prevented from directly touching. Thereby, it is possible to suppress the contact of the symmetric component from the excrement other than the excrement to be inspected with the contact portion, and to improve the inspection accuracy.
  • the inspection section has a main body to which the contact section is fixed.
  • the second surface is covered with the water-repellent portion, and at least a part of the third surface is exposed from the water-repellent portion. Since the second surface of the contact portion is a surface opposite to the first surface fixed to the main body, it is a portion exposed from the main body. Therefore, the second surface of the contact portion is a portion that the wearer can easily touch. By covering the part which the wearer easily touches with the water-repellent part, the wearer can be prevented from touching the contact part, and the inspection accuracy can be improved.
  • the third surface connecting the first surface and the second surface is a portion that is difficult for the wearer to touch.
  • the inspection section is a part of the packaging sheet.
  • the wrapping sheet has a contact portion for contacting the excrement for displaying the health condition, and a display portion for displaying the health condition of the wearer in accordance with a target component contained in the excretion.
  • the contact portion and the display portion are not exposed before opening the package, and are exposed when the package is opened.
  • the contact portion and the display portion are not exposed before opening the package, and are exposed by opening the package, so that the contact portion and the display portion can be prevented from contacting other things before the inspection, Inspection accuracy can be improved.
  • the absorbent article may be an absorbent article such as a sanitary napkin, panty liner, incontinence pad, stool pad.
  • the absorbent article may be an article used by being attached to the inside of a wearing article such as underwear.
  • the absorbent article 1 of the present embodiment is a sanitary napkin.
  • FIG. 1 is a plan view of the absorbent article according to the first embodiment as viewed from the skin side.
  • FIG. 2 is a sectional view taken along line F2-F2 shown in FIG.
  • FIG. 3 is a plan view of the absorbent article according to the first embodiment as viewed from the skin surface side.
  • the “skin side” corresponds to the side facing the wearer's skin during wearing (during use).
  • the “non-skin side” corresponds to the side that is turned away from the wearer's skin during wearing (during use).
  • the absorbent article 1 has a front-rear direction L and a width direction W.
  • the front-rear direction L is a direction extending from the front side (abdominal side) to the rear side (back side) of the wearer, or a direction extending from the rear side of the wearer to the front side.
  • the width direction W is a direction orthogonal to the front-rear direction L.
  • the absorbent article has a thickness direction T extending to the skin surface side T1 and the non-skin surface side T2.
  • the absorbent article 1 has a central area S3, a front area S1, and a rear area S2.
  • the central area S3 is an area having an excretion port contact portion that contacts an excretion port (for example, a vaginal opening) of the wearer.
  • the central region S3 is located at the crotch of the underwear. That is, the central region is a region located between the wearer's crotch, that is, between the wearer's feet.
  • the front side area S1 is located on the front side of the central area S3.
  • the rear area S2 is located behind the central area S3.
  • the absorbent article 1 may have, for example, a front side area S1, a rear side area S2, and a central area S3 so as to divide the absorbent article 1 into three equal parts in the front-rear direction L.
  • the absorbent article 1 includes the inspection member 20, the front side member 40, and the back side member 60.
  • the inspection member 20 is a member for inspecting a wearer's health condition. Details of the inspection member 20 will be described later.
  • the surface member 40 is a member that includes at least a liquid-permeable top sheet and is disposed closer to the skin surface T1 than the inspection member 20. Therefore, the front-side member (top sheet) easily comes into direct contact with the wearer's skin, and the inspection member 20 can be prevented from coming into contact with the skin. In the present embodiment, the front surface side member 40 is configured only by the top sheet.
  • the surface-side member (top sheet) 40 is made of any sheet-like material having a structure that allows liquid to pass through, such as a nonwoven fabric, a woven fabric, a perforated plastic sheet, or a mesh sheet.
  • a nonwoven fabric such as a nonwoven fabric, a woven fabric, a perforated plastic sheet, or a mesh sheet.
  • a mesh sheet such as a nonwoven fabric, a woven fabric, a perforated plastic sheet, or a mesh sheet.
  • any of natural fibers and chemical fibers can be used.
  • the back side member 60 is a member that includes at least a liquid-impermeable back sheet and is disposed on the non-skin side T2 with respect to the inspection member 20.
  • the back surface side member 60 is constituted only by the top sheet.
  • the back side member (back sheet) 60 may be a laminated non-woven fabric mainly composed of polyethylene sheet, polypropylene, or the like, a breathable resin film, a sheet in which a breathable resin film is bonded to a non-woven fabric such as spun bond or spun lace, or the like. Can be used.
  • the inspection member 20 displays the health condition of the wearer with an indicator.
  • an immunochromatography method or a test paper method can be used for examining the health condition.
  • the immunochromatography method is performed by dropping excrement (for example, blood) on a member (for example, a cellulose membrane) on which labeled particles containing antibodies are spread. If the excrement contains a target component (antigen) to be tested, the target component and the antibody cause an antigen-antibody reaction to form a complex. The formed complex moves on the membrane by capillary action. A different type of antibody (indicator) is linearly arranged at the destination of the complex. The complex binds to another type of antibody and develops a color. The presence or absence of coloration (color change) indicates the health condition of the wearer. The wearer can confirm the health condition by visually determining the presence or absence of coloration.
  • a color is formed when the indicator contained in the test member 20 reacts with the target component contained in the excrement.
  • the presence or absence of coloration indicates the health condition of the wearer.
  • the wearer can visually confirm the coloration (change in the color of the indicator) by the indicator to confirm the health condition.
  • Excretions include, for example, blood, urine, stool, and sweat.
  • Items indicating health status include, for example, physical condition-related (pH, iron deficiency anemia, renal function, myocardial infarction, inflammation / infection, nutritional status evaluation, etc.), pregnancy-related (physiological cycle prediction, ovulation prediction, etc.), mental-related (Depression, drugs, etc.).
  • the target components to be tested include, for example, urine waste (urine specific gravity), leukocytes, hydrogen ions (pH), proteins, glucose, ketone bodies, urobilinogen, bilirubin, urinary occult blood, nitrite, steroids, peptides, and aromatics Compound, FSH (follicle stimulating hormone), BUN (Urea @ nitorogen), AlB (Albumin), LPS (lipopolysaccharide), hCG (human chorionic gonadotropin), LH (luteinizing hormone), U-ALB, CRP (C-reactiv) Protein), myoglobin, CK-MB, troponin I, troponin T, hemoglobin, strep A, HBs antibody, HIV antibody, TP antibody, rotavirus, influenza virus, adenovirus, DNA, O-157, cocaine, marijuana, morphine For example, That.
  • FSH follicle stimulating hormone
  • BUN Ultra @ nitorogen
  • the inspection member 20 has a contact part 22 and a display part 24.
  • the contact part 22 is a part for making excrement contact.
  • the display unit 24 is a part that displays the health condition of the wearer according to the target component contained in the excrement.
  • the contact portion 22 includes at least a region where the labeled particles including the antibody are arranged.
  • the target component (antigen) and the antibody contained in the excretion cause an antigen-antibody reaction to form a complex.
  • the display unit 24 includes at least a region where an indicator (another type of antibody) that is colored by binding to the complex is arranged. Therefore, when the immunochromatography method is used, the contact part 22 and the display part 24 are arranged at different positions.
  • the contact portion 22 includes at least a region where the indicator is arranged. Since the indicator contained in the contact part 22 reacts with the target component to give a color, the contact part 22 and the display part 24 are arranged at the same position. Therefore, in this case, the contact part 22 and the display part 24 are the same.
  • the contact portion 22, that is, the display portion 24 includes an indicator for displaying the health condition of the wearer.
  • the contact section 22 includes label particles, and the display section 24 includes an indicator for displaying a wearer's health condition.
  • the contact part 22 may not include the indicator.
  • the indicator is a chemical substance (inorganic or organic) that is colored by reacting with the target component or a component derived from the target component (for example, a complex).
  • the inspection member 20 may be any member that can hold the indicator.
  • the inspection member 20 can be made of any material such as paper, nonwoven fabric, and woven fabric.
  • the rigidity of the inspection member 20 may be equal to or less than the rigidity of the member used for the absorbent article 1. Thereby, even if the absorbent article 1 is provided with the inspection member 20, it becomes easy to suppress deterioration of the touch of the wearer.
  • the inspection member 30 may be, for example, a linear plate shape.
  • the front side member 40 covers at least a part of the display unit 24. As shown in FIGS. 1 and 2, the front-side member 40 covers the entire display unit 24.
  • the indicator contained in the display unit 24 becomes less likely to touch the skin, and damage to the skin by the indicator can be suppressed.
  • the excrement of the wearer reaches the inspection member 20 through the surface-side member 40, and is displayed on the inspection member 20 (display unit 24) in accordance with the target component included in the excrement.
  • the wearer's health status is displayed.
  • the front-side member 40 covers the display unit 24, the wearer cannot visually recognize the display unit 24 in the state of the absorbent article 1 in FIG.
  • the front-side member 40 can be peeled off from the rear-side member 60 so that the display unit 24 can be viewed. Accordingly, after the wearer removes the absorbent article 1 from the body, the display unit 24 is exposed by peeling the front-side member 40 from the back-side member 60. Therefore, it becomes easier for the wearer to visually recognize the display unit 24.
  • the wearer can check the health of the wearer by visually recognizing the exposed display section 24. In addition, the wearer does not need to carry the inspection member 20 and can easily check it, for example, even when going out.
  • An opening 45 is formed in the front side member 40.
  • the opening 45 is a through-hole that penetrates the surface-side member 40.
  • the opening 45 may have a first opening 451 and a second opening 452.
  • the first opening 451 is an opening that overlaps the contact portion 22 in the thickness direction T. Therefore, the first opening 451 overlapping the contact portion 22 in the thickness direction T is formed in the front surface side member 40.
  • the first opening 451 may be a through-hole that penetrates the surface-side member 40 in the thickness direction T. Accordingly, even if the excrement is a fixed substance or a semi-solid substance and it is difficult to diffuse the excrement, the excrement easily reaches the contact portion 22. Therefore, the excrement (target component) necessary for the inspection can reach the contact portion 22 and the inspection accuracy can be improved.
  • the display section 24 does not have to overlap the opening 45 in the thickness direction T. Since the display unit 24 containing the indicator does not overlap with the opening 45, the display unit 24 does not directly contact the wearer's skin, so that damage to the skin due to the indicator can be suppressed.
  • the second opening 452 is an opening that does not overlap with the contact portion 22 in the thickness direction T.
  • the second opening 452 may be an opening that does not overlap with the inspection member 20. The excrement that has passed through the second opening 452 reaches the back member 60, then moves on the back member 60, and can reach the contact part 22.
  • the opening 45 may be arranged at a position in contact with the excretion opening of the wearer. Therefore, the opening 45 may be arranged in the central area S3. Thereby, the excrement reaches the opening 45 without moving (diffusing) on the front side member 40. Therefore, it is possible to omit the movement of the excrement from the excretion point to the opening 45.
  • the excrement required for the examination can reach the contact portion 22 in a short time, and the examination accuracy can be improved while shortening the examination time.
  • the inspection member 20 is disposed in at least one of the front side area S1, the rear side area S2, and the center area S3. As shown in FIG. 1, the inspection member 20 may be disposed so as to straddle the rear side area S2 and the central area S3.
  • the contact part 22 may be located at least in the central area S3, and the display part 24 may be located at least in the rear area S2 (or the front area S1).
  • the display unit 24 by disposing the display unit 24 in the rear area S2 (or the front area S1), the distance from the rear end (or the front end) of the absorbent article 1 in the front-rear direction L to the display unit 24 is reduced. Accordingly, the wearer can immediately expose the display unit 24 by peeling the surface-side member 40 from the rear end (or the front end) of the absorbent article 1, and the wearer can remove the display unit 24. Easy to see.
  • the absorbent article 1 is provided with a bonding portion 70 for bonding the front side member 40 and the back side member 60. It may have a joining region BR and a non-joining region NBR where the joining portion 70 is not provided.
  • the joining portion 70 may be arranged between the front side member 40 and the back side member 60 in the thickness direction T.
  • the bonding region BR (that is, the bonding portion 70) is disposed on the outer peripheral portion of the absorbent article 1 (the front surface member 40 / the rear surface member 60) in a plan view of the absorbent article 1. Good.
  • the outer peripheral portion may be configured by an end in the front-rear direction L and an end in the width direction W of the absorbent article 1.
  • the joint 70 may be arranged in a region other than the outer peripheral portion.
  • the non-bonding region NBR may be arranged at least at a part of the end of the absorbent article 1 in the front-rear direction L. As shown in FIG. 3, the non-bonding region NBR may be arranged at the rear end of the absorbent article 1 in the front-rear direction L.
  • the wearer puts a finger in the non-joining region NBR, pinches the skin side T1 and the non-skin side T2 of the front-side member 40, and then pulls the front-side member 40 away from the rear-side member 60, thereby obtaining the front surface.
  • the side member 40 and the back side member 60 can be easily separated.
  • the non-joining region NBR at the rear end of the absorbent article 1, even if the front side of the absorbent article 1 is soiled with excrement, the wearer does not touch the excrement and the front side member is not used. 40 can be peeled off from the back side member 60.
  • the non-bonding region NBR may be arranged at the front end of the absorbent article 1 in the front-rear direction L.
  • the wearer when removing the absorbent article 1 from the underwear, the wearer often removes the absorbent article 1 from the front side, which is easily visible.
  • the non-bonding region NBR is arranged at the front end of the absorbent article 1 in the front-rear direction L, when removing the absorbent article 1 from the underwear, the front side of the absorbent article 1 is grasped with one hand. The part can be grasped and the finger of the other hand can be put into the non-joining area NBR. Thereby, the wearer can easily perform the operation of peeling the front surface side member 40.
  • the non-bonding region NBR may be arranged at at least one of the front end and the rear end of the absorbent article 1 in the front-rear direction L.
  • the non-bonding region NBR may be arranged at both the front end and the rear end of the absorbent article 1 in the front-rear direction L.
  • the bonding region BR (the bonding portion 70) may be provided by a bonding process such as an emboss seal using an adhesive or pressure or heat.
  • the non-joining region NBR may be provided by not performing the joining process.
  • the front-side member 40 and the back-side member 60 may be joined by a peelable joint 70 so that the front-side member 40 can be separated from the back-side member 60.
  • the peelable joint 70 may be arranged in at least one of the front area S1, the rear area S2, and the central area S3.
  • the joint 70 may be arranged only in the region where the display unit 24 is located.
  • the joint 70 may be arranged only in the rear area S2, and the non-peelable joint 70 may be arranged in the front area S1 and the central area S3.
  • the inspection member 20 is disposed between the front side member 40 and the back side member 60 in the thickness direction T. Therefore, it is arranged on the back side member 60.
  • the inspection member 20 does not need to be fixed to both the front side member 40 and the back side member 60 with an adhesive or the like. Thereby, the fibers constituting the front side member 40 and / or the back side member 60 do not adhere to the inspection member 30, and the front side member 40 can be easily separated from the back side member 60. Further, since the fibers do not adhere to the inspection member 30, the display unit 24 is easily visible.
  • the inspection member 20 may be joined and fixed to at least one of the front side member 40 and the back side member 60. Accordingly, it is possible to prevent the contact portion 22 from being shifted from the first opening 451 and not overlapping the first opening 451 in the thickness direction T.
  • the inspection member 20 may be joined to the back surface side member 60 by, for example, a hot melt adhesive (HMA).
  • HMA hot melt adhesive
  • At least the contact portion 24 does not need to be joined (fixed) in order to prevent the excrement E from becoming difficult to contact the contact portion 22 due to an adhesive or the like.
  • at least the display unit 22 does not need to be joined (fixed) to the front surface member 40 and the back surface member 60.
  • the inspection member 30 may have a fixed part configured by at least a part of a part other than the contact part 22 and the display part 44. At least one of the front-side member 40 and the back-side member 60 and the fixed portion of the inspection member 30 may be joined (fixed) by the adhesive applied on the fixed portion. Thereby, it is possible to suppress the displacement of the contact portion 22 without fixing the contact portion 22 and the display portion 44.
  • FIG. 4 is a cross-sectional view of the absorbent article 1 according to the second embodiment. The description of the same parts as in the first embodiment is omitted.
  • the front side member 40 may include a first front side member 42 and a second front side member 44.
  • the first front side member 42 may be made of the same material as the above-described top sheet. Therefore, the front side member 40 may be configured by a plurality of sheets including a top sheet (first front side member 42).
  • the second surface-side member 44 is a member arranged on the non-skin side with respect to the first surface-side member 42.
  • the second front side member 44 may be a liquid permeable sheet. In this case, the second front side member 44 may be made of the same material as the top sheet.
  • the second front side member 44 may be a liquid impermeable sheet. In this case, the second front side member 44 may be made of the same material as the above-described back sheet.
  • the first surface-side member 42 and the second surface-side member 44 may be joined to each other by, for example, a hot melt adhesive (HMA).
  • HMA hot melt adhesive
  • the first surface side member 42 has no opening 45 formed therein.
  • a first opening 451 is formed in the second surface side member 44.
  • the opening 45 is formed only in some of the sheets constituting the front-side member 40.
  • the inspection member 20 is not exposed because the first front side member 42 covers the first opening 451 and the contact portion 22.
  • the excrement easily reaches the contact portion 22 by passing through the first opening 451. Therefore, it is possible to further suppress the deterioration of the touch of the wearer and the damage to the skin due to the indicator while shortening the inspection time and improving the inspection accuracy.
  • the first openings 451 are formed in the liquid impermeable sheet. Even if the front side member 40 has a liquid impermeable sheet, excrement can pass through the second front side member 44 (liquid impermeable sheet) through the first opening 451. Thus, the excrement can reach the inspection member 20 (the contact portion 22), and the health condition of the wearer can be displayed on the display portion 24. On the other hand, the indicator contained in the inspection member 20 may be dissolved in the excrement reaching the inspection member 20.
  • the liquid impermeable sheet which is the second front side member 44, does not allow the excrement to pass through except for the first opening 451, so that the excrement can be prevented from returning to the first front side member 42. Therefore, damage to the wearer's skin due to the indicator contained in the excrement can be suppressed.
  • the back side member 60 may include a first back side member 62 and a second back side member 64.
  • the first back side member 62 may be a liquid permeable sheet, and may be made of the same material as the above-described top sheet.
  • the first back side member 62 may be a sheet (hydrophilic sheet) having a higher hydrophilicity or fiber density than the first front side member 42 which is a liquid permeable sheet included in the front side member 40.
  • the inspection member 20 may be disposed on the first back side member 62. Therefore, the inspection member 20 may be in direct contact with the first back side member 62.
  • the first back side member 62 is higher in hydrophilicity or fiber density than the first front side member 42, the first back side member 62 has a stronger force to draw in excrement. Therefore, it becomes easier for the excrement (target component) to reach the inspection member 20 in a short time.
  • the excrement is drawn in toward the first back side member 62 and becomes difficult to return to the first front side member 42. Even if the indicator is dissolved in the excrement, the excrement can be maintained on the first back side member 62. The effect on the wearer's skin by the indicator contained in the excrement can be suppressed.
  • the fiber density can be measured by a known method.
  • the fiber density is obtained by cutting out the target site from the absorbent article 1 as a target sample, measuring the mass per unit area of the target sample (g / m2), measuring the thickness (m) of the target sample, and measuring the target sample. It can be calculated by dividing the mass per unit area by the thickness of the target sample (g / m3).
  • the mass of the fiber per unit area is determined, for example, by measuring the mass of the target sample with a direct reading balance (for example, an electronic balance HF-300 manufactured by Kensei Kogyo Co., Ltd.), measuring the area of the target sample, and measuring the mass per unit area. The mass may be calculated.
  • the thickness of the target sample is determined, for example, by using a dial thickness gauge ID-C1012C manufactured by Mitutoyo Corporation or the equivalent, setting the contact area to 20 cm 2 and the contact pressure to 3 gf / cm 2 to set the target portion.
  • the measurement may be performed by applying a pressure, the comparison may be made visually, or the comparison may be made using an image obtained by photographing a cross section of the absorbent article 1 cut in the longitudinal direction.
  • the hydrophilicity can be measured by a well-known method. For example, first, five pieces of filter paper are stacked and placed horizontally, and a test piece to be measured is placed on the filter paper. Second, test specimens are marked at 2 cm intervals in each of the longitudinal and transverse directions. One drop (approximately 0.05 g) of artificial urine is dropped at 20 places with a pipette. The artificial urine is dropped at 20 places in 1 minute and 10 seconds. Thirdly, after being left for 30 seconds from the end of dropping at 20 locations, the locations absorbed by the test piece are counted. It is assumed that the more the absorption points of the test piece, the higher the hydrophilicity. (The higher the hydrophilicity, the stronger the liquid absorbing power than the lower hydrophilicity.)
  • the second back side member 64 corresponds to the above-described back sheet, and may be made of the same material as the above-described back sheet.
  • FIG. 5 is a cross-sectional view of the absorbent article 1 according to the third embodiment. The description of the same parts as those of the first and second embodiments will be omitted.
  • the absorbent article 1 may have the second opening 452 that does not overlap with the inspection member 20 in the thickness direction T.
  • the second opening 452 may be a through hole that penetrates the front surface side member 40. Thereby, the excrement can reach the first back side member 62 in a shorter time by passing through the second opening 452 as compared with the case where the second opening 452 is not formed.
  • the first back side member 62 When the first back side member 62 is a liquid permeable sheet, as shown in FIG. 5, the first back side member 62 can be diffused and reach the inspection member 20 (contact portion 22).
  • the inspection member 20 when the absorbent article 1 has only the second opening 452, the inspection member 20 is not exposed when viewed from the skin surface side T1. Therefore, since the inspection member 20 does not directly contact the wearer's skin, deterioration of the wearer's touch can be suppressed, and damage to the skin by the indicator can be suppressed.
  • the package may be a package for packaging an absorbent article having no inspection member, which is different from the absorbent articles described in the first to third embodiments.
  • FIG. 6 is a perspective view of a package 100 according to the fourth embodiment.
  • FIG. 7 is an enlarged perspective view of the inspection unit 130 according to the fourth embodiment.
  • FIG. 8 is a cross-sectional view of the inspection unit taken along line F8-F8 shown in FIG. 7, and is a diagram for explaining a use state of the inspection unit.
  • the package 100 may have a longitudinal direction X, a width direction Y, and a thickness direction Z that are orthogonal to each other.
  • the longitudinal direction X may be a direction that defines the length of the package 100 (a packaging sheet 120 described later).
  • the width direction Y may be a direction that defines the width of the package 100 (the packaging sheet 120).
  • the thickness direction Z may be a direction that defines the thickness of the package 100 (the packaging sheet 120).
  • the package 100 has an absorbent article 110, a packaging sheet 120, and an inspection unit 130.
  • the absorbent article 110 is an article that can absorb the excrement of the wearer.
  • Absorbent article 110 may be an absorbent article such as a sanitary napkin, panty liner, incontinence pad, stool pad.
  • the absorbent article may be an article used by being attached to the inside of a wearing article such as underwear.
  • the absorbent article 110 of the present embodiment is a sanitary napkin.
  • the packaging sheet 120 is a sheet for individually packaging the absorbent articles 110. By removing the packaging sheet 120 when using the absorbent article 110, the absorbent article 110 is exposed and can be used.
  • the packaging sheet 120 may be made of any sheet-like material such as a nonwoven fabric, a woven fabric, a perforated plastic sheet, a mesh sheet, and the like.
  • a nonwoven fabric such as a nonwoven fabric, a woven fabric, a perforated plastic sheet, a mesh sheet, and the like.
  • the material of the woven or nonwoven fabric any of natural fibers and chemical fibers can be used.
  • the packaging sheet 120 may have a first edge 121e and a second edge 122e that are edges in the longitudinal direction X of the packaging sheet 120 (see the lower diagram in FIG. 16).
  • the first edge 121e may be an edge located outside the package 100
  • the second edge 122e may be located inside the package 100.
  • the edge may be The inside of the package 100 is the inside of the package 100 in the thickness direction Z in the package state.
  • the packaging sheet 120 has a first sheet portion 121 having a first edge 121e and a second sheet having a second edge 122e in a packaging state in which the absorbent articles 110 are individually packaged. And a portion 122.
  • the first sheet portion 121 may be located outside the package 100, and a part of the second sheet portion 122 may be located inside the package 100. Therefore, a part of the second sheet portion 122 may be covered by the first sheet portion 121 in the thickness direction Z.
  • the inspection unit 130 is for inspecting the health condition of the wearer.
  • the inspection unit 130 displays the health condition of the wearer according to the target component contained in the excrement of the wearer.
  • inspection unit 130 is fixed to packaging sheet 120. Therefore, it should be noted that the packaging sheet 120 and the inspection unit 130 are separate bodies.
  • the wearer removes the absorbent article 110 from the body after use, and replaces the absorbent article 110.
  • the wearer removes the new absorbent article 110 from the packaging sheet 120 and uses it. Since the inspection unit 130 is fixed to the removed packaging sheet 120 with the packaging sheet 120, the inspection unit 130 can be used for excrement attached to the absorbent article 110 removed from the body. Since the wearer does not need to carry the inspection unit 130 separately, the wearer can easily check the health condition.
  • the inspection unit 130 displays the health condition of the wearer using an indicator. More specifically, the reaction unit 140 included in the inspection unit 130 displays the health condition of the wearer using an indicator.
  • an immunochromatography method or a test paper method can be used for examining the health condition.
  • the immunochromatography method is performed by dropping excrement (for example, blood) on a member (for example, a cellulose membrane) on which labeled particles containing antibodies are spread. If the excrement contains a target component (antigen) to be tested, the target component and the antibody cause an antigen-antibody reaction to form a complex. The formed complex moves on the membrane by capillary action. A different type of antibody (indicator) is linearly arranged at the destination of the complex. The complex binds to another type of antibody and develops a color. The presence or absence of coloration (color change) indicates the health condition of the wearer. The wearer can confirm the health condition by visually determining the presence or absence of coloration.
  • a color is formed when an indicator contained in the inspection unit 130 reacts with a target component contained in excrement.
  • the presence or absence of coloration indicates the health condition of the wearer.
  • the wearer can visually confirm the coloration (change in the color of the indicator) by the indicator to confirm the health condition.
  • Excretions include, for example, blood, urine, stool, and sweat.
  • Items indicating health status include, for example, physical condition-related (pH, iron deficiency anemia, renal function, myocardial infarction, inflammation / infection, nutritional status evaluation, etc.), pregnancy-related (physical cycle prediction, ovulation prediction, etc.), mental-related (Depression, drugs, etc.).
  • the target components to be tested include, for example, urine waste (urine specific gravity), leukocytes, hydrogen ions (pH), proteins, glucose, ketone bodies, urobilinogen, bilirubin, urinary occult blood, nitrite, steroids, peptides, and aromatics Compound, FSH (follicle stimulating hormone), BUN (Urea @ nitorogen), AlB (Albumin), LPS (lipopolysaccharide), hCG (human chorionic gonadotropin), LH (luteinizing hormone), U-ALB, CRP (C-reactiv) Protein), myoglobin, CK-MB, troponin I, troponin T, hemoglobin, strep A, HBs antibody, HIV antibody, TP antibody, rotavirus, influenza virus, adenovirus, DNA, O-157, cocaine, marijuana, morphine For example, That.
  • FSH follicle stimulating hormone
  • BUN Ultra @ nitorogen
  • the reaction section 140 (inspection section 130) has a contact section 142.
  • the contact part 142 is a part that makes excretions come into contact in order to display a health condition.
  • the reaction unit 140 (inspection unit 130) may include a display unit 144, as described later.
  • the display part 144 is a part that displays the health condition of the wearer with an indicator according to the target component contained in the excrement.
  • the contact portion 142 includes at least a region where the labeled particles including the antibody are arranged.
  • the target component (antigen) and the antibody contained in the excretion cause an antigen-antibody reaction to form a complex.
  • the display unit 144 includes at least a region where an indicator (another type of antibody) that is colored by binding to the complex is arranged. Therefore, when the immunochromatography method is used, the contact part 142 and the display part 144 are arranged at different positions.
  • the contact portion 142 includes at least a region where the indicator is arranged. Since the indicator contained in the contact portion 142 reacts with the target component to give a color, the contact portion 142 and the display portion 144 are arranged at the same position. Therefore, in this case, the contact part 142 and the display part 144 are the same.
  • the contact portion 142 when the test strip method is used, the contact portion 142, that is, the display portion 144 includes an indicator for displaying the wearer's health condition.
  • the contact section 142 when the immunochromatography method is used, the contact section 142 includes label particles, and the display section 144 includes an indicator for displaying a wearer's health condition.
  • the contact part 142 when the contact part 142 is provided only to guide the excrement (target component) to the display part 144, the contact part 142 may not include the indicator.
  • the indicator is a chemical substance (inorganic or organic) that is colored by reacting with the target component or a component derived from the target component (for example, a complex).
  • the inspection unit 130 may be any member that can hold the indicator.
  • inspection unit 130 may be a member that can be fixed to packaging sheet 120.
  • the inspection unit 130 may be made of any material such as paper, nonwoven fabric, woven fabric, and resin film.
  • the inspection unit 130 may have a main body 132 that supports the reaction unit 140.
  • the reaction section 140 may be fixed on the main body 132. That is, the reaction section 140 may be provided on the main body 132.
  • the inspection unit 130 may be a lead tape that is peeled off from the packaging sheet to open the package 100. More specifically, the main body 132 has a function as a lead tape. Since the lead tape is used as the inspection unit 130, it is not necessary to add a new member to the package 100 as the inspection unit 130. Accordingly, even if the package 100 has the inspection unit 130, the production efficiency of the package 100 does not need to be reduced.
  • inspection section 130 (lead tape) is fixed to the packaging sheet 120 by an adhesive section (not shown).
  • the contact portion 142 (the reaction portion 140) may overlap the packaging sheet 120 in the thickness direction Z. More specifically, the inspection unit 130 may be fixed to the packaging sheet 120 in a region where the contact unit 142 overlaps the packaging sheet 120 in the thickness direction Z.
  • the wearer causes the inspection unit 130 (contact portion 142) to contact the excrement E from the surface of the packaging sheet 120 opposite to the surface on which the contact portion 142 is arranged. Can be.
  • the excrement E can be brought into contact with the contact portion 142 without the finger of the wearer touching the excrement E. For this reason, a wearer can inspect a health condition hygienically.
  • the indicator does not react with the target component other than the excrement E (specifically, the target component attached to the finger), and the inspection accuracy can be improved.
  • the inspection unit 130 may be arranged so as to straddle the first edge 121e of the packaging sheet 120 (that is, the first sheet portion 121). Therefore, the inspection unit 130 may be disposed so as to straddle the first sheet part 121 and the second sheet part 122.
  • the inspection unit 130 (the main body unit 132) extends from the first edge 121e to the outside of the packaging sheet 120 when the packaging body 100 is unsealed and the fixing unit 132a that is secured to the packaging sheet 120.
  • An extension 132b may be provided (see FIG. 8).
  • the fixing portion 132a may be disposed on the first sheet portion 121, and the extending portion 132b may be disposed on the second sheet portion 122.
  • inspection section 130 has reaction section 140 (contact section 142) in fixing section 132a.
  • the wearer may hold the extension 132b and open the package 100. Therefore, the presence of the reaction portion 140 in the fixing portion 132a makes it difficult for the wearer's finger to touch the contact portion 142. Since the wearer's finger does not touch the contact part 142, the indicator does not react with the target component other than the excrement E (specifically, the target component attached to the finger), and the inspection accuracy can be improved.
  • the main body 132 may have a folded portion 134 in which the end of the main body 132 in the longitudinal direction X is folded. Thereby, the wearer can easily peel the lead tape (inspection unit 130) by gripping the folded back portion 134.
  • FIG. 9 is a cross-sectional view of the inspection unit 130 according to the fifth embodiment.
  • FIG. 10 is a cross-sectional view for explaining a use state of the inspection unit 130 according to the fifth embodiment. The description of the same parts as those in the above-described embodiment will be omitted.
  • the contact part 142 (the reaction part 140) is disposed on the extension part 132b.
  • the wearer since the extending portion 132b extends to the outside of the packaging sheet 120, the wearer holds the packaging sheet 120 and holds the contact portion disposed on the extending portion 132b.
  • the part 142 can be brought into contact with the excrement E. Thereby, the wearer's finger can keep a certain distance from the excrement E. Therefore, the wearer can bring the excrement E into contact with the contact portion 142 without touching the excrement E and the contact portion 142. Therefore, the wearer can inspect the health condition hygienically.
  • FIG. 11 is a diagram for explaining a use state of the inspection unit 130 according to the sixth embodiment. The description of the same parts as those in the above embodiments will be omitted.
  • the inspection unit 130 has a display unit 144.
  • the display unit 144 is disposed between the main body 132 and the packaging sheet 120 in the thickness direction Z. That is, the first surface 144a, which is one main surface of the display unit 144, is covered with the main body 132, and the second surface 144b, which is the other main surface of the display unit 144, is formed of the packaging sheet 120 (first sheet). Part 121). Therefore, the display unit 144 is not exposed. Thereby, even if the wearer is likely to touch the display unit 144 unintentionally, by touching the part covered by the main body 132 or the packaging sheet 120, the wearer can directly touch the indicator. Can be suppressed. Thereby, even if the indicator can damage the skin, the safety of the wearer can be improved.
  • the coloration by the indicator indicating the health condition may be visible.
  • the wearer can visually recognize the coloring by the indicator. Therefore, it is possible to easily grasp the health status indicated by the display unit 144 while improving the safety of the wearer.
  • the main body 132 may be transparent or semi-permeable, and the wearer may be able to visually recognize the color via the main body 132.
  • the main body 132 may be colorless and transparent. This makes it easier to visually recognize the color.
  • the packaging sheet 120 may be transparent or semi-permeable, and the wearer may be able to visually recognize the color through the packaging sheet 120.
  • the packaging sheet 120 may be colorless and transparent. This makes it easier to visually recognize the color.
  • visible refers to a distance of about 30 to 50 cm in a room (approximately: 500 to 750 lx (lux)) brightly illuminated in daylight white (color temperature reference: 4600 to 5400 K (Kelvin)). This means that a subject having good visual acuity (1.0 or more) with both eyes can visually recognize the subject when looking at the subject.
  • the first surface 144a is a surface fixed to the main body 132
  • the second surface 144b is a surface fixed to the packaging sheet 120.
  • the coloration by the indicator may be visible from the first surface 144a side.
  • the display 144 on the first surface 144a side may include more indicator than the display 144 on the second surface 144b side. Therefore, the coloration by the indicator may be more easily recognized on the first surface 144a side than on the second surface 144b side.
  • the coloring by the indicator may be visible only on the first surface 144a side.
  • the wearer can visually recognize the color from the surface on the side opposite to the surface on which the excrement E is applied (the side of the main body 132), so that the obstruction of the visual recognition due to the attachment of the excrement E is suppressed. it can. Thereby, coloration can be confirmed more accurately.
  • the coloration by the indicator may be visible from the second surface 144b side.
  • the display 144 on the second surface 144b side may include more indicator than the display 144 on the first surface 144a side. Therefore, the coloration by the indicator may be more easily visually recognized on the second surface 144b side than on the first surface 144a side.
  • the coloring by the indicator may be visible only on the second surface 144b side. Thus, even if the exposed main body 132 is soiled, the color can be visually recognized from the second surface 144b that is not exposed in the packaged state, so that the color can be confirmed more accurately.
  • At least a part of the contact portion 142 may be exposed from the first edge 121e of the packaging sheet 120 in the opened state in order to facilitate contact with the excrement E.
  • At least one of the main body 132 and the packaging sheet 120 may have water repellency, similarly to the water repellent part 150 described later.
  • FIG. 12 is a perspective view of the inspection unit 130 according to the seventh embodiment.
  • FIG. 13 is a sectional view taken along line F13-F13 shown in FIG. The description of the same parts as those in the above embodiments will be omitted.
  • the inspection unit 130 has a contact unit 142 and a display unit 144. Part of the contact portion 142 is covered with the water-repellent portion 150.
  • the inspection section 130 has the main body 132 to which the reaction section 140 (the contact section 142 and the display section 144) is fixed.
  • the contact portion 142 may have a first surface 142a, a second surface 142b, and a third surface 142c.
  • the first surface 142a is a surface fixed to the main body 132.
  • the second surface 142b is a surface opposite to the first surface 142a.
  • the third surface 142c is a surface connecting the first surface 142a and the second surface 142b.
  • the second surface 142b is covered by the water-repellent part 150. At least a portion of the third surface 142c is exposed from the water-repellent portion 150.
  • the water-repellent portion 150 may be provided by performing a water-repellent process of attaching (applying) a water-repellent agent to a part of the contact portion 142 using a water-repellent spray, a coating device, or the like.
  • the member constituting the main body 132 of the inspection unit 130 may be impregnated with a water repellent.
  • a portion to which the water repellent is not to be attached (for example, (a part of) the contact portion 142) may be covered with a masking tape or the like.
  • the contact section 142 After covering a part of the reaction section 140 (contact section 142) with the water-repellent section 150, the contact section 142 may be exposed by peeling off a masking tape or the like. The second surface 142b may be covered with a water-repellent member.
  • the water repellent may be a silicone water repellent or a fluorine water repellent. It is preferable that the water repellent (water repellent portion 150) does not easily discolor.
  • the water-repellent agent (water-repellent portion 150) may be permeable or semi-permeable. When the water repellent (the water repellent portion 150) covers the display portion 144, a colorless and transparent material may be used in order to make the coloration easily visible.
  • the second surface 142b of the contact portion 142 is a portion exposed from the main body 132 because it is a surface opposite to the first surface 142a fixed to the main body 132. Therefore, the second surface 142b of the contact portion 142 is a portion that the wearer can easily touch. By covering the portion that the wearer easily touches with the water-repellent portion 150, the wearer can be prevented from touching the contact portion 142, and the inspection accuracy can be improved.
  • the third surface 142c connecting the first surface 142a and the second surface 142b is a portion that is difficult for the wearer to touch. By exposing a portion that is difficult for the wearer to touch from the water-repellent portion 150, the target component can be brought into contact with the contact portion 142, and an inspection can be performed.
  • the exposed surface of the third surface 142c may be located on the outer edge side in the width direction of the main body 132.
  • the non-exposed surface in which the third surface 142c is covered with the water-repellent portion 150 may be located on the longitudinal end side of the main body 132.
  • the display unit 144 may have a first surface 144a, a second surface 144b, and a third surface 144c, like the contact unit 142. Accordingly, it is possible to suppress the wearer from directly touching the indicator contained in the display unit 144. Thereby, even if the indicator can damage the skin, the safety of the wearer can be improved. Further, in a state where the display unit 144 is covered with the water-repellent unit 150, the coloration by the indicator indicating the health condition may be visible. Thereby, even if the display part 144 is covered with the water-repellent part 150, the wearer can visually recognize the coloring by the indicator. Therefore, it is possible to easily grasp the health status indicated by the display unit 144 while improving the safety of the wearer.
  • FIG. 14 is a perspective view of the inspection unit 130 according to the eighth embodiment. The description of the same parts as those in the above embodiments will be omitted.
  • the exposed surface of the third surface 142c may be located not only on the outer edge side in the width direction Y of the main body 132 but also on the end side in the longitudinal direction X of the main body 132. This increases the exposed area of the third surface 142c, so that the inspection can be performed in a shorter time.
  • the second surface 142b is covered with the water-repellent portion 150, the wearer can be prevented from touching the contact portion 142, and the inspection accuracy can be improved.
  • FIG. 15 is a perspective view of the inspection unit 130 according to the ninth embodiment. The description of the same parts as those in the above embodiments will be omitted.
  • the exposed surface of the third surface 142c may be located on the end side in the longitudinal direction X of the main body 132.
  • the non-exposed surface in which the third surface 142c is covered with the water-repellent portion 150 may be located on the outer edge side in the width direction Y of the main body 132. Accordingly, even if the wearer grips the outer edge in the width direction Y of the inspection section 130 (the main body section 132), the wearer can be prevented from touching the contact section 142, so that the inspection accuracy can be improved.
  • the end in the longitudinal direction X of the reaction section 140 located on the center side in the longitudinal direction X of the main body section 132 may or may not be covered by the water-repellent section 150.
  • FIG. 16 is a perspective view of a package 100 according to the tenth embodiment. 16 shows a state before the package 100 is opened, and a lower diagram in FIG. 16 shows a state where the package 100 is opened. The description of the same parts as those in the above embodiments will be omitted.
  • the inspection unit 130 is fixed to the packaging sheet 120.
  • the inspection unit 130 is a part of the packaging sheet 120. Therefore, the packaging sheet 120 has the reaction section 140 (the contact section 142 and the display section 144).
  • the reaction section 140 (the contact section 142 and the display section 144) is not exposed before the package 100 is opened. On the other hand, as shown in the lower diagram of FIG. 16, the reaction section 140 is exposed by opening the package 100.
  • the reaction section 140 it is possible to prevent the reaction section 140 from contacting other components before the inspection, and to improve the inspection accuracy.
  • a reaction section 140 (inspection section 130) may be provided on the packaging sheet 120. Therefore, the inspection unit 130 is a part of the packaging sheet 120. In the present embodiment, the inspection unit 130 may be a part of the first sheet part 121. Before opening (packaged state), the inspection unit 130 may be arranged on a surface of the first sheet portion 121 that is not exposed.
  • the reaction section 140 may be arranged so as to be sandwiched between the packaging sheet 120 (that is, the first sheet portion 121 and the second sheet portion 122) before opening. Thereby, the indicator can be prevented from attaching to the absorbent article 110, and the safety of the wearer can be enhanced.
  • the inspection unit 130 is a part of the wrapping sheet 120 (the first sheet portion 121 in the present embodiment)
  • an indicator for displaying the health condition of the wearer may be applied to the wrapping sheet 120.
  • the packaging sheet 120 may be impregnated with a solution constituting the indicator.
  • FIG. 17 is a perspective view of a package 100 according to the eleventh embodiment.
  • FIG. 17 shows a state where the package 100 is opened. The description of the same parts as those in the above embodiments will be omitted.
  • perforations 125 for forming a part of the packaging sheet 120 as the inspection unit 130 may be formed on the packaging sheet 120.
  • the wearer may be able to acquire the inspection unit 130 by cutting the perforations 125.
  • the reaction section 140 may be arranged so as not to face the absorbent article 110 but to face the packaging sheet 120.
  • the inspection unit 130 may be a part of the second sheet part 122. Before opening (packaged state), the inspection unit 130 may be arranged on a surface of the second sheet portion 122 that is not exposed. The inspection unit 130 may be arranged so as to face the unexposed surface of the first sheet portion 121 before opening. Thereby, the indicator can be prevented from attaching to the absorbent article 110, and the safety of the wearer can be enhanced.
  • the package 100 has a lead tape, but the package 100 does not have to have a lead tape.
  • the end of the first sheet portion 121 in the longitudinal direction X including the first edge 121e may be joined by, for example, an adhesive or heat sealing. Thereby, the opening of the package 100 may be sealed.
  • the first back side member 62 may be a sheet (hydrophilic sheet) having a higher hydrophilicity or fiber density than the first front side member 42, but is not limited thereto.
  • the first back side member 62 may be higher in hydrophilicity or fiber density than all the liquid permeable sheets of the front side member 40.
  • the first back side member 62 is a sheet (hydrophilic sheet) having higher hydrophilicity or fiber density than the first front side member 42, all the sheets constituting the front side member 40 are liquid permeable sheets. It may be. Excretion is more likely to reach the back side member 60 by diffusion than in the case where the front side member 40 includes a liquid impermeable sheet. The excrement that has reached the back side member 60 can diffuse through the first back side member 62 and reach the contact portion 22. Therefore, it is possible to further suppress the deterioration of the touch of the wearer and the damage to the skin due to the indicator while shortening the inspection time and improving the inspection accuracy.
  • the front side member 40 may have the second opening 452 penetrating the front side member 40. Thereby, the excrement can be more easily reached the contact portion 22 by the openings 45 (the first opening 451 and the second opening 452) without exposing the inspection member 20.
  • the first surface-side member 42 is configured by one or two sheets, but is not limited thereto.
  • the first surface side member 42 may be configured by three or more sheets.
  • the first front-side member 42 has three layers in which the liquid-impermeable sheet (second front-side member) is sandwiched in the thickness direction T by two liquid-permeable sheets (first and third front-side members). Sheet.
  • excrement is diffused in the liquid-permeable sheet (third surface-side member) disposed on the non-skin side with respect to the liquid-impermeable sheet (second surface-side member). The excrement easily comes into contact also from the skin surface side T1 of the inspection member 20.
  • the liquid impermeable sheet allows the excrement (target component) required for the examination to reach the contact portion 22 in a short time while suppressing damage to the wearer's skin due to the indicator contained in the excrement.
  • the front-side member 40 includes a liquid-impermeable sheet
  • at least the liquid-impermeable sheet has an opening for moving excreta to the non-skin side T2 than the liquid-impermeable sheet. Is formed.
  • the back side member 60 may be configured by three or more sheets.
  • the back side member 60 includes a hydrophilic sheet having a higher hydrophilicity or fiber density than the liquid-permeable sheet included in the front side member, the hydrophilic sheet may not be disposed on the inspection member 20. . That is, the hydrophilic sheet does not need to contact the inspection member 20.
  • a liquid permeable sheet may be disposed between the hydrophilic sheet and the inspection member 20 in the thickness direction T. The hydrophilic sheet may make it difficult for the excrement to return to the front side member 40 by drawing the excrement through the liquid permeable sheet.
  • the back side member 60 when the front side member 40 is peeled off from the back side member 60, the back side member 60 may be fixed and the front side member 40 may be peeled off from the back side member 60.
  • the front side member 40 may be fixed and the back side member 60 may be peeled from the front side member 40.
  • the front side member 40 can be separated from the back side member 60.
  • the inspection member 20 has a linear plate shape.
  • the inspection member 20 may have, for example, one or more folds. Therefore, the inspection member 20 may have, for example, a two-fold or three-fold shape.
  • the inspection member 20 may be configured by a member folded into a Z shape. Thereby, the inspection member 20 can be arranged inside the absorbent article 1 in a compact state. Since the area of the inspection member 20 is reduced, deterioration of the touch of the wearer due to the inspection member 20 can be easily suppressed.
  • the inspection member 20 may be arranged in a state where the contact portion 22 is folded so as to contact at least one of the front surface member 40 and the rear surface member 60. This makes it easier for the excrement to reach the contact portion 22 even when the inspection member 20 is folded.
  • the inspection member 20 may be disposed in a state where the display unit 22 is folded such that the display unit 22 contacts at least one of the front surface member 40 and the rear surface member 60.
  • the wearer can visually recognize the display unit 22 as soon as the front-side member 40 is peeled off. Thereby, the wearer can easily check the health condition.
  • the inspection member 20 may be configured by a tape member for a post-processing tape having an adhesive portion having the contact portion 22 and the display portion 24.
  • the used absorbent article 1 may be fixed in a rounded state so that the skin contact surface is not exposed by the adhesive portion of the inspection member 20 as the tape member for the post-treatment tape.
  • the wearer can use the inspection member 20 as a tape member for a post-processing tape after inspecting the health condition, and can effectively utilize the inspection member 20.
  • the tape member for the post-processing tape may have a shape folded into a Z shape as described above.
  • the wearer may acquire the examination information by sending color information (image information and / or video information) indicating the color of the display unit 24 to the network (management server). For example, after the wearer peels off the front-side member 40 from the back-side member 60, the wearer (user) presents the exposed display unit 24 by, for example, photographing the display unit 24 with a camera built in a communication device owned by the wearer (user). Color information may be acquired. The wearer can send the color information to the management server via the communication device. The wearer may send user information indicating the wearer's information together with the coloration information.
  • color information image information and / or video information
  • the user information is, for example, at least one of a user identifier, a communication device identifier, information indicating the type of excrement, information indicating the type of the absorbent article 1 (the inspection member 20), information specifying the target component, and the like. is there.
  • the wearer may house the absorbent article 1 including the inspection member 20 or the inspection member 20 itself in an accommodation device capable of detecting a color reaction by the indicator.
  • the storage device may irradiate the display unit 24 with visible light in order to detect a color reaction.
  • the storage device irradiates special light having a special wavelength different from visible light (for example, ultraviolet light having a shorter wavelength than visible light) to the inspection member 20 that can confirm coloration by the indicator by applying the special light.
  • Light having a wavelength may be applied to the display unit 24.
  • the accommodation device may acquire color information by photographing while irradiating visible light or special light in the accommodation device. As described above, by photographing the display unit 24 while irradiating light in the storage device, it is possible to accurately confirm the coloration without being affected by the surrounding environment.
  • the accommodation device may send the color information acquired by photographing the display unit 24 to a network (management server).
  • the accommodation device may include the identifier of the accommodation device as the user information.
  • the housing device may send the acquired color information to the communication device owned by the wearer.
  • the wearer may determine the presence or absence of coloration by displaying the display unit 24 on the communication device. Thereby, the wearer can check the health condition more accurately.
  • the wearer may send the color information acquired from the housing device to the network via the communication device, as described above.
  • the management server can determine the health condition of the wearer (user) based on the coloration information (and the user information).
  • the management server may transmit the information indicating the determination result to the communication device that is the source of the color information.
  • the management server may transmit the advice information indicating the advice based on the determination result to the communication device together with the determination information indicating the determination result. Even when the management server receives the color information from the accommodation device, the management server determines the associated communication device based on the identifier (user identifier) of the communication device associated with the accommodation device identifier (ie, The determination information (and the advice information) may be transmitted to a communication device owned by the user.
  • the communication device may display the determination result based on the determination information received by the communication device. Thereby, the wearer can grasp the health condition based on the displayed determination result. The wearer can obtain an objective determination result, not based on the wearer's own determination.
  • the communication device may display the advice. Thereby, the wearer can grasp the advice.
  • the communication device has a program for executing the above-described various processes.
  • the communication device has a memory for storing a program and a processor for executing the program stored in the memory.
  • the program may be obtainable from a network (for example, a management server).
  • the absorbent article 1 is a sanitary napkin, but is not limited thereto.
  • the absorbent article 1 may be a tape-type or pants-type disposable diaper, for example.
  • the inspection member 20 is disposed so as to straddle the rear side area S2 and the central area S3.
  • the inspection member 20 may be arranged only in one of the front area S1, the rear area S2, and the central area S3. Thereby, the deterioration of the touch of the wearer may be suppressed by reducing the region where the inspection member 20 is arranged.
  • the central region S3 may be a region where a leg opening is provided around the wearer's leg.
  • the leg opening is a portion that is recessed inward in the width direction from the outer edge of the absorbent article toward the inside in the width direction.
  • the central region S3 may be a region in which a portion that is recessed inward in the width direction from the outer edge of the absorbent core is provided toward the inside in the width direction.
  • the central region S3 may be a region where the middle and high portions, which are regions thicker than the surrounding absorbent cores, are arranged.
  • the central area S3 may be an area where the wing is provided.
  • reaction part 140 (the contact part 142 and / or the display part 144) is covered with the water-repellent part 150, but is not limited thereto.
  • the reaction section 140 may be any member that can suppress the wearer's finger from touching the contact section 142 or the indicator, for example, and may be covered with another member that does not have water repellency. Good.
  • the inspection unit 130 has a function as a lead tape, but is not limited to this.
  • the inspection unit 130 may be different from a lead tape.
  • the inspection unit 130 may be arranged so as not to straddle the first edge 121e of the packaging sheet 120 (that is, the first sheet portion 121).
  • the inspection unit 130 may be arranged (fixed) only on the first sheet portion 121 exposed on one side of the packaging sheet 120 in the thickness direction Z. Thereby, the wearer can easily grasp the inspection unit 130 before opening the package 100.
  • the inspection unit 130 exposes the first sheet portion 121 in the packaged state, as in the tenth embodiment. It may be placed (fixed) on a surface that does not. As in the eleventh embodiment, in the packaged state, the inspection unit 130 is arranged (fixed) on the unexposed surface of the second sheet portion 122 so as to face the unexposed surface of the first sheet portion 121. May be. This makes it difficult for the indicator to touch other things before the test, and makes it difficult for the indicator to adhere to other things. Therefore, the safety of the wearer can be improved. In addition, the inspection unit 130 is also less likely to be stained, and the inspection accuracy can be improved.
  • the inspection unit 130 has a linear plate shape.
  • the inspection unit 130 may have, for example, one or more folds. Therefore, the inspection unit 130 may have, for example, a two-fold or three-fold shape.
  • the inspection unit 130 may be configured by a member folded in a Z shape. Thereby, the inspection unit 130 can be fixed to the packaging sheet 120 in a compact state.
  • the inspection unit 130 may be fixed to the packaging sheet 120 in a state where the inspection unit 130 is folded so that the reaction unit 140 is not exposed. Thereby, it is possible to suppress the thing other than the excrement E from touching the contact portion 142 before use, and it is possible to improve the inspection accuracy.
  • the inspection member When the inspection member is folded, the folded inspection member can be extended (spread) before use. Thereby, the inspection unit 130 can be brought into contact with the excrement E while the position where the wearer grips the inspection unit 130 is kept away from the excrement E. The excrement E hardly adheres to the wearer, and the wearer can hygienically inspect the health condition.
  • the inspection unit 130 may be configured by a tape member for a post-processing tape having an adhesive unit having the reaction unit 140.
  • the used absorbent article may be fixed in a rounded state so that the skin contact surface is not exposed by the adhesive portion of the inspection unit 130 as a tape member for the post-treatment tape.
  • the inspection unit 130 By using the inspection unit 130 as the tape member, the absorbent article can be sanitarily disposed. In this manner, the wearer can use the inspection unit 130 as a tape member for a post-processing tape after inspecting the health condition, and the inspection unit 130 can be effectively used.
  • the tape member for the post-processing tape may have a shape folded into a Z shape as described above.
  • the wearer may acquire the test information by sending color information (image information and / or video information) indicating the color of the display unit 144 to the network (management server).
  • the wearer presents the inspection unit 130 (display unit 144) colored by attaching to the excrement E by, for example, photographing with a camera built in a communication device owned by the wearer (user).
  • Color information may be acquired.
  • the wearer can send the color information to the management server via the communication device.
  • the wearer may send user information indicating the wearer's information together with the coloration information.
  • the user information is, for example, at least one of an identifier of the user, an identifier of the communication device, information indicating the type of excrement, information indicating the type of the absorbent article 110 (inspection unit 130), information specifying the target component, and the like. is there.
  • the wearer may house the inspection unit 130 in a housing device capable of detecting a color reaction by the indicator.
  • the storage device may irradiate the display unit 144 with visible light to detect a color reaction.
  • the storage device irradiates special light having a special wavelength different from visible light (for example, ultraviolet light having a shorter wavelength than visible light) to the inspection unit 130 that can confirm coloring by the indicator.
  • the display 144 may be irradiated with light having a wavelength.
  • the accommodation device may acquire color information by photographing while irradiating visible light or special light in the accommodation device. As described above, by photographing the display unit 144 while irradiating light in the storage device, it is possible to accurately confirm coloration without being affected by the surrounding environment.
  • the accommodation device may send the color information acquired by photographing the display unit 144 to the network (management server).
  • the accommodation device may include the identifier of the accommodation device as the user information.
  • the housing device may send the acquired color information to the communication device owned by the wearer.
  • the wearer may determine the presence or absence of color by displaying the display unit 144 indicated by the color information on the communication device. Thereby, the wearer can check the health condition more accurately.
  • the wearer may send the color information acquired from the housing device to the network via the communication device, as described above.
  • the management server can determine the health condition of the wearer (user) based on the coloration information (and the user information).
  • the management server may transmit the information indicating the determination result to the communication device that is the source of the color information.
  • the management server may transmit the advice information indicating the advice based on the determination result to the communication device together with the determination information indicating the determination result. Even when the management server receives the color information from the accommodation device, the management server determines the associated communication device based on the identifier (user identifier) of the communication device associated with the accommodation device identifier (ie, The determination information (and the advice information) may be transmitted to a communication device owned by the user.
  • the communication device may display the determination result based on the determination information received by the communication device. Thereby, the wearer can grasp the health condition based on the displayed determination result. The wearer can obtain an objective determination result, not based on the wearer's own determination.
  • the communication device may display the advice. Thereby, the wearer can grasp the advice.
  • the communication device has a program for executing the above-described various processes.
  • the communication device has a memory for storing a program and a processor for executing the program stored in the memory.
  • the program may be obtainable from a network (for example, a management server).

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

An absorbent article 1 comprises: an inspection member 20 for inspecting the state of health of the wearer; a front surface-side member 40 that includes at least a liquid-permeable top sheet, and that is disposed more on a skin surface side T1 than the inspection member 20; and a rear surface-side member 60 that includes at least a liquid-impermeable back sheet, and that is disposed more on the skin surface side T1 than the inspection member 20. The inspection member 20 has a contact section 22 that is brought into contact with excrement which has passed through the front surface-side member 40, and a display section 24 that displays, via an indicator, the state of health of the wearer in accordance with a target component contained in the excrement. The front surface-side member 40 covers at least a portion of the display section 24. The front surface-side member 40 can be peeled off from the rear surface-side member 60 so that the display section 24 is visually recognizable.

Description

吸収性物品、及び包装体Absorbent articles and packages
 本発明は、吸収性物品、及び包装体に関する。 The present invention relates to an absorbent article and a package.
 特許文献1の図1には、着用者の健康状態を検査するための検査部材を有する吸収性物品が開示されている。検査部材は、吸収性物品の肌面側に配置されているセンサを有する。センサが排泄物に含まれる対象成分を検出することで、着用者の健康状態を確認することができる。 図 FIG. 1 of Patent Document 1 discloses an absorbent article having an inspection member for inspecting a wearer's health condition. The inspection member has a sensor arranged on the skin side of the absorbent article. By detecting the target component contained in the excrement by the sensor, the health condition of the wearer can be confirmed.
特表2003-517584号公報JP-T-2003-517584
 特許文献1に開示された吸収性物品では、センサが肌面側で露出している。このため、吸収性物品の着用時に、センサが着用者の肌に直接触れてしまうため、吸収性物品に対する着用者の肌触りが悪化するおそれがある。また、センサは、対象成分を検出するための指示薬を含んでいる。従って、吸収性物品の着用時に、センサに含まれる指示薬が着用者の肌に触れるため、指示薬により着用者の肌がダメージを受ける虞がある。 で は In the absorbent article disclosed in Patent Document 1, the sensor is exposed on the skin side. For this reason, when the absorbent article is worn, the sensor directly touches the wearer's skin, so that the wearer's feel to the absorbent article may be deteriorated. Further, the sensor includes an indicator for detecting the target component. Therefore, when the absorbent article is worn, the indicator contained in the sensor touches the wearer's skin, and the indicator may damage the wearer's skin.
 そこで、本発明は、上述した課題を解決するためになされたものであり、着用者の肌触りの悪化を抑制し易く、かつ指示薬による肌へのダメージを抑制し易い吸収性物品、及び包装体を提供する。 Therefore, the present invention has been made in order to solve the above-described problems, and it is an object of the present invention to provide an absorbent article and a package that are easy to suppress deterioration of the touch of a wearer and that are easy to suppress damage to the skin by an indicator. provide.
 本開示に係る吸収性物品は、着用者の健康状態を検査するための検査部材と、液透過性のトップシートを少なくとも含み、かつ前記検査部材よりも肌面側に配置されている表面側部材と、液不透過性のバックシートを少なくとも含み、かつ前記検査部材よりも肌面側に配置されている裏面側部材と、を備える。前記検査部材は、前記表面側部材を通過した排泄物を接触させる接触部と、前記排泄物に含まれる対象成分に応じて前記着用者の健康状態を指示薬により表示する表示部と、を有する。前記表面側部材は、前記表示部の少なくとも一部を覆っている。前記表面側部材は、前記表示部が視認可能になるように前記裏面側部材から剥離可能である。 The absorbent article according to the present disclosure is a surface-side member that includes at least a test member for testing a wearer's health condition and a liquid-permeable top sheet, and that is disposed closer to the skin than the test member. And a back-side member that includes at least a liquid-impermeable back sheet and is disposed closer to the skin than the inspection member. The inspection member has a contact portion that contacts the excrement that has passed through the surface-side member, and a display portion that displays the wearer's health condition using an indicator according to a target component included in the excrement. The front side member covers at least a part of the display unit. The front side member is peelable from the back side member so that the display unit can be visually recognized.
 本開示に係る包装体は、吸収性物品と、前記吸収性物品を個別に包装する包装シートと、着用者の健康状態を検査するための検査部と、を有する。前記検査部は、着用者の排泄物に含まれる対象成分に応じて前記着用者の健康状態を表示する。前記検査部は、前記包装シートと固定されている又は前記包装シートの一部である。 The package according to the present disclosure includes an absorbent article, a packaging sheet for individually packaging the absorbent article, and an inspection unit for inspecting a wearer's health condition. The inspection unit displays a health condition of the wearer according to a target component included in the excrement of the wearer. The inspection unit is fixed to the packaging sheet or is a part of the packaging sheet.
第1実施形態に係る吸収性物品を肌面側から見た平面図である。It is the top view which looked at the absorptive article concerning a 1st embodiment from the skin side. 図1に示すF2-F2線に沿った断面図である。FIG. 2 is a sectional view taken along line F2-F2 shown in FIG. 第1実施形態に係る吸収性物品を肌面側から見た平面図である。It is the top view which looked at the absorptive article concerning a 1st embodiment from the skin side. 第2実施形態に係る吸収性物品の断面図である。It is sectional drawing of the absorbent article which concerns on 2nd Embodiment. 第3実施形態に係る吸収性物品の断面図である。It is sectional drawing of the absorbent article which concerns on 3rd Embodiment. 第4実施形態に係る包装体の斜視図である。It is a perspective view of a package concerning a 4th embodiment. 第4実施形態に係る検査部の拡大斜視図である。It is an expansion perspective view of an inspection part concerning a 4th embodiment. 図7に示すF8-F8線に沿った断面図である。FIG. 8 is a sectional view taken along line F8-F8 shown in FIG. 7. 第5実施形態に係る検査部の拡大斜視図である。It is an expansion perspective view of an inspection part concerning a 5th embodiment. 第5実施形態に係る検査部の使用状態を説明するための断面図である。It is sectional drawing for demonstrating the use condition of the test | inspection part which concerns on 5th Embodiment. 第6実施形態に係る検査部の使用状態を説明するための図である。It is a figure for explaining the use state of the inspection part concerning a 6th embodiment. 第7実施形態に係る検査部の斜視図である。It is a perspective view of an inspection part concerning a 7th embodiment. 図12に示すF13-F13線に沿った断面図である。FIG. 13 is a sectional view taken along line F13-F13 shown in FIG. 第8実施形態に係る検査部の斜視図である。It is a perspective view of an inspection part concerning an 8th embodiment. 第9実施形態に係る検査部の斜視図である。It is a perspective view of an inspection part concerning a 9th embodiment. 第10実施形態に係る包装体の斜視図である。It is a perspective view of the package concerning a 10th embodiment. 第11実施形態に係る包装体の斜視図である。It is a perspective view of a package concerning an eleventh embodiment.
 (1)実施形態の概要
 本明細書及び添付図面の記載により、少なくとも以下の事項が明らかとなる。
(1) Outline of Embodiment At least the following matters will be apparent from the description of the present specification and the accompanying drawings.
 一態様に係る吸収性物品は、着用者の健康状態を検査するための検査部材と、液透過性のトップシートを少なくとも含み、かつ前記検査部材よりも肌面側に配置されている表面側部材と、液不透過性のバックシートを少なくとも含み、かつ前記検査部材よりも肌面側に配置されている裏面側部材と、を備える。前記検査部材は、前記表面側部材を通過した排泄物を接触させる接触部と、前記排泄物に含まれる対象成分に応じて前記着用者の健康状態を指示薬により表示する表示部と、を有する。前記表面側部材は、前記表示部の少なくとも一部を覆っている。前記表面側部材は、前記表示部が視認可能になるように前記裏面側部材から剥離可能である。 An absorbent article according to one aspect is a surface-side member that includes at least a test member for testing a wearer's health condition and a liquid-permeable top sheet, and that is disposed closer to the skin than the test member. And a back-side member that includes at least a liquid-impermeable back sheet and is disposed closer to the skin than the inspection member. The inspection member has a contact portion that contacts the excrement that has passed through the surface-side member, and a display portion that displays the wearer's health condition using an indicator according to a target component included in the excrement. The front side member covers at least a part of the display unit. The front side member is peelable from the back side member so that the display unit can be visually recognized.
 本態様によれば、吸収性物品が着用されている場合、着用者の排泄物は、表面側部材を通じて検査部材に到達し、検査部材(表示部)には、排泄物に含まれる対象成分に応じて着用者の健康状態が表示される。表面側部材が表示部の少なくとも一部を覆っているため、着用者は、吸収性物品を身体から外した後に、表面側部材を裏面側部材から剥離することで、表示部が露出するため、表示部を視認し易くなる。着用者は、露出した表示部を視認することで、健康状態を確認することができる。また、表面側部材は、前記検査部材よりも肌面側に配置されており、かつ着用者の健康状態を指示薬により表示する表示部の少なくとも一部を覆っている。これにより、着用者の肌に表面側部材(トップシート)が直接触れ易くなり、表示部に含まれる指示薬が肌に触れ難くなる。従って、吸収性物品が検査部材を備えていても、着用者の肌触りの悪化を抑制し易く、かつ指示薬による肌へのダメージを抑制し易くすることができる。 According to this aspect, when the absorbent article is worn, the excrement of the wearer reaches the inspection member through the surface-side member, and the inspection member (display unit) displays the target component contained in the excrement. The wearer's health condition is displayed accordingly. Because the front-side member covers at least a part of the display unit, the wearer removes the absorbent article from the body, and then peels off the front-side member from the back-side member to expose the display unit. The display unit is easily visible. The wearer can confirm the health condition by visually recognizing the exposed display unit. The front-side member is disposed closer to the skin than the inspection member, and covers at least a part of a display unit that displays the health condition of the wearer with an indicator. This makes it easier for the front-side member (top sheet) to directly touch the wearer's skin, making it difficult for the indicator contained in the display unit to touch the skin. Therefore, even if the absorbent article is provided with the inspection member, it is easy to suppress deterioration of the touch of the wearer, and to easily suppress damage to the skin by the indicator.
 好ましい一態様によれば、前記表面側部材には、厚さ方向において前記接触部と重なる開孔が形成されている。排泄物が、表面側部材を構成する繊維等の隙間を通り抜けて接触部へ到達する場合、排泄物が開孔を通る場合と比べて、検査に必要な量の排泄物が接触部へ到達するまでに時間がかかったり、一部の排泄物が接触部へ到達できないことがある。そこで、表面側部材に接触部と重なる開孔を形成することで、排泄物が開孔を通ると接触部にすぐに到達するため、検査に必要な量の排泄物が素早く到達しやすくなる。短時間で検査に必要な排泄物を接触部に到達させることができ、検査時間を短縮しつつ、検査精度を向上できる。 According to a preferred aspect, an opening is formed in the front surface member so as to overlap the contact portion in a thickness direction. When the excrement passes through the gap of the fiber or the like constituting the surface side member and reaches the contact portion, the amount of excrement required for the inspection reaches the contact portion as compared with the case where the excrement passes through the opening. May take some time, or some excrement may not reach the contact area. Therefore, by forming an opening that overlaps with the contact portion on the surface side member, the excrement immediately reaches the contact portion when passing through the opening, so that the amount of excrement required for the inspection easily reaches quickly. The excrement required for the examination can reach the contact portion in a short time, and the examination accuracy can be improved while shortening the examination time.
 好ましい一態様によれば、前記表面側部材は、前記トップシートを含む複数のシートにより構成される。前記開孔は、前記複数のシートのうち一部のシートにのみ形成されている。複数のシートのうち、残りのシートが開孔(及び接触部)を覆っているため、検査部材が露出しない。これにより、検査精度を向上させつつも、検査部材が着用者の肌に触れることを確実に抑制できる。 According to a preferred embodiment, the front-side member is constituted by a plurality of sheets including the top sheet. The opening is formed only in some of the plurality of sheets. Since the remaining sheet covers the opening (and the contact portion) among the plurality of sheets, the inspection member is not exposed. Thus, it is possible to reliably prevent the inspection member from touching the wearer's skin while improving the inspection accuracy.
 好ましい一態様によれば、前記接触部と前記表示部とは、異なる位置に配置されている。前記表示部は、前記厚さ方向において前記開孔と重ならない。対象成分に応じて反応する指示薬を含む表示部が開孔と重ならないことで、着用者の肌に表示部が直接接触しないため、指示薬による肌へのダメージを抑制できる。 According to a preferred aspect, the contact section and the display section are arranged at different positions. The display unit does not overlap the opening in the thickness direction. Since the display unit containing the indicator reacting according to the target component does not overlap with the opening, the display unit does not directly contact the wearer's skin, so that damage to the skin due to the indicator can be suppressed.
 好ましい一態様によれば、前記表面側部材は、前記トップシートよりも非肌面側に配置される液不透過性シートを含む。前記開孔は、少なくとも前記液不透過性シートに形成されている。表面側部材が液不透過性シートを有していても、排泄物は、開孔を通じて液不透過性シートを通過することができる。これにより、検査部材に排泄物を到達させることができ、着用者の健康状態を表示部に表示できる。一方で、検査部材に到達した排泄物には、検査部材に含まれる指示薬が溶解する可能性がある。液不透過性シートは、開孔を除いて、排泄物を通過させないため、排泄物がトップシートへ戻ることを抑制できる。このため、排泄物に含まれる指示薬による着用者の肌へのダメージを抑制できる。 According to a preferred embodiment, the front-side member includes a liquid-impermeable sheet disposed on a non-skin side than the top sheet. The opening is formed at least in the liquid impermeable sheet. Even if the front side member has the liquid impermeable sheet, the excrement can pass through the liquid impermeable sheet through the opening. Thereby, the excrement can reach the inspection member, and the health condition of the wearer can be displayed on the display unit. On the other hand, the indicator contained in the inspection member may be dissolved in the excrement reaching the inspection member. Since the liquid impermeable sheet does not allow excrement to pass through except for the opening, the excrement can be prevented from returning to the top sheet. Therefore, damage to the wearer's skin due to the indicator contained in the excrement can be suppressed.
 好ましい一態様によれば、前記開孔は、前記表面側部材を貫通する貫通孔である。排泄物が、表面側部材を構成する繊維の隙間を通り抜けて接触部へ到達する場合、排泄物が開孔を通る場合と比べて、検査に必要な量の排泄物が接触部へ到達するまでに時間がかかったり、一部の排泄物が接触部へ到達できないことがある。そこで、表面側部材に貫通孔が形成されているため、排泄物が貫通孔を通り、接触部にすぐに到達できるため、検査に必要な量の排泄物が素早く到達しやすくなる。短時間で検査に必要な排泄物を接触部に到達させることができ、検査精度を向上できる。 According to a preferred embodiment, the opening is a through-hole that penetrates the surface-side member. When the excrement reaches the contact portion through the gap between the fibers constituting the surface-side member, compared to when the excrement passes through the opening, the amount of excrement required for the test reaches the contact portion. May take a long time or some excrement may not reach the contact part. Therefore, since the through-hole is formed in the front surface side member, the excrement can pass through the through-hole and immediately reach the contact portion, so that the amount of excrement necessary for the inspection can easily reach quickly. The excrement required for the inspection can reach the contact portion in a short time, and the inspection accuracy can be improved.
 好ましい一態様によれば、前記裏面側部材は、前記表面側部材に含まれる液透過性シートよりも親水性又は繊維密度が高い親水性シートを含む。前記検査部材は、前記親水性シート上に配置されている。表面側部材に含まれる液透過性シートよりも裏面側部材に配置されている液透過性シートの方が親水性又は繊維密度が高いため、排泄物がトップシートへ戻ることを抑制できる。このため、排泄物に含まれる指示薬による着用者の肌への影響を抑制できる。 According to a preferred embodiment, the back side member includes a hydrophilic sheet having a higher hydrophilicity or a higher fiber density than the liquid-permeable sheet included in the front side member. The inspection member is disposed on the hydrophilic sheet. Since the liquid-permeable sheet disposed on the back-side member has a higher hydrophilicity or fiber density than the liquid-permeable sheet included in the front-side member, the excrement can be prevented from returning to the top sheet. For this reason, the influence of the indicator contained in the excrement on the wearer's skin can be suppressed.
 一態様に係る包装体は、吸収性物品と、前記吸収性物品を個別に包装する包装シートと、着用者の健康状態を検査するための検査部と、を有する。前記検査部は、着用者の排泄物に含まれる対象成分に応じて前記着用者の健康状態を表示する。前記検査部は、前記包装シートと固定されている又は前記包装シートの一部である。 包装 A package according to one aspect includes an absorbent article, a packaging sheet for individually packaging the absorbent article, and an inspection unit for inspecting a wearer's health condition. The inspection unit displays a health condition of the wearer according to a target component included in the excrement of the wearer. The inspection unit is fixed to the packaging sheet or is a part of the packaging sheet.
 本態様によれば、検査部は、吸収性物品と別部材であるため、吸収性物品の着用時に、指示薬により着用者の肌がダメージを受けることがない。 According to this aspect, since the inspection unit is a separate member from the absorbent article, the wearer's skin is not damaged by the indicator when the absorbent article is worn.
 なお、着用者が、検査部材が取り付けられていない吸収性物品を着用し、当該吸収性物品を交換する際に、吸収性物品が付着した排泄物に対して検査部材を用いることが想定される。しかしながら、この場合には、着用者が検査部材を常に携帯しなければならないため、特に外出先では、着用者が健康状態を手軽に検査できないおそれがある。そこで、着用者が手軽に健康状態を検査できる包装体が望まれている。 In addition, when the wearer wears the absorbent article to which the inspection member is not attached and replaces the absorbent article, it is assumed that the inspection member is used for the excrement to which the absorbent article is attached. . However, in this case, since the wearer must always carry the inspection member, there is a possibility that the wearer may not be able to easily check the health condition, especially when going out. Therefore, a package that allows the wearer to easily check the health condition is desired.
 本態様によれば、着用者は、接触部が配置されている面と反対側の包装シートの面から排泄物へ、検査部(接触部)を接触させることにより、排泄物及び接触部に触れることなく、接触部へ排泄物を接触させることができる。このため、着用者は、衛生的に健康状態を検査することができる。 According to this aspect, the wearer contacts the excrement and the contact portion by bringing the inspection section (contact portion) into contact with the excrement from the surface of the packaging sheet opposite to the surface on which the contact portion is arranged. Without this, the excrement can be brought into contact with the contact portion. For this reason, a wearer can inspect a health condition hygienically.
 好ましい一態様によれば、前記検査部は、前記健康状態を表示させるために前記排泄物を接触させる接触部を有する。前記接触部は、前記包装シートと厚さ方向で重なっている。着用者は、接触部が配置されている面と反対側の包装シートの面から排泄物へ、検査部(接触部)を接触させることにより、排泄物及び接触部に触れることなく、接触部へ排泄物を接触させることができる。このため、着用者は、衛生的に健康状態を検査することができる。 According to a preferred aspect, the inspection unit has a contact unit that contacts the excrement to display the health condition. The contact portion overlaps the packaging sheet in a thickness direction. The wearer contacts the excrement from the surface of the packaging sheet opposite to the surface on which the contact portion is disposed, and contacts the inspection portion (contact portion), so that the excrement and the contact portion are not contacted. Excrement can be brought into contact. For this reason, a wearer can inspect a health condition hygienically.
 好ましい一態様によれば、前記検査部は、前記健康状態を表示させるために前記排泄物を接触させる接触部を有する。前記検査部は、前記包装シートの端縁を跨ぐように配置されている。前記検査部は、前記包装体が開封された状態において前記包装シートの外側へ前記端縁から延出する延出部を有する。前記接触部は、前記延出部に配置されている。延出部は包装シートの外側へ延出しているため、着用者は、包装シートを把持した状態で、延出部に配置されている接触部を排泄物に接触させることで、排泄物からある程度の距離を保つことができる。このため、着用者は、排泄物及び接触部に触れることなく、接触部へ排泄物を接触させることができる。従って、着用者は、衛生的に健康状態を検査することができる。 According to a preferred aspect, the inspection unit has a contact unit that contacts the excrement to display the health condition. The inspection unit is disposed so as to straddle an edge of the packaging sheet. The inspection unit has an extension that extends from the edge to the outside of the packaging sheet when the packaging body is opened. The contact part is arranged on the extension part. Since the extension portion extends to the outside of the packaging sheet, the wearer grips the packaging sheet and contacts the contact portion arranged on the extension portion with the excrement, so that the wearer has some Can keep the distance. Therefore, the wearer can make the excrement contact the contact portion without touching the excrement and the contact portion. Therefore, the wearer can inspect the health condition hygienically.
 好ましい一態様によれば、前記検査部は、前記包装体を開封するために前記包装シートから剥がされるリードテープである。リードテープを検査部として用いるため、検査部として新たな部材を包装体へ追加せずにすむ。 According to a preferred aspect, the inspection section is a lead tape that is peeled off from the packaging sheet to open the packaging body. Since the lead tape is used as the inspection unit, it is not necessary to add a new member to the package as the inspection unit.
 好ましい一態様によれば、前記検査部は、指示薬を含み、かつ前記排泄物に含まれる対象成分に応じて前記着用者の健康状態を前記指示薬により表示する表示部を有する。前記表示部の少なくとも一部は、撥水性を有する撥水部に覆われている。着用者が表示部を触ったとしても、撥水性を有する撥水部に覆われている部分に触れることで、着用者が、指示薬に直接触れることを抑制できる。これにより、指示薬が肌にダメージを与え得るものであっても、着用者の安全性を高めることができる。 According to a preferred aspect, the inspection unit includes a display unit that includes an indicator and displays the health condition of the wearer with the indicator according to a target component included in the excrement. At least a part of the display section is covered with a water-repellent section having water repellency. Even if the wearer touches the display section, the wearer can be prevented from directly touching the indicator by touching the portion covered with the water repellent section having water repellency. Thereby, even if the indicator can damage the skin, the safety of the wearer can be improved.
 好ましい一態様によれば、前記表示部が前記撥水部に覆われている状態で、前記健康状態を示す前記指示薬による呈色を視認可能である。表示部が撥水部に覆われていても、着用者は、指示薬による呈色を視認可能である。従って、着用者の安全性を高めつつ、表示部が示す健康状態を容易に把握することができる。 According to a preferred aspect, in a state where the display section is covered with the water-repellent section, coloration by the indicator indicating the health condition can be visually recognized. Even if the display section is covered with the water-repellent section, the wearer can visually recognize the coloring by the indicator. Therefore, the health condition indicated by the display unit can be easily grasped while enhancing the safety of the wearer.
 好ましい一態様によれば、前記検査部は、前記健康状態を表示させるために前記排泄物を接触させる接触部を有する。前記接触部の一部は、撥水性を有する撥水部に覆われている。着用者が、意図せずに接触部に触れそうになったとしても、撥水性を有する撥水部に覆われている部分に触れることで、着用者の指などについた対象成分が、接触部に直接触れることを抑制できる。これにより、検査対象となる排泄物以外から、対称成分が接触部に触れることを抑制でき、検査精度を向上できる。 According to a preferred aspect, the inspection unit has a contact unit that contacts the excrement to display the health condition. Part of the contact portion is covered with a water-repellent portion having water repellency. Even if the wearer comes into contact with the contact part unintentionally, by touching the part covered with the water-repellent part having water repellency, the target component attached to the wearer's finger etc. Can be prevented from directly touching. Thereby, it is possible to suppress the contact of the symmetric component from the excrement other than the excrement to be inspected with the contact portion, and to improve the inspection accuracy.
 好ましい一態様によれば、前記検査部は、前記接触部が固定されている本体部を有する。前記接触部は、前記本体部に固定される第1面と、前記第1面と反対側の面である第2面と、前記第1面と前記第2面とをつなぐ第3面と、を有する。前記第2面は、前記撥水部により覆われており、前記第3面の少なくとも一部は、前記撥水部から露出している。
接触部の第2面は、本体部に固定される第1面と反対側の面であるため、本体部から露出している部分である。従って、接触部の第2面は、着用者が触れ易い部分である。着用者が触れ易い部分を撥水部で覆うことで、着用者が、接触部に触れることを抑制でき、検査精度を向上できる。一方で、第1面と第2面とをつなぐ第3面は、着用者が触れ難い部分である。着用者が触れ難い部分を撥水部から露出させることで、対象成分を接触部に触れさせることができ、検査を行うことができる。
According to a preferred aspect, the inspection section has a main body to which the contact section is fixed. A first surface fixed to the main body, a second surface opposite to the first surface, a third surface connecting the first surface and the second surface, Having. The second surface is covered with the water-repellent portion, and at least a part of the third surface is exposed from the water-repellent portion.
Since the second surface of the contact portion is a surface opposite to the first surface fixed to the main body, it is a portion exposed from the main body. Therefore, the second surface of the contact portion is a portion that the wearer can easily touch. By covering the part which the wearer easily touches with the water-repellent part, the wearer can be prevented from touching the contact part, and the inspection accuracy can be improved. On the other hand, the third surface connecting the first surface and the second surface is a portion that is difficult for the wearer to touch. By exposing a portion that is difficult for the wearer to touch from the water-repellent portion, the target component can be brought into contact with the contact portion, and an inspection can be performed.
 好ましい一態様によれば、前記検査部は、前記包装シートの一部である。前記包装シートは、前記健康状態を表示させるために前記排泄物を接触させる接触部と、前記排泄物に含まれる対象成分に応じて前記着用者の健康状態を表示する表示部と、を有する。前記接触部及び前記表示部は、前記包装体の開封前において露出しておらず、かつ、前記包装体の開封により露出する。接触部及び表示部は、包装体の開封前において露出しておらず、かつ包装体の開封により露出するため、接触部及び表示部が、検査前に他のものに接触することを抑制でき、検査精度を向上できる。 According to a preferred embodiment, the inspection section is a part of the packaging sheet. The wrapping sheet has a contact portion for contacting the excrement for displaying the health condition, and a display portion for displaying the health condition of the wearer in accordance with a target component contained in the excretion. The contact portion and the display portion are not exposed before opening the package, and are exposed when the package is opened. The contact portion and the display portion are not exposed before opening the package, and are exposed by opening the package, so that the contact portion and the display portion can be prevented from contacting other things before the inspection, Inspection accuracy can be improved.
 (2)吸収性物品の概略構成
 以下、図面を参照して、実施形態に係る吸収性物品の概略ついて説明する。吸収性物品は、生理用ナプキン、パンティライナー、失禁パッド、糞便パッドのような吸収性物品であってよい。吸収性物品は、下着のような着用物品の内側に取り付けられて使用される物品であってよい。本実施の形態の吸収性物品1は、生理用ナプキンである。
(2) Schematic Configuration of Absorbent Article Hereinafter, an outline of the absorbent article according to the embodiment will be described with reference to the drawings. The absorbent article may be an absorbent article such as a sanitary napkin, panty liner, incontinence pad, stool pad. The absorbent article may be an article used by being attached to the inside of a wearing article such as underwear. The absorbent article 1 of the present embodiment is a sanitary napkin.
 なお、以下の図面の記載において、同一又は類似の部分には、同一又は類似の符号を付している。ただし、図面は模式的なものであり、各寸法の比率等は現実のものとは異なる場合があることに留意すべきである。したがって、具体的な寸法等は、以下の説明を参酌して判断すべきである。また、図面相互間においても互いの寸法の関係や比率が異なる部分が含まれる場合がある。 In the following description of the drawings, the same or similar parts are denoted by the same or similar reference numerals. However, it should be noted that the drawings are schematic and ratios of dimensions may be different from actual ones. Therefore, specific dimensions and the like should be determined in consideration of the following description. Further, there may be a case in which parts having different dimensional relationships and ratios between drawings are included.
 図1は、第1実施形態に係る吸収性物品を肌面側から見た平面図である。図2は、図1に示すF2-F2線に沿った断面図である。図3は、第1実施形態に係る吸収性物品を肌面側から見た平面図である。 FIG. 1 is a plan view of the absorbent article according to the first embodiment as viewed from the skin side. FIG. 2 is a sectional view taken along line F2-F2 shown in FIG. FIG. 3 is a plan view of the absorbent article according to the first embodiment as viewed from the skin surface side.
 なお、「肌面側」は、着用中(使用中)に着用者の肌に面する側に相当する。「非肌面側」は、着用中(使用中)に着用者の肌とは反対に向けられる側に相当する。 The “skin side” corresponds to the side facing the wearer's skin during wearing (during use). The “non-skin side” corresponds to the side that is turned away from the wearer's skin during wearing (during use).
 図1及び図2に示すように、吸収性物品1は、前後方向L及び幅方向Wを有する。前後方向Lは、着用者の前側(腹側)から後側(背側)に延びる方向、又は着用者の後側から前側に延びる方向である。幅方向Wは、前後方向Lと直交する方向である。吸収性物品は、肌面側T1と非肌面側T2に延びる厚さ方向Tを有する。 As shown in FIGS. 1 and 2, the absorbent article 1 has a front-rear direction L and a width direction W. The front-rear direction L is a direction extending from the front side (abdominal side) to the rear side (back side) of the wearer, or a direction extending from the rear side of the wearer to the front side. The width direction W is a direction orthogonal to the front-rear direction L. The absorbent article has a thickness direction T extending to the skin surface side T1 and the non-skin surface side T2.
 吸収性物品1は、中央域S3、前側域S1及び後側域S2を有する。中央域S3は、着用者の排泄口(例えば膣口)に当接する排泄口当接部を有する領域である。吸収性物品が下着に装着されたときに、中央域S3は、下着の股下部に位置する。つまり、中央域は、着用者の股下、すなわち着用者の両足の間に配置される領域である。前側域S1は、中央域S3よりも前側に位置する。後側域S2は、中央域S3よりも後側に位置する。吸収性物品1は、例えば、吸収性物品1を前後方向Lに3等分に分けるように、前側域S1、後側域S2、中央域S3を有してよい。 The absorbent article 1 has a central area S3, a front area S1, and a rear area S2. The central area S3 is an area having an excretion port contact portion that contacts an excretion port (for example, a vaginal opening) of the wearer. When the absorbent article is worn on the underwear, the central region S3 is located at the crotch of the underwear. That is, the central region is a region located between the wearer's crotch, that is, between the wearer's feet. The front side area S1 is located on the front side of the central area S3. The rear area S2 is located behind the central area S3. The absorbent article 1 may have, for example, a front side area S1, a rear side area S2, and a central area S3 so as to divide the absorbent article 1 into three equal parts in the front-rear direction L.
 吸収性物品1は、検査部材20と、表面側部材40と、裏面側部材60と、を備える。 The absorbent article 1 includes the inspection member 20, the front side member 40, and the back side member 60.
 検査部材20は、着用者の健康状態を検査するための部材である。検査部材20の詳細は後述する。 The inspection member 20 is a member for inspecting a wearer's health condition. Details of the inspection member 20 will be described later.
 表面側部材40は、液透過性のトップシートを少なくとも含み、かつ検査部材20よりも肌面側T1に配置されている部材である。従って、着用者の肌に表面側部材(トップシート)が直接触れ易くなり、検査部材20が肌に触れることを抑制できる。本実施の形態では、表面側部材40は、トップシートのみにより構成されている。 The surface member 40 is a member that includes at least a liquid-permeable top sheet and is disposed closer to the skin surface T1 than the inspection member 20. Therefore, the front-side member (top sheet) easily comes into direct contact with the wearer's skin, and the inspection member 20 can be prevented from coming into contact with the skin. In the present embodiment, the front surface side member 40 is configured only by the top sheet.
 表面側部材(トップシート)40は、不織布、織布、有孔プラスチックシート、メッシュシート等、液体を透過する構造を有する任意のシート状の材料から構成される。織布や不織布の素材としては、天然繊維、化学繊維のいずれも使用できる。 The surface-side member (top sheet) 40 is made of any sheet-like material having a structure that allows liquid to pass through, such as a nonwoven fabric, a woven fabric, a perforated plastic sheet, or a mesh sheet. As the material of the woven or nonwoven fabric, any of natural fibers and chemical fibers can be used.
 裏面側部材60は、液不透過性のバックシートを少なくとも含み、かつ検査部材20よりも非肌面側T2に配置されている部材である。本実施の形態では、裏面側部材60は、トップシートのみにより構成されている。 The back side member 60 is a member that includes at least a liquid-impermeable back sheet and is disposed on the non-skin side T2 with respect to the inspection member 20. In the present embodiment, the back surface side member 60 is constituted only by the top sheet.
 裏面側部材(バックシート)60は、ポリエチレンシート、ポリプロピレン等を主体としたラミネート不織布、通気性の樹脂フィルム、スパンボンド、又はスパンレース等の不織布に通気性の樹脂フィルムが接合されたシートなどを用いることができる。 The back side member (back sheet) 60 may be a laminated non-woven fabric mainly composed of polyethylene sheet, polypropylene, or the like, a breathable resin film, a sheet in which a breathable resin film is bonded to a non-woven fabric such as spun bond or spun lace, or the like. Can be used.
 検査部材20は、着用者の健康状態を指示薬により表示する。本実施の形態では、健康状態を検査するために、例えば、イムノクロマト法、又は試験紙法を用いることができる。 The inspection member 20 displays the health condition of the wearer with an indicator. In the present embodiment, for examining the health condition, for example, an immunochromatography method or a test paper method can be used.
 イムノクロマト法は、抗体を含む標識粒子が敷き詰められた部材(例えば、セルロース膜)上に、排泄物(例えば、血液など)を滴下することで行われる。排泄物中に、検査対象となる対象成分(抗原)が含まれている場合、当該対象成分と抗体とが抗原抗体反応を起こして複合体を形成する。形成された複合体は、毛細管現象によって膜上を移動する。複合体の移動先には、別種の抗体(指示薬)が線状に配置されている。複合体が、別種の抗体と結合して呈色する。呈色(色の変化)の有無により着用者の健康状態が示される。着用者は、呈色の有無を目視により判定することで健康状態を確認することができる。 The immunochromatography method is performed by dropping excrement (for example, blood) on a member (for example, a cellulose membrane) on which labeled particles containing antibodies are spread. If the excrement contains a target component (antigen) to be tested, the target component and the antibody cause an antigen-antibody reaction to form a complex. The formed complex moves on the membrane by capillary action. A different type of antibody (indicator) is linearly arranged at the destination of the complex. The complex binds to another type of antibody and develops a color. The presence or absence of coloration (color change) indicates the health condition of the wearer. The wearer can confirm the health condition by visually determining the presence or absence of coloration.
 試験紙法は、検査部材20に含まれる指示薬が、排泄物に含まれる対象成分と反応することにより呈色する。呈色(指示薬の色の変化)の有無により着用者の健康状態が示される。着用者は、指示薬による呈色(指示薬の色の変化)を目視により判定することで健康状態を確認することができる。 In the test paper method, a color is formed when the indicator contained in the test member 20 reacts with the target component contained in the excrement. The presence or absence of coloration (change in the color of the indicator) indicates the health condition of the wearer. The wearer can visually confirm the coloration (change in the color of the indicator) by the indicator to confirm the health condition.
 排泄物は、例えば、血液、尿、大便、汗などが挙げられる。健康状態を示す項目は、例えば、体調関連(pH、鉄欠乏性貧血、腎機能、心筋梗塞、炎症・感染症、栄養状態評価など)、妊娠関連(生理周期予測、排卵予測など)、精神関連(鬱傾向、薬物など)が挙げられる。検査対象となる対象成分は、例えば、尿中老廃物(尿比重)、白血球、水素イオン(pH)、蛋白質、ブドウ糖、ケトン体、ウロビリノーゲン、ビリルビン、尿潜血、亜硝酸塩、ステロイド、ペプチド、芳香族化合物、FSH(卵胞刺激ホルモン)、BUN(Urea nitorogen)、AlB(Albumin)、LPS(リポ多糖)、hCG(ヒト絨毛性ゴナドトロピン)、LH(黄体刺激ホルモン)、U-ALB、CRP(C-リアクディブ・プロテイン)、ミオグロビン、CK-MB、トロポニンI、トロポニンT、ヘモグロビン、ストレップA、HBs抗体、HIV抗体、TP抗体、ロタウイルス、インフルエンザウイルス、アデノウイルス、DNA、O-157、コカイン、マリファナ、モルヒネなどが一例として挙げられる。 Excretions include, for example, blood, urine, stool, and sweat. Items indicating health status include, for example, physical condition-related (pH, iron deficiency anemia, renal function, myocardial infarction, inflammation / infection, nutritional status evaluation, etc.), pregnancy-related (physiological cycle prediction, ovulation prediction, etc.), mental-related (Depression, drugs, etc.). The target components to be tested include, for example, urine waste (urine specific gravity), leukocytes, hydrogen ions (pH), proteins, glucose, ketone bodies, urobilinogen, bilirubin, urinary occult blood, nitrite, steroids, peptides, and aromatics Compound, FSH (follicle stimulating hormone), BUN (Urea @ nitorogen), AlB (Albumin), LPS (lipopolysaccharide), hCG (human chorionic gonadotropin), LH (luteinizing hormone), U-ALB, CRP (C-reactiv) Protein), myoglobin, CK-MB, troponin I, troponin T, hemoglobin, strep A, HBs antibody, HIV antibody, TP antibody, rotavirus, influenza virus, adenovirus, DNA, O-157, cocaine, marijuana, morphine For example, That.
 検査部材20は、接触部22と表示部24とを有する。接触部22は、排泄物を接触させる部分である。表示部24は、排泄物に含まれる対象成分に応じて着用者の健康状態を表示する部分である。 The inspection member 20 has a contact part 22 and a display part 24. The contact part 22 is a part for making excrement contact. The display unit 24 is a part that displays the health condition of the wearer according to the target component contained in the excrement.
 例えば、イムノクロマト法では、接触部22は、抗体を含む標識粒子が配置されている領域を少なくとも含む。排泄物が接触部22に触れることで、排泄物に含まれる対象成分(抗原)と抗体とが抗原抗体反応を起こして複合体を形成する。表示部24は、複合体と結合して呈色する指示薬(別種の抗体)が配置されている領域を少なくとも含む。従って、イムノクロマト法が用いられる場合、接触部22と表示部24とは異なる位置に配置されている。一方、試験紙法では、接触部22は、指示薬が配置されている領域を少なくとも含む。接触部22に含まれる指示薬が対象成分と反応して呈色するため、接触部22と表示部24とが同じ位置に配置されている。従って、この場合、接触部22と表示部24とは、同一のものである。 For example, in the immunochromatography, the contact portion 22 includes at least a region where the labeled particles including the antibody are arranged. When the excrement touches the contact portion 22, the target component (antigen) and the antibody contained in the excretion cause an antigen-antibody reaction to form a complex. The display unit 24 includes at least a region where an indicator (another type of antibody) that is colored by binding to the complex is arranged. Therefore, when the immunochromatography method is used, the contact part 22 and the display part 24 are arranged at different positions. On the other hand, in the test paper method, the contact portion 22 includes at least a region where the indicator is arranged. Since the indicator contained in the contact part 22 reacts with the target component to give a color, the contact part 22 and the display part 24 are arranged at the same position. Therefore, in this case, the contact part 22 and the display part 24 are the same.
 以上のように、試験紙法が用いられる場合、接触部22、すなわち、表示部24は、着用者の健康状態を表示するための指示薬を含む。イムノクロマト法が用いられる場合、接触部22は、標識粒子を含み、表示部24は、着用者の健康状態を表示するための指示薬を含む。なお、接触部22は、排泄物(対象成分)を表示部24へ誘導させるためにのみ設けられている場合、指示薬を含まなくてよい。 As described above, when the test paper method is used, the contact portion 22, that is, the display portion 24 includes an indicator for displaying the health condition of the wearer. When the immunochromatography method is used, the contact section 22 includes label particles, and the display section 24 includes an indicator for displaying a wearer's health condition. When the contact part 22 is provided only for guiding the excrement (target component) to the display part 24, the contact part 22 may not include the indicator.
 なお、指示薬は、対象成分又は対象成分を由来とする成分(例えば、複合体)と反応することにより呈色する化学物質(無機物、有機物)である。 指示 The indicator is a chemical substance (inorganic or organic) that is colored by reacting with the target component or a component derived from the target component (for example, a complex).
 検査部材20は、指示薬を保持できる部材であればよい。検査部材20は、例えば、紙、不織布、織布などのいずれかの材料により構成できる。検査部材20の剛性は、吸収性物品1に使用される部材の剛性以下であってよい。これにより、吸収性物品1が検査部材20を備えていても、着用者の肌触りの悪化を抑制し易くなる。図1等に示すように、検査部材30は、例えば、直線状の板状であってよい。 The inspection member 20 may be any member that can hold the indicator. The inspection member 20 can be made of any material such as paper, nonwoven fabric, and woven fabric. The rigidity of the inspection member 20 may be equal to or less than the rigidity of the member used for the absorbent article 1. Thereby, even if the absorbent article 1 is provided with the inspection member 20, it becomes easy to suppress deterioration of the touch of the wearer. As shown in FIG. 1 and the like, the inspection member 30 may be, for example, a linear plate shape.
 図1及び図2に示すように、表面側部材40は、表示部24の少なくとも一部を覆っている。図1及び図2に示すように、表面側部材40は、表示部24の全てを覆っている。表示部24に含まれる指示薬が肌に触れ難くなり、指示薬による肌へのダメージを抑制できる。 表面 As shown in FIGS. 1 and 2, the front side member 40 covers at least a part of the display unit 24. As shown in FIGS. 1 and 2, the front-side member 40 covers the entire display unit 24. The indicator contained in the display unit 24 becomes less likely to touch the skin, and damage to the skin by the indicator can be suppressed.
 吸収性物品1が着用されている場合、着用者の排泄物は、表面側部材40を通じて検査部材20に到達し、検査部材20(表示部24)には、排泄物に含まれる対象成分に応じて着用者の健康状態が表示される。 When the absorbent article 1 is worn, the excrement of the wearer reaches the inspection member 20 through the surface-side member 40, and is displayed on the inspection member 20 (display unit 24) in accordance with the target component included in the excrement. The wearer's health status is displayed.
 ここで、表面側部材40が表示部24を覆っているため、着用者は、図1における吸収性物品1の状態では、表示部24を視認することができない。しかしながら、図3に示すように、表面側部材40は、表示部24が視認可能になるように、裏面側部材60から剥離可能である。従って、着用者は、吸収性物品1を身体から外した後に、表面側部材40を裏面側部材60から剥離することで、表示部24が露出する。従って、着用者が表示部24を視認し易くなる。着用者は、露出した表示部24を視認することで、着用者の健康状態を確認することができる。また、着用者は、検査部材20を携帯する必要がなく、例えば、外出先でも容易に確認可能である。 Here, since the front-side member 40 covers the display unit 24, the wearer cannot visually recognize the display unit 24 in the state of the absorbent article 1 in FIG. However, as shown in FIG. 3, the front-side member 40 can be peeled off from the rear-side member 60 so that the display unit 24 can be viewed. Accordingly, after the wearer removes the absorbent article 1 from the body, the display unit 24 is exposed by peeling the front-side member 40 from the back-side member 60. Therefore, it becomes easier for the wearer to visually recognize the display unit 24. The wearer can check the health of the wearer by visually recognizing the exposed display section 24. In addition, the wearer does not need to carry the inspection member 20 and can easily check it, for example, even when going out.
 表面側部材40には、開孔45が形成されている。本実施の形態では、開孔45は、表面側部材40を貫通する貫通孔である。開孔45は、第1開孔451と第2開孔452とを有してよい。第1開孔451は、厚さ方向Tにおいて接触部22と重なる開孔である。
従って、表面側部材40には、厚さ方向Tにおいて接触部22と重なる第1開孔451が形成されている。排泄物が第1開孔451を通ることで、表面側部材40を構成する繊維等の隙間を通り抜ける場合と比べて、接触部22へ到達し易くなる。このため、短時間で検査に必要な排泄物(対象成分)を接触部22に到達させることができ、検査時間を短縮しつつ、検査精度を向上できる。
An opening 45 is formed in the front side member 40. In the present embodiment, the opening 45 is a through-hole that penetrates the surface-side member 40. The opening 45 may have a first opening 451 and a second opening 452. The first opening 451 is an opening that overlaps the contact portion 22 in the thickness direction T.
Therefore, the first opening 451 overlapping the contact portion 22 in the thickness direction T is formed in the front surface side member 40. By passing the excrement through the first opening 451, it becomes easier to reach the contact portion 22 as compared with a case where the excrement passes through a gap such as a fiber constituting the front surface side member 40. For this reason, the excrement (target component) required for the inspection can reach the contact portion 22 in a short time, and the inspection time can be shortened and the inspection accuracy can be improved.
 図2に示すように、第1開孔451は、厚さ方向Tにおいて表面側部材40を貫通する貫通孔であってよい。これにより、排泄物が固定物又は半固形物であり、表面側部材40を拡散し難かったとしても、排泄物が接触部22へ到達し易くなる。従って、検査に必要な排泄物(対象成分)を接触部22に到達させることができ、検査精度を向上できる。 As shown in FIG. 2, the first opening 451 may be a through-hole that penetrates the surface-side member 40 in the thickness direction T. Accordingly, even if the excrement is a fixed substance or a semi-solid substance and it is difficult to diffuse the excrement, the excrement easily reaches the contact portion 22. Therefore, the excrement (target component) necessary for the inspection can reach the contact portion 22 and the inspection accuracy can be improved.
 表示部24は、厚さ方向Tにおいて開孔45と重なっていなくてよい。指示薬を含む表示部24が開孔45と重ならないことで、着用者の肌に表示部24が直接接触しないため、指示薬による肌へのダメージを抑制できる。 (4) The display section 24 does not have to overlap the opening 45 in the thickness direction T. Since the display unit 24 containing the indicator does not overlap with the opening 45, the display unit 24 does not directly contact the wearer's skin, so that damage to the skin due to the indicator can be suppressed.
 第2開孔452は、厚さ方向Tにおいて接触部22と重ならない開孔である。第2開孔452は、検査部材20と重ならない開孔であってよい。なお、第2開孔452を通った排泄物は、裏面側部材60へ到達した後、裏面側部材60上を移動し、接触部22へ到達することができる。 The second opening 452 is an opening that does not overlap with the contact portion 22 in the thickness direction T. The second opening 452 may be an opening that does not overlap with the inspection member 20. The excrement that has passed through the second opening 452 reaches the back member 60, then moves on the back member 60, and can reach the contact part 22.
 開孔45は、着用者の排泄口に当接する位置に配置されてよい。従って、開孔45は、中央域S3に配置されてよい。これにより、排泄物が、表面側部材40を移動(拡散)しなくても開孔45へ到達する。従って、排泄物が排泄された地点から開孔45まで排泄物が移動することを省略できる。短時間で検査に必要な排泄物を接触部22に到達させることができ、検査時間を短縮しつつ、検査精度を向上できる。 The opening 45 may be arranged at a position in contact with the excretion opening of the wearer. Therefore, the opening 45 may be arranged in the central area S3. Thereby, the excrement reaches the opening 45 without moving (diffusing) on the front side member 40. Therefore, it is possible to omit the movement of the excrement from the excretion point to the opening 45. The excrement required for the examination can reach the contact portion 22 in a short time, and the examination accuracy can be improved while shortening the examination time.
 検査部材20は、前側域S1、後側域S2、中央域S3の少なくともいずれかに配置される。図1に示すように、検査部材20は、後側域S2と中央域S3とに跨がって配置されてよい。接触部22が、少なくとも中央域S3に位置し、表示部24が、少なくとも後側域S2(又は前側域S1)に位置してよい。これにより、排泄口に当接する領域に、接触部22が位置するため、排泄物が接触部22に到達し易くなる。また、表示部24が後側域S2(又は前側域S1)に配置することにより、吸収性物品1の前後方向Lの後端部(又は前端部)から表示部24までの距離が短くなる。従って、着用者が、吸収性物品1の後端部(又は前端部)から表面側部材40を剥離することで、表示部24をすぐに露出させることができ、着用者が、表示部24を容易に視認できる。 The inspection member 20 is disposed in at least one of the front side area S1, the rear side area S2, and the center area S3. As shown in FIG. 1, the inspection member 20 may be disposed so as to straddle the rear side area S2 and the central area S3. The contact part 22 may be located at least in the central area S3, and the display part 24 may be located at least in the rear area S2 (or the front area S1). Thereby, since the contact portion 22 is located in a region in contact with the excretion opening, excrement easily reaches the contact portion 22. In addition, by disposing the display unit 24 in the rear area S2 (or the front area S1), the distance from the rear end (or the front end) of the absorbent article 1 in the front-rear direction L to the display unit 24 is reduced. Accordingly, the wearer can immediately expose the display unit 24 by peeling the surface-side member 40 from the rear end (or the front end) of the absorbent article 1, and the wearer can remove the display unit 24. Easy to see.
 表面側部材40と裏面側部材60とが別部材であることにより剥離可能であってよい。図3に示すように、表面側部材40と裏面側部材60とを剥離可能とするために、吸収性物品1は、表面側部材40と裏面側部材60とを接合する接合部70が設けられる接合領域BRと、接合部70が設けられない非接合領域NBRとを有してよい。接合部70は、厚さ方向Tにおいて、表面側部材40と裏面側部材60との間に配置されてよい。 Because the front side member 40 and the back side member 60 are separate members, they may be peelable. As shown in FIG. 3, in order to allow the front side member 40 and the back side member 60 to be peelable, the absorbent article 1 is provided with a bonding portion 70 for bonding the front side member 40 and the back side member 60. It may have a joining region BR and a non-joining region NBR where the joining portion 70 is not provided. The joining portion 70 may be arranged between the front side member 40 and the back side member 60 in the thickness direction T.
 図3に示すように、接合領域BR(すなわち、接合部70)は、吸収性物品1の平面視において、吸収性物品1(表面側部材40/裏面側部材60)の外周部に配置されてよい。外周部は、吸収性物品1の前後方向Lの端部及び幅方向Wの端部により構成されてよい。なお、接合部70は、外周部以外の領域に配置されてよい。 As shown in FIG. 3, the bonding region BR (that is, the bonding portion 70) is disposed on the outer peripheral portion of the absorbent article 1 (the front surface member 40 / the rear surface member 60) in a plan view of the absorbent article 1. Good. The outer peripheral portion may be configured by an end in the front-rear direction L and an end in the width direction W of the absorbent article 1. Note that the joint 70 may be arranged in a region other than the outer peripheral portion.
 非接合領域NBRは、吸収性物品1の前後方向Lの端部の少なくとも一部に配置されてよい。図3に示すように、非接合領域NBRは、吸収性物品1の前後方向Lの後端部に配置されてよい。着用者は、非接合領域NBRに指を入れて、表面側部材40の肌面側T1と非肌面側T2とをつまんだ後に、表面側部材40を裏面側部材60から引き離すことで、表面側部材40と裏面側部材60とを容易に剥離することができる。また、非接合領域NBRは、吸収性物品1の後端部に配置することで、吸収性物品1の前側部分が排泄物で汚れていても、着用者が排泄物に触れずに表面側部材40を裏面側部材60から剥離することができる。 The non-bonding region NBR may be arranged at least at a part of the end of the absorbent article 1 in the front-rear direction L. As shown in FIG. 3, the non-bonding region NBR may be arranged at the rear end of the absorbent article 1 in the front-rear direction L. The wearer puts a finger in the non-joining region NBR, pinches the skin side T1 and the non-skin side T2 of the front-side member 40, and then pulls the front-side member 40 away from the rear-side member 60, thereby obtaining the front surface. The side member 40 and the back side member 60 can be easily separated. Further, by disposing the non-joining region NBR at the rear end of the absorbent article 1, even if the front side of the absorbent article 1 is soiled with excrement, the wearer does not touch the excrement and the front side member is not used. 40 can be peeled off from the back side member 60.
 また、非接合領域NBRは、吸収性物品1の前後方向Lの前端部に配置されてよい。吸収性物品1が下着に取り付けられているケースでは、吸収性物品1を下着から外す際に、着用者は、視認し易い吸収性物品1の前側から外すことが多い。このため、非接合領域NBRは、吸収性物品1の前後方向Lの前端部に配置されている場合には、吸収性物品1を下着から外す際に、一方の手で吸収性物品1の前側部分を把持し、他方の手の指を非接合領域NBRに入れることができる。これにより、着用者が、表面側部材40を剥離する作業を容易に行うことができる。 非 The non-bonding region NBR may be arranged at the front end of the absorbent article 1 in the front-rear direction L. In the case where the absorbent article 1 is attached to the underwear, when removing the absorbent article 1 from the underwear, the wearer often removes the absorbent article 1 from the front side, which is easily visible. For this reason, when the non-bonding region NBR is arranged at the front end of the absorbent article 1 in the front-rear direction L, when removing the absorbent article 1 from the underwear, the front side of the absorbent article 1 is grasped with one hand. The part can be grasped and the finger of the other hand can be put into the non-joining area NBR. Thereby, the wearer can easily perform the operation of peeling the front surface side member 40.
 従って、非接合領域NBRは、吸収性物品1の前後方向Lの前端部及び後端部の少なくとも一方に配置されてよい。非接合領域NBRは、吸収性物品1の前後方向Lの前端部及び後端部の両方に配置されてよい。 Therefore, the non-bonding region NBR may be arranged at at least one of the front end and the rear end of the absorbent article 1 in the front-rear direction L. The non-bonding region NBR may be arranged at both the front end and the rear end of the absorbent article 1 in the front-rear direction L.
 なお、接合領域BR(接合部70)は、接着剤、又は圧力や熱によるエンボスシールなどの接合処理により設けられてよい。非接合領域NBRは、当該接合処理を行わないことで設けられてよい。 The bonding region BR (the bonding portion 70) may be provided by a bonding process such as an emboss seal using an adhesive or pressure or heat. The non-joining region NBR may be provided by not performing the joining process.
 また、表面側部材40が裏面側部材60から剥離可能とするために、表面側部材40と裏面側部材60との少なくとも一部は、剥離可能な接合部70によって接合されてよい。剥離可能な接合部70は、前側域S1、後側域S2、中央域S3の少なくともいずれかに配置されてよい。例えば、当該接合部70は、表示部24が位置する領域にのみ配置されてよい。例えば、当該接合部70は、後側域S2のみに配置されてよく、剥離不能な接合部70が、前側域S1及び中央域S3に配置されてよい。これにより、着用者が、表示部24をすぐに露出させることができ、着用者が、表示部24を容易に視認できる。 In addition, at least a part of the front-side member 40 and the back-side member 60 may be joined by a peelable joint 70 so that the front-side member 40 can be separated from the back-side member 60. The peelable joint 70 may be arranged in at least one of the front area S1, the rear area S2, and the central area S3. For example, the joint 70 may be arranged only in the region where the display unit 24 is located. For example, the joint 70 may be arranged only in the rear area S2, and the non-peelable joint 70 may be arranged in the front area S1 and the central area S3. Thereby, the wearer can immediately expose the display unit 24, and the wearer can easily visually recognize the display unit 24.
 図2に示すように、検査部材20は、厚さ方向Tにおいて表面側部材40と裏面側部材60との間に配置されている。従って、裏面側部材60上に配置されている。 As shown in FIG. 2, the inspection member 20 is disposed between the front side member 40 and the back side member 60 in the thickness direction T. Therefore, it is arranged on the back side member 60.
 検査部材20は、接着剤等により、表面側部材40と裏面側部材60との両方に固定されなくてよい。これにより、表面側部材40及び/又は裏面側部材60を構成する繊維が検査部材30に付着せずに、表面側部材40を裏面側部材60から剥離し易くすることができる。また、検査部材30に繊維が付着しないため、表示部24を視認し易い。 (4) The inspection member 20 does not need to be fixed to both the front side member 40 and the back side member 60 with an adhesive or the like. Thereby, the fibers constituting the front side member 40 and / or the back side member 60 do not adhere to the inspection member 30, and the front side member 40 can be easily separated from the back side member 60. Further, since the fibers do not adhere to the inspection member 30, the display unit 24 is easily visible.
 或いは、検査部材20は、表面側部材40と裏面側部材60との少なくとも一方に接合され、固定されてよい。これにより、第1開孔451から接触部22がずれて、厚さ方向Tにおいて第1開孔451と重ならなくなることを抑制できる。例えば、検査部材20は、例えば、ホットメルト型接着剤(HMA)により裏面側部材60と接合されてよい。接着剤等により排泄物Eが接触部22へ接触し難くなることを抑制するために、少なくとも接触部24は、接合(固定)されなくてよい。また、表示部24を視認し易くするため、少なくとも表示部22は、表面側部材40及び裏面側部材60と接合(固定)されなくてよい。検査部材30は、接触部22及び表示部44以外の部分の少なくとも一部により構成される固定部を有してよい。固定部上に塗布された接着剤により、表面側部材40と裏面側部材60との少なくとも一方と検査部材30の固定部とが接合(固定)されてよい。これにより、接触部22及び表示部44を固定することなく、接触部22がずれることを抑制できる。 Alternatively, the inspection member 20 may be joined and fixed to at least one of the front side member 40 and the back side member 60. Accordingly, it is possible to prevent the contact portion 22 from being shifted from the first opening 451 and not overlapping the first opening 451 in the thickness direction T. For example, the inspection member 20 may be joined to the back surface side member 60 by, for example, a hot melt adhesive (HMA). At least the contact portion 24 does not need to be joined (fixed) in order to prevent the excrement E from becoming difficult to contact the contact portion 22 due to an adhesive or the like. In addition, in order to make the display unit 24 easily visible, at least the display unit 22 does not need to be joined (fixed) to the front surface member 40 and the back surface member 60. The inspection member 30 may have a fixed part configured by at least a part of a part other than the contact part 22 and the display part 44. At least one of the front-side member 40 and the back-side member 60 and the fixed portion of the inspection member 30 may be joined (fixed) by the adhesive applied on the fixed portion. Thereby, it is possible to suppress the displacement of the contact portion 22 without fixing the contact portion 22 and the display portion 44.
 (3)第2実施形態
 次に、第2実施形態に係る吸収性物品1について図4を用いて説明する。図4は、第2実施形態に係る吸収性物品1の断面図である。なお、第1実施形態と同様の部分は、説明を省略する。
(3) Second Embodiment Next, an absorbent article 1 according to a second embodiment will be described with reference to FIG. FIG. 4 is a cross-sectional view of the absorbent article 1 according to the second embodiment. The description of the same parts as in the first embodiment is omitted.
 図4に示すように、表面側部材40は、第1表面側部材42と第2表面側部材44とを有してよい。第1表面側部材42は、上述のトップシートと同様の材料から構成されてよい。従って、表面側部材40は、トップシート(第1表面側部材42)を含む複数のシートにより構成されよい。 表面 As shown in FIG. 4, the front side member 40 may include a first front side member 42 and a second front side member 44. The first front side member 42 may be made of the same material as the above-described top sheet. Therefore, the front side member 40 may be configured by a plurality of sheets including a top sheet (first front side member 42).
 第2表面側部材44は、第1表面側部材42よりも非肌面側に配置される部材である。第2表面側部材44は、液透過性シートであってよい。この場合、第2表面側部材44は、トップシートと同様の材料から構成されてよい。第2表面側部材44は、液不透過性シートであってよい。この場合、第2表面側部材44は、上述のバックシートと同様の材料から構成されてよい。第1表面側部材42と第2表面側部材44とは、例えば、ホットメルト型接着剤(HMA)により接接合されてよい。 The second surface-side member 44 is a member arranged on the non-skin side with respect to the first surface-side member 42. The second front side member 44 may be a liquid permeable sheet. In this case, the second front side member 44 may be made of the same material as the top sheet. The second front side member 44 may be a liquid impermeable sheet. In this case, the second front side member 44 may be made of the same material as the above-described back sheet. The first surface-side member 42 and the second surface-side member 44 may be joined to each other by, for example, a hot melt adhesive (HMA).
 第1表面側部材42には、開孔45が形成されていない。一方で、第2表面側部材44には、第1開孔451が形成されている。開孔45は、表面側部材40を構成する複数のシートのうち一部のシートにのみに形成されている。これにより、第1表面側部材42が第1開孔451及び接触部22を覆っているため、検査部材20が露出しない。これにより、検査部材が着用者の肌に直接触れることを確実に抑制できる。また、排泄物は、第1表面側部材42を通り抜けた後は、第1開孔451を通ることで、接触部22へ到達し易くなる。従って、検査時間の短縮及び検査精度の向上を図りつつ、着用者の肌触りの悪化及び指示薬による肌のダメージをより抑制できる。 開 The first surface side member 42 has no opening 45 formed therein. On the other hand, a first opening 451 is formed in the second surface side member 44. The opening 45 is formed only in some of the sheets constituting the front-side member 40. Thus, the inspection member 20 is not exposed because the first front side member 42 covers the first opening 451 and the contact portion 22. Thereby, it can suppress reliably that an inspection member touches a wearer's skin directly. Further, after passing through the first surface side member 42, the excrement easily reaches the contact portion 22 by passing through the first opening 451. Therefore, it is possible to further suppress the deterioration of the touch of the wearer and the damage to the skin due to the indicator while shortening the inspection time and improving the inspection accuracy.
 第2表面側部材44が液不透過性シートである場合、第1開孔451は、液不透過性シートに形成されている。表面側部材40が液不透過性シートを有していても、排泄物は、第1開孔451を通じて第2表面側部材44(液不透過性シート)を通過することができる。これにより、検査部材20(接触部22)に排泄物を到達させることができ、着用者の健康状態を表示部24に表示できる。一方で、検査部材20に到達した排泄物には、検査部材20に含まれる指示薬が溶解する可能性がある。第2表面側部材44である液不透過性シートは、第1開孔451を除いて、排泄物を通過させないため、排泄物が第1表面側部材42へ戻ることを抑制できる。従って、排泄物に含まれる指示薬による着用者の肌へのダメージを抑制できる。 場合 When the second front side member 44 is a liquid impermeable sheet, the first openings 451 are formed in the liquid impermeable sheet. Even if the front side member 40 has a liquid impermeable sheet, excrement can pass through the second front side member 44 (liquid impermeable sheet) through the first opening 451. Thus, the excrement can reach the inspection member 20 (the contact portion 22), and the health condition of the wearer can be displayed on the display portion 24. On the other hand, the indicator contained in the inspection member 20 may be dissolved in the excrement reaching the inspection member 20. The liquid impermeable sheet, which is the second front side member 44, does not allow the excrement to pass through except for the first opening 451, so that the excrement can be prevented from returning to the first front side member 42. Therefore, damage to the wearer's skin due to the indicator contained in the excrement can be suppressed.
 裏面側部材60は、第1裏面側部材62と第2裏面側部材64とを有してよい。第1裏面側部材62は、液透過性シートであってよく、上述のトップシートと同様の材料から構成されてよい。第1裏面側部材62は、表面側部材40に含まれる液透過性シートである第1表面側部材42よりも親水性又は繊維密度が高いシート(親水性シート)であってよい。 The back side member 60 may include a first back side member 62 and a second back side member 64. The first back side member 62 may be a liquid permeable sheet, and may be made of the same material as the above-described top sheet. The first back side member 62 may be a sheet (hydrophilic sheet) having a higher hydrophilicity or fiber density than the first front side member 42 which is a liquid permeable sheet included in the front side member 40.
 図4に示すように、検査部材20は、第1裏面側部材62上に配置されてよい。従って、検査部材20は、第1裏面側部材62と(直接)当接していてよい。第1表面側部材42よりも第1裏面側部材62の方が親水性又は繊維密度が高い場合、第1裏面側部材62の方が排泄物を引き込む力が強い。従って、排泄物(対象成分)を検査部材20へ短時間で到達させ易くなる。加えて、排泄物は、第1裏面側部材62の方へ引き込まれ、第1表面側部材42へ戻り難くなる。排泄物に指示薬が溶解したとしても、排泄物を第1裏面側部材62に維持することができる。排泄物に含まれる指示薬による着用者の肌への影響を抑制できる。 検 査 As shown in FIG. 4, the inspection member 20 may be disposed on the first back side member 62. Therefore, the inspection member 20 may be in direct contact with the first back side member 62. When the first back side member 62 is higher in hydrophilicity or fiber density than the first front side member 42, the first back side member 62 has a stronger force to draw in excrement. Therefore, it becomes easier for the excrement (target component) to reach the inspection member 20 in a short time. In addition, the excrement is drawn in toward the first back side member 62 and becomes difficult to return to the first front side member 42. Even if the indicator is dissolved in the excrement, the excrement can be maintained on the first back side member 62. The effect on the wearer's skin by the indicator contained in the excrement can be suppressed.
 なお、繊維密度は、周知の方法で測定することができる。例えば、繊維密度は、対象部位を吸収性物品1から対象サンプルとして切り出し、対象サンプル単位面積当たりの質量(g/m2)を測定し、対象サンプルの厚さ(m)を測定して、対象サンプル単位面積当たりの質量を対象サンプルの厚さで除することで算出することができる(g/m3)。単位面積当たりの繊維の質量は、例えば、対象サンプルの質量を直示天秤(例えば、研精工業株式会社製  電子天秤HF-300)で測定し、対象サンプルの面積を測定し、単位面積当たりの質量を算出してもよい。対象サンプルの厚さは、例えば、ミツトヨ(株)製のダイアルシックネスゲージID-C1012C又はそれと同等のものを使用し、接触子の面積を20cm2、接触圧を3gf/cm2に設定して対象部位を加圧して測定したり、その他、目視で比較したり、吸収性物品1を長手方向に切った断面を撮影した画像を用いて比較したりしてもよい。 繊 維 The fiber density can be measured by a known method. For example, the fiber density is obtained by cutting out the target site from the absorbent article 1 as a target sample, measuring the mass per unit area of the target sample (g / m2), measuring the thickness (m) of the target sample, and measuring the target sample. It can be calculated by dividing the mass per unit area by the thickness of the target sample (g / m3). The mass of the fiber per unit area is determined, for example, by measuring the mass of the target sample with a direct reading balance (for example, an electronic balance HF-300 manufactured by Kensei Kogyo Co., Ltd.), measuring the area of the target sample, and measuring the mass per unit area. The mass may be calculated. The thickness of the target sample is determined, for example, by using a dial thickness gauge ID-C1012C manufactured by Mitutoyo Corporation or the equivalent, setting the contact area to 20 cm 2 and the contact pressure to 3 gf / cm 2 to set the target portion. The measurement may be performed by applying a pressure, the comparison may be made visually, or the comparison may be made using an image obtained by photographing a cross section of the absorbent article 1 cut in the longitudinal direction.
 親水性は、周知の方法で測定することができる。例えば、第1に、濾紙を5枚重ねて水平に置き、濾紙の上に測定対象の試験片をのせる。第2に、縦方向及び横方向のそれぞれにおいて2cm間隔で試験片に印を付す。ピペットで人工尿1滴(約0.05g)を20箇所に滴下する。人工尿の滴下は、1分10秒で20カ所に行う。第3に、20箇所滴下終了から30秒放置した後、試験片に吸収されている箇所を数える。試験片の吸収箇所が多い程、親水性が高いものとする。(親水性の高い側では親水性が低い側に比べて液を吸収する力が強くなる。)
 なお、第2裏面側部材64は、上述のバックシートに対応し、上述のバックシートと同様の材料から構成されてよい。
The hydrophilicity can be measured by a well-known method. For example, first, five pieces of filter paper are stacked and placed horizontally, and a test piece to be measured is placed on the filter paper. Second, test specimens are marked at 2 cm intervals in each of the longitudinal and transverse directions. One drop (approximately 0.05 g) of artificial urine is dropped at 20 places with a pipette. The artificial urine is dropped at 20 places in 1 minute and 10 seconds. Thirdly, after being left for 30 seconds from the end of dropping at 20 locations, the locations absorbed by the test piece are counted. It is assumed that the more the absorption points of the test piece, the higher the hydrophilicity. (The higher the hydrophilicity, the stronger the liquid absorbing power than the lower hydrophilicity.)
The second back side member 64 corresponds to the above-described back sheet, and may be made of the same material as the above-described back sheet.
 (4)第3実施形態
 次に、第3実施形態に係る吸収性物品1について図5を用いて説明する。図5は、第3実施形態に係る吸収性物品1の断面図である。なお、第1及び第2実施形態と同様の部分は、説明を省略する。
(4) Third Embodiment Next, an absorbent article 1 according to a third embodiment will be described with reference to FIG. FIG. 5 is a cross-sectional view of the absorbent article 1 according to the third embodiment. The description of the same parts as those of the first and second embodiments will be omitted.
 図5に示すように、吸収性物品1は、検査部材20と厚さ方向Tにおいて重ならない第2開孔452を有してよい。第2開孔452は、表面側部材40を貫通する貫通孔であってよい。これにより、排泄物は、第2開孔452を通ることで、第2開孔452が形成されていない場合と比べて、第1裏面側部材62にまで短時間で到達することができる。 吸収 As shown in FIG. 5, the absorbent article 1 may have the second opening 452 that does not overlap with the inspection member 20 in the thickness direction T. The second opening 452 may be a through hole that penetrates the front surface side member 40. Thereby, the excrement can reach the first back side member 62 in a shorter time by passing through the second opening 452 as compared with the case where the second opening 452 is not formed.
 第1裏面側部材62が液透過性シートである場合、図5に示すように、第1裏面側部材62を拡散して、検査部材20(接触部22)にまで到達することができる。ここで、吸収性物品1は、第2開孔452のみを有している場合、肌面側T1から視て、検査部材20は露出してない。従って、着用者の肌に検査部材20が直接接触しないため、着用者の肌触りの悪化を抑制でき、かつ指示薬による肌へのダメージを抑制できる。 When the first back side member 62 is a liquid permeable sheet, as shown in FIG. 5, the first back side member 62 can be diffused and reach the inspection member 20 (contact portion 22). Here, when the absorbent article 1 has only the second opening 452, the inspection member 20 is not exposed when viewed from the skin surface side T1. Therefore, since the inspection member 20 does not directly contact the wearer's skin, deterioration of the wearer's touch can be suppressed, and damage to the skin by the indicator can be suppressed.
 (5)第4実施形態
 次に、第4実施形態に係る包装体について説明する。なお、上述の実施形態と同様の部分は、説明を省略する。また、包装体は上記第1実施形態~第3実施形態に記載した吸収性物品とは異なる、検査部材を有していない吸収性物品を包装する包装体であってもよい。
(5) Fourth Embodiment Next, a package according to a fourth embodiment will be described. The description of the same parts as those in the above-described embodiment will be omitted. Further, the package may be a package for packaging an absorbent article having no inspection member, which is different from the absorbent articles described in the first to third embodiments.
 図6は、第4実施形態に係る包装体100の斜視図である。図7は、第4実施形態に係る検査部130の拡大斜視図である。図8は、図7に示すF8-F8線に沿った検査部の断面図であり、検査部の使用状態を説明するための図である。 FIG. 6 is a perspective view of a package 100 according to the fourth embodiment. FIG. 7 is an enlarged perspective view of the inspection unit 130 according to the fourth embodiment. FIG. 8 is a cross-sectional view of the inspection unit taken along line F8-F8 shown in FIG. 7, and is a diagram for explaining a use state of the inspection unit.
 図6に示すように、包装体100は、互いに直交する長手方向X、幅方向Y、厚さ方向Zを有してよい。長手方向Xは、包装体100(後述する包装シート120)の長さを規定する方向であってよい。幅方向Yは、包装体100(包装シート120))の幅を規定する方向であってよい。厚さ方向Zは、包装体100(包装シート120)の厚さを規定する方向であってよい。 As shown in FIG. 6, the package 100 may have a longitudinal direction X, a width direction Y, and a thickness direction Z that are orthogonal to each other. The longitudinal direction X may be a direction that defines the length of the package 100 (a packaging sheet 120 described later). The width direction Y may be a direction that defines the width of the package 100 (the packaging sheet 120). The thickness direction Z may be a direction that defines the thickness of the package 100 (the packaging sheet 120).
 図6に示すように、包装体100は、吸収性物品110と、包装シート120と、検査部130とを有する。 包装 As shown in FIG. 6, the package 100 has an absorbent article 110, a packaging sheet 120, and an inspection unit 130.
 吸収性物品110は、着用者の排泄物を吸収可能な物品である。吸収性物品110は、生理用ナプキン、パンティライナー、失禁パッド、糞便パッドのような吸収性物品であってよい。吸収性物品は、下着のような着用物品の内側に取り付けられて使用される物品であってよい。本実施の形態の吸収性物品110は、生理用ナプキンである。 The absorbent article 110 is an article that can absorb the excrement of the wearer. Absorbent article 110 may be an absorbent article such as a sanitary napkin, panty liner, incontinence pad, stool pad. The absorbent article may be an article used by being attached to the inside of a wearing article such as underwear. The absorbent article 110 of the present embodiment is a sanitary napkin.
 包装シート120は、吸収性物品110を個別に包装するシートである。吸収性物品110の使用時に包装シート120が外されることにより、吸収性物品110が露出し、使用可能となる。 The packaging sheet 120 is a sheet for individually packaging the absorbent articles 110. By removing the packaging sheet 120 when using the absorbent article 110, the absorbent article 110 is exposed and can be used.
 包装シート120は、例えば、不織布、織布、有孔プラスチックシート、メッシュシート等、任意のシート状の材料から構成されてよい。織布や不織布の素材としては、天然繊維、化学繊維のいずれも使用できる。 The packaging sheet 120 may be made of any sheet-like material such as a nonwoven fabric, a woven fabric, a perforated plastic sheet, a mesh sheet, and the like. As the material of the woven or nonwoven fabric, any of natural fibers and chemical fibers can be used.
 図6に示すように、包装シート120は、包装シート120の長手方向Xの端縁である第1端縁121eと第2端縁122eとを有してよい(図16の下図参照)。吸収性物品110が個別に包装された包装状態において、第1端縁121eは、包装体100の外側に位置する端縁であってよく、第2端縁122eは、包装体100の内側に位置する端縁であってよい。なお、包装体100の内側とは、包装状態の包装体100における厚さ方向Zの内側である。 As shown in FIG. 6, the packaging sheet 120 may have a first edge 121e and a second edge 122e that are edges in the longitudinal direction X of the packaging sheet 120 (see the lower diagram in FIG. 16). In the packaging state in which the absorbent articles 110 are individually packaged, the first edge 121e may be an edge located outside the package 100, and the second edge 122e may be located inside the package 100. The edge may be The inside of the package 100 is the inside of the package 100 in the thickness direction Z in the package state.
 図6に示すように、包装シート120は、吸収性物品110が個別に包装された包装状態において、第1端縁121eを有する第1シート部分121と、第2端縁122eを有する第2シート部分122とを有してよい。第1シート部分121は、包装体100の外側に位置してよく、第2シート部分122の一部は、包装体100の内側に位置してよい。従って、第2シート部分122の一部は、第1シート部分121により厚さ方向Zにおいて覆われてよい。 As shown in FIG. 6, the packaging sheet 120 has a first sheet portion 121 having a first edge 121e and a second sheet having a second edge 122e in a packaging state in which the absorbent articles 110 are individually packaged. And a portion 122. The first sheet portion 121 may be located outside the package 100, and a part of the second sheet portion 122 may be located inside the package 100. Therefore, a part of the second sheet portion 122 may be covered by the first sheet portion 121 in the thickness direction Z.
 検査部130は、着用者の健康状態を検査するためのものである。検査部130は、着用者の排泄物に含まれる対象成分に応じて着用者の健康状態を表示する。本実施の形態では、検査部130は、包装シート120と固定されている。従って、包装シート120と検査部130とは別体であることに留意すべきである。 The inspection unit 130 is for inspecting the health condition of the wearer. The inspection unit 130 displays the health condition of the wearer according to the target component contained in the excrement of the wearer. In the present embodiment, inspection unit 130 is fixed to packaging sheet 120. Therefore, it should be noted that the packaging sheet 120 and the inspection unit 130 are separate bodies.
 ここで、着用者は、吸収性物品110を使用後に身体から外して、吸収性物品110を交換する。吸収性物品110を交換する際に、着用者は、新しい吸収性物品110を包装シート120から外して使用する。外された包装シート120には、検査部130が当該包装シート120と固定されているため、身体から外した吸収性物品110に付着した排泄物に対して当該検査部130を用いることができる。着用者は、検査部130を別途携帯する必要はないため、健康状態を手軽に検査できる。 Here, the wearer removes the absorbent article 110 from the body after use, and replaces the absorbent article 110. When replacing the absorbent article 110, the wearer removes the new absorbent article 110 from the packaging sheet 120 and uses it. Since the inspection unit 130 is fixed to the removed packaging sheet 120 with the packaging sheet 120, the inspection unit 130 can be used for excrement attached to the absorbent article 110 removed from the body. Since the wearer does not need to carry the inspection unit 130 separately, the wearer can easily check the health condition.
 検査部130は、着用者の健康状態を指示薬により表示する。より詳細には、検査部130が有する反応部140において、着用者の健康状態を指示薬により表示する。本実施の形態では、健康状態を検査するために、例えば、イムノクロマト法、又は試験紙法を用いることができる。 (4) The inspection unit 130 displays the health condition of the wearer using an indicator. More specifically, the reaction unit 140 included in the inspection unit 130 displays the health condition of the wearer using an indicator. In the present embodiment, for examining the health condition, for example, an immunochromatography method or a test paper method can be used.
 イムノクロマト法は、抗体を含む標識粒子が敷き詰められた部材(例えば、セルロース膜)上に、排泄物(例えば、血液など)を滴下することで行われる。排泄物中に、検査対象となる対象成分(抗原)が含まれている場合、当該対象成分と抗体とが抗原抗体反応を起こして複合体を形成する。形成された複合体は、毛細管現象によって膜上を移動する。複合体の移動先には、別種の抗体(指示薬)が線状に配置されている。複合体が、別種の抗体と結合して呈色する。呈色(色の変化)の有無により着用者の健康状態が示される。着用者は、呈色の有無を目視により判定することで健康状態を確認することができる。 The immunochromatography method is performed by dropping excrement (for example, blood) on a member (for example, a cellulose membrane) on which labeled particles containing antibodies are spread. If the excrement contains a target component (antigen) to be tested, the target component and the antibody cause an antigen-antibody reaction to form a complex. The formed complex moves on the membrane by capillary action. A different type of antibody (indicator) is linearly arranged at the destination of the complex. The complex binds to another type of antibody and develops a color. The presence or absence of coloration (color change) indicates the health condition of the wearer. The wearer can confirm the health condition by visually determining the presence or absence of coloration.
 試験紙法は、検査部130に含まれる指示薬が、排泄物に含まれる対象成分と反応することにより呈色する。呈色(指示薬の色の変化)の有無により着用者の健康状態が示される。着用者は、指示薬による呈色(指示薬の色の変化)を目視により判定することで健康状態を確認することができる。 In the test paper method, a color is formed when an indicator contained in the inspection unit 130 reacts with a target component contained in excrement. The presence or absence of coloration (change in the color of the indicator) indicates the health condition of the wearer. The wearer can visually confirm the coloration (change in the color of the indicator) by the indicator to confirm the health condition.
 排泄物は、例えば、血液、尿、大便、汗などが挙げられる。健康状態を示す項目は、例えば、体調関連(pH、鉄欠乏性貧血、腎機能、心筋梗塞、炎症・感染症、栄養状態評価など)、妊娠関連(生理周期予測、排卵予測など)、精神関連(鬱傾向、薬物など)が挙げられる。検査対象となる対象成分は、例えば、尿中老廃物(尿比重)、白血球、水素イオン(pH)、蛋白質、ブドウ糖、ケトン体、ウロビリノーゲン、ビリルビン、尿潜血、亜硝酸塩、ステロイド、ペプチド、芳香族化合物、FSH(卵胞刺激ホルモン)、BUN(Urea nitorogen)、AlB(Albumin)、LPS(リポ多糖)、hCG(ヒト絨毛性ゴナドトロピン)、LH(黄体刺激ホルモン)、U-ALB、CRP(C-リアクディブ・プロテイン)、ミオグロビン、CK-MB、トロポニンI、トロポニンT、ヘモグロビン、ストレップA、HBs抗体、HIV抗体、TP抗体、ロタウイルス、インフルエンザウイルス、アデノウイルス、DNA、O-157、コカイン、マリファナ、モルヒネなどが一例として挙げられる。 Excretions include, for example, blood, urine, stool, and sweat. Items indicating health status include, for example, physical condition-related (pH, iron deficiency anemia, renal function, myocardial infarction, inflammation / infection, nutritional status evaluation, etc.), pregnancy-related (physical cycle prediction, ovulation prediction, etc.), mental-related (Depression, drugs, etc.). The target components to be tested include, for example, urine waste (urine specific gravity), leukocytes, hydrogen ions (pH), proteins, glucose, ketone bodies, urobilinogen, bilirubin, urinary occult blood, nitrite, steroids, peptides, and aromatics Compound, FSH (follicle stimulating hormone), BUN (Urea @ nitorogen), AlB (Albumin), LPS (lipopolysaccharide), hCG (human chorionic gonadotropin), LH (luteinizing hormone), U-ALB, CRP (C-reactiv) Protein), myoglobin, CK-MB, troponin I, troponin T, hemoglobin, strep A, HBs antibody, HIV antibody, TP antibody, rotavirus, influenza virus, adenovirus, DNA, O-157, cocaine, marijuana, morphine For example, That.
 反応部140(検査部130)は、接触部142を有する。接触部142は、健康状態を表示させるために排泄物を接触させる部分である。反応部140(検査部130)は、後述するように、表示部144を有してよい。表示部144は、排泄物に含まれる対象成分に応じて着用者の健康状態を指示薬により表示する部分である。 The reaction section 140 (inspection section 130) has a contact section 142. The contact part 142 is a part that makes excretions come into contact in order to display a health condition. The reaction unit 140 (inspection unit 130) may include a display unit 144, as described later. The display part 144 is a part that displays the health condition of the wearer with an indicator according to the target component contained in the excrement.
 例えば、イムノクロマト法では、接触部142は、抗体を含む標識粒子が配置されている領域を少なくとも含む。排泄物が接触部142に触れることで、排泄物に含まれる対象成分(抗原)と抗体とが抗原抗体反応を起こして複合体を形成する。表示部144は、複合体と結合して呈色する指示薬(別種の抗体)が配置されている領域を少なくとも含む。従って、イムノクロマト法が用いられる場合、接触部142と表示部144とは異なる位置に配置されている。一方、試験紙法では、接触部142は、指示薬が配置されている領域を少なくとも含む。接触部142に含まれる指示薬が対象成分と反応して呈色するため、接触部142と表示部144とが同じ位置に配置されている。従って、この場合、接触部142と表示部144とは、同一のものである。 For example, in the immunochromatography method, the contact portion 142 includes at least a region where the labeled particles including the antibody are arranged. When the excrement touches the contact portion 142, the target component (antigen) and the antibody contained in the excretion cause an antigen-antibody reaction to form a complex. The display unit 144 includes at least a region where an indicator (another type of antibody) that is colored by binding to the complex is arranged. Therefore, when the immunochromatography method is used, the contact part 142 and the display part 144 are arranged at different positions. On the other hand, in the test paper method, the contact portion 142 includes at least a region where the indicator is arranged. Since the indicator contained in the contact portion 142 reacts with the target component to give a color, the contact portion 142 and the display portion 144 are arranged at the same position. Therefore, in this case, the contact part 142 and the display part 144 are the same.
 以上のように、試験紙法が用いられる場合、接触部142、すなわち、表示部144は、着用者の健康状態を表示するための指示薬を含む。イムノクロマト法が用いられる場合、接触部142は、標識粒子を含み、表示部144は、着用者の健康状態を表示するための指示薬を含む。なお、接触部142は、排泄物(対象成分)を表示部144へ誘導させるためにのみ設けられている場合、指示薬を含まなくてよい。 As described above, when the test strip method is used, the contact portion 142, that is, the display portion 144 includes an indicator for displaying the wearer's health condition. When the immunochromatography method is used, the contact section 142 includes label particles, and the display section 144 includes an indicator for displaying a wearer's health condition. In addition, when the contact part 142 is provided only to guide the excrement (target component) to the display part 144, the contact part 142 may not include the indicator.
 なお、指示薬は、対象成分又は対象成分を由来とする成分(例えば、複合体)と反応することにより呈色する化学物質(無機物、有機物)である。 指示 The indicator is a chemical substance (inorganic or organic) that is colored by reacting with the target component or a component derived from the target component (for example, a complex).
 検査部130は、指示薬を保持できる部材であればよい。本実施の形態では、検査部130は、包装シート120に固定可能な部材であればよい。検査部130は、例えば、紙、不織布、織布、樹脂フィルムなどのいずれかの材料により構成されてよい。 The inspection unit 130 may be any member that can hold the indicator. In the present embodiment, inspection unit 130 may be a member that can be fixed to packaging sheet 120. The inspection unit 130 may be made of any material such as paper, nonwoven fabric, woven fabric, and resin film.
 検査部130は、反応部140を支持する本体部132を有してよい。本体部132上に反応部140が固定されてよい。すなわち、本体部132上に反応部140は設けられてよい。検査部130は、包装体100を開封するために包装シートから剥がされるリードテープであってよい。より詳細には、本体部132がリードテープとしての機能を有する。リードテープを検査部130として用いるため、検査部130として新たな部材を包装体100へ追加せずに済む。これにより、包装体100が検査部130を有していても、包装体100の生産効率を低減せずに済む。 The inspection unit 130 may have a main body 132 that supports the reaction unit 140. The reaction section 140 may be fixed on the main body 132. That is, the reaction section 140 may be provided on the main body 132. The inspection unit 130 may be a lead tape that is peeled off from the packaging sheet to open the package 100. More specifically, the main body 132 has a function as a lead tape. Since the lead tape is used as the inspection unit 130, it is not necessary to add a new member to the package 100 as the inspection unit 130. Accordingly, even if the package 100 has the inspection unit 130, the production efficiency of the package 100 does not need to be reduced.
 なお、検査部130(リードテープ)は、粘着部(不図示)により包装シート120に固定されている。 Note that the inspection section 130 (lead tape) is fixed to the packaging sheet 120 by an adhesive section (not shown).
 図6及び図7に示すように、接触部142(反応部140)は、厚さ方向Zにおいて包装シート120と重なってよい。より詳細には、接触部142が厚さ方向Zにおいて包装シート120と重なる領域において、検査部130は、包装シート120と固定されてよい。これにより、図8に示すように、着用者は、接触部142が配置されている面と反対側の包装シート120の面から排泄物Eへ、検査部130(接触部142)を接触させることができる。この場合、着用者の指が排泄物Eに触れることなく、接触部142へ排泄物Eを接触させることができる。このため、着用者は、衛生的に健康状態を検査することができる。また、着用者の指が接触部142へ触れないため、排泄物E以外の対象成分(具体的には、指に付着している対象成分)に指示薬が反応せず、検査精度を向上できる。 接触 As shown in FIGS. 6 and 7, the contact portion 142 (the reaction portion 140) may overlap the packaging sheet 120 in the thickness direction Z. More specifically, the inspection unit 130 may be fixed to the packaging sheet 120 in a region where the contact unit 142 overlaps the packaging sheet 120 in the thickness direction Z. Thereby, as shown in FIG. 8, the wearer causes the inspection unit 130 (contact portion 142) to contact the excrement E from the surface of the packaging sheet 120 opposite to the surface on which the contact portion 142 is arranged. Can be. In this case, the excrement E can be brought into contact with the contact portion 142 without the finger of the wearer touching the excrement E. For this reason, a wearer can inspect a health condition hygienically. In addition, since the wearer's finger does not touch the contact portion 142, the indicator does not react with the target component other than the excrement E (specifically, the target component attached to the finger), and the inspection accuracy can be improved.
 図6及び図7に示されるように、検査部130は、包装シート120(すなわち、第1シート部分121)の第1端縁121eを跨ぐように配置されてよい。従って、検査部130は、第1シート部分121と第2シート部分122とに跨がって配置されてよい。また、検査部130(本体部132)は、包装シート120に固定されている固定部132aと、包装体100が開封された開封状態において包装シート120の外側へ第1端縁121eから延出する延出部132bとを有してよい(図8参照)。包装状態では、固定部132aが、第1シート部分121上に配置され、延出部132bが第2シート部分122上に配置されてよい。本実施の形態では、検査部130は、固定部132aにおいて反応部140(接触部142)を有する。 As shown in FIGS. 6 and 7, the inspection unit 130 may be arranged so as to straddle the first edge 121e of the packaging sheet 120 (that is, the first sheet portion 121). Therefore, the inspection unit 130 may be disposed so as to straddle the first sheet part 121 and the second sheet part 122. In addition, the inspection unit 130 (the main body unit 132) extends from the first edge 121e to the outside of the packaging sheet 120 when the packaging body 100 is unsealed and the fixing unit 132a that is secured to the packaging sheet 120. An extension 132b may be provided (see FIG. 8). In the wrapped state, the fixing portion 132a may be disposed on the first sheet portion 121, and the extending portion 132b may be disposed on the second sheet portion 122. In the present embodiment, inspection section 130 has reaction section 140 (contact section 142) in fixing section 132a.
 ここで、検査部130が、リードテープである場合、着用者は、延出部132bを把持して、包装体100を開封することがある。従って、固定部132aに反応部140が存在することにより、着用者の指が接触部142へ触れ難くなる。着用者の指が接触部142へ触れないことにより、排泄物E以外の対象成分(具体的には、指に付着している対象成分)に指示薬が反応せず、検査精度を向上できる。 Here, when the inspection unit 130 is a lead tape, the wearer may hold the extension 132b and open the package 100. Therefore, the presence of the reaction portion 140 in the fixing portion 132a makes it difficult for the wearer's finger to touch the contact portion 142. Since the wearer's finger does not touch the contact part 142, the indicator does not react with the target component other than the excrement E (specifically, the target component attached to the finger), and the inspection accuracy can be improved.
 なお、本体部132は、長手方向Xにおける本体部132の端部が折り返されている折り返し部134を有してよい。これにより、着用者は、折り返し部134を把持することにより、リードテープ(検査部130)を剥離し易くできる。 The main body 132 may have a folded portion 134 in which the end of the main body 132 in the longitudinal direction X is folded. Thereby, the wearer can easily peel the lead tape (inspection unit 130) by gripping the folded back portion 134.
 (6)第5実施形態
 次に、第5実施形態に係る包装体100について、図9及び図10を用いて説明する。図9は、第5実施形態に係る検査部130の断面図である。図10は、第5実施形態に係る検査部130の使用状態を説明するための断面図である。なお、上述の実施形態と同様の部分は、説明を省略する。
(6) Fifth Embodiment Next, a package 100 according to a fifth embodiment will be described with reference to FIGS. 9 and 10. FIG. 9 is a cross-sectional view of the inspection unit 130 according to the fifth embodiment. FIG. 10 is a cross-sectional view for explaining a use state of the inspection unit 130 according to the fifth embodiment. The description of the same parts as those in the above-described embodiment will be omitted.
 第5実施形態では、接触部142(反応部140)は、延出部132bに配置されている。この場合、図10に示すように、延出部132bは包装シート120の外側へ延出しているため、着用者は、包装シート120を把持した状態で、延出部132bに配置されている接触部142を排泄物Eに接触させることができる。これにより、着用者の指が、排泄物Eからある程度の距離を保つことができる。このため、着用者は、排泄物E及び接触部142に触れることなく、接触部142へ排泄物Eを接触させることができる。従って、着用者は、衛生的に健康状態を検査することができる。 で は In the fifth embodiment, the contact part 142 (the reaction part 140) is disposed on the extension part 132b. In this case, as shown in FIG. 10, since the extending portion 132b extends to the outside of the packaging sheet 120, the wearer holds the packaging sheet 120 and holds the contact portion disposed on the extending portion 132b. The part 142 can be brought into contact with the excrement E. Thereby, the wearer's finger can keep a certain distance from the excrement E. Therefore, the wearer can bring the excrement E into contact with the contact portion 142 without touching the excrement E and the contact portion 142. Therefore, the wearer can inspect the health condition hygienically.
 (7)第6実施形態
 次に、第6実施形態に係る包装体100について、図11を用いて説明する。図11は、第6実施形態に係る検査部130の使用状態を説明するための図である。なお、上述の各実施形態と同様の部分は、説明を省略する。
(7) Sixth Embodiment Next, a package 100 according to a sixth embodiment will be described with reference to FIG. FIG. 11 is a diagram for explaining a use state of the inspection unit 130 according to the sixth embodiment. The description of the same parts as those in the above embodiments will be omitted.
 図11に示すように、検査部130(反応部140)は、表示部144を有する。表示部144は、厚さ方向Zにおいて、本体部132と包装シート120との間に配置されている。すなわち、表示部144の一方の主面である第1面144aは、本体部132に覆われており、表示部144の他方の主面である第2面144bは、包装シート120(第1シート部分121)に覆われている。従って、表示部144は、露出していない。これにより、着用者が意図せずに表示部144に触れそうになったとしても、本体部132又は包装シート120に覆われている部分に触れることで、着用者が、指示薬に直接触れることを抑制できる。これにより、指示薬が肌にダメージを与え得るものであっても、着用者の安全性を高めることができる。 検 査 As shown in FIG. 11, the inspection unit 130 (reaction unit 140) has a display unit 144. The display unit 144 is disposed between the main body 132 and the packaging sheet 120 in the thickness direction Z. That is, the first surface 144a, which is one main surface of the display unit 144, is covered with the main body 132, and the second surface 144b, which is the other main surface of the display unit 144, is formed of the packaging sheet 120 (first sheet). Part 121). Therefore, the display unit 144 is not exposed. Thereby, even if the wearer is likely to touch the display unit 144 unintentionally, by touching the part covered by the main body 132 or the packaging sheet 120, the wearer can directly touch the indicator. Can be suppressed. Thereby, even if the indicator can damage the skin, the safety of the wearer can be improved.
 また、表示部144が、本体部132及び包装シート120に覆われている状態で、健康状態を示す指示薬による呈色を視認可能であってよい。これにより、表示部144が本体部132及び包装シート120に覆われていても、着用者は、指示薬による呈色を視認可能である。従って、着用者の安全性を高めつつ、表示部144が示す健康状態を容易に把握することができる。 In addition, in a state where the display unit 144 is covered with the main body 132 and the packaging sheet 120, the coloration by the indicator indicating the health condition may be visible. Thereby, even if the display part 144 is covered with the main body part 132 and the packaging sheet 120, the wearer can visually recognize the coloring by the indicator. Therefore, it is possible to easily grasp the health status indicated by the display unit 144 while improving the safety of the wearer.
 例えば、本体部132は、透過性又は半透過性を有し、着用者は、本体部132を介して呈色を視認可能であってよい。本体部132は、無色透明であってよい。これにより、呈色を視認し易くなる。また、包装シート120は、透過性又は半透過性を有し、着用者は、包装シート120を介して呈色を視認可能であってよい。包装シート120は、無色透明であってよい。これにより、呈色を視認し易くなる。 For example, the main body 132 may be transparent or semi-permeable, and the wearer may be able to visually recognize the color via the main body 132. The main body 132 may be colorless and transparent. This makes it easier to visually recognize the color. In addition, the packaging sheet 120 may be transparent or semi-permeable, and the wearer may be able to visually recognize the color through the packaging sheet 120. The packaging sheet 120 may be colorless and transparent. This makes it easier to visually recognize the color.
 なお、本発明における「視認可能」とは、昼白色(色温度目安 4600~5400 K(ケルビン))で明るく照明された室内(目安:500~750 lx(ルクス))で約30~50cmの距離で、良好な視力(1.0以上)を両眼に有する被験者が対象物を見たときに視認できる事を意味している。 The term “visible” in the present invention refers to a distance of about 30 to 50 cm in a room (approximately: 500 to 750 lx (lux)) brightly illuminated in daylight white (color temperature reference: 4600 to 5400 K (Kelvin)). This means that a subject having good visual acuity (1.0 or more) with both eyes can visually recognize the subject when looking at the subject.
 なお、本実施の形態では、第1面144aは、本体部132に固定されている面であり、第2面144bは、包装シート120に固定されている面である。第1面144a側から指示薬による呈色を視認可能であってよい。第1面144a側の表示部144は、第2面144b側の表示部144よりも指示薬を多く含んでいてもよい。従って、第1面144a側の方が第2面144b側の方よりも指示薬による呈色を視認し易くてよい。指示薬による呈色を第1面144a側でのみ視認可能であってよい。これにより、図11に示すように、着用者は、排泄物Eを付ける面と反対側(本体部132側)の面から呈色を視認できるため、排泄物Eの付着による視認の阻害を抑制できる。これにより、呈色をより正確に確認できる。 In the present embodiment, the first surface 144a is a surface fixed to the main body 132, and the second surface 144b is a surface fixed to the packaging sheet 120. The coloration by the indicator may be visible from the first surface 144a side. The display 144 on the first surface 144a side may include more indicator than the display 144 on the second surface 144b side. Therefore, the coloration by the indicator may be more easily recognized on the first surface 144a side than on the second surface 144b side. The coloring by the indicator may be visible only on the first surface 144a side. Thereby, as shown in FIG. 11, the wearer can visually recognize the color from the surface on the side opposite to the surface on which the excrement E is applied (the side of the main body 132), so that the obstruction of the visual recognition due to the attachment of the excrement E is suppressed. it can. Thereby, coloration can be confirmed more accurately.
 また、第2面144b側から指示薬による呈色を視認可能であってよい。第2面144b側の表示部144は、第1面144a側の表示部144よりも指示薬を多く含んでいてもよい。従って、第2面144b側の方が第1面144a側の方よりも指示薬による呈色を視認し易くてよい。指示薬による呈色を第2面144b側でのみ視認可能であってよい。これにより、露出している本体部132が汚れたとしても、包装状態において露出していない第2面144b側から呈色を視認できるため、呈色をより正確に確認できる。 Also, the coloration by the indicator may be visible from the second surface 144b side. The display 144 on the second surface 144b side may include more indicator than the display 144 on the first surface 144a side. Therefore, the coloration by the indicator may be more easily visually recognized on the second surface 144b side than on the first surface 144a side. The coloring by the indicator may be visible only on the second surface 144b side. Thus, even if the exposed main body 132 is soiled, the color can be visually recognized from the second surface 144b that is not exposed in the packaged state, so that the color can be confirmed more accurately.
 なお、図11に示すように、接触部142の少なくとも一部は、排泄物Eに接触させやすくするために、開封状態において、包装シート120の第1端縁121eから露出してよい。 As shown in FIG. 11, at least a part of the contact portion 142 may be exposed from the first edge 121e of the packaging sheet 120 in the opened state in order to facilitate contact with the excrement E.
 本体部132及び包装シート120の少なくとも一方は、後述する撥水部150と同様に、撥水性を有してよい。 少 な く と も At least one of the main body 132 and the packaging sheet 120 may have water repellency, similarly to the water repellent part 150 described later.
 (8)第7実施形態
 次に、第7実施形態に係る包装体100について、図12及び図13を用いて説明する。図12は、第7実施形態に係る検査部130の斜視図である。図13は、図12に示すF13-F13線に沿った断面図である。なお、上述の各実施形態と同様の部分は、説明を省略する。
(8) Seventh Embodiment Next, a package 100 according to a seventh embodiment will be described with reference to FIGS. FIG. 12 is a perspective view of the inspection unit 130 according to the seventh embodiment. FIG. 13 is a sectional view taken along line F13-F13 shown in FIG. The description of the same parts as those in the above embodiments will be omitted.
 図12及び図13に示すように、検査部130は、接触部142と表示部144とを有する。接触部142の一部は、撥水部150に覆われている。 As shown in FIGS. 12 and 13, the inspection unit 130 has a contact unit 142 and a display unit 144. Part of the contact portion 142 is covered with the water-repellent portion 150.
 着用者が意図せずに接触部142に触れそうになったとしても、撥水性を有する撥水部150に覆われている部分に触れることで、着用者の指などについた対象成分が、接触部142に直接触れることを抑制できる。これにより、検査対象となる排泄物以外から、対称成分が接触部142に触れることを抑制でき、検査精度を向上できる。 Even if the wearer comes into contact with the contact portion 142 unintentionally, by touching the portion covered with the water-repellent portion 150 having water repellency, the target component attached to the wearer's finger or the like may come into contact with the component. Direct contact with the part 142 can be suppressed. Thereby, it is possible to suppress the contact of the symmetrical component from the excrement other than the inspection target with the contact portion 142, and it is possible to improve the inspection accuracy.
 本実施の形態では、検査部130は、反応部140(接触部142と表示部144)が固定されている本体部132を有する。図13に示すように、接触部142は、第1面142aと第2面142bと、第3面142cと、を有してよい。第1面142aは、本体部132に固定される面である。第2面142bは、第1面142aと反対側の面である。第3面142cは、第1面142aと第2面142bとをつなぐ面である。 In the present embodiment, the inspection section 130 has the main body 132 to which the reaction section 140 (the contact section 142 and the display section 144) is fixed. As shown in FIG. 13, the contact portion 142 may have a first surface 142a, a second surface 142b, and a third surface 142c. The first surface 142a is a surface fixed to the main body 132. The second surface 142b is a surface opposite to the first surface 142a. The third surface 142c is a surface connecting the first surface 142a and the second surface 142b.
 第2面142bは撥水部150により覆われている。第3面142cの少なくとも一部は、撥水部150から露出している。例えば、撥水スプレー、コーティング装置などにより、接触部142の一部に撥水剤を付着(塗布)する撥水加工することにより、撥水部150が設けられてよい。検査部130の本体部132を構成する部材を、撥水剤に含浸してもよい。撥水剤を付着させたくない部分(例えば、接触部142(の一部))は、マスキングテープ等により覆っていてよい。反応部140(接触部142)の一部を撥水部150により覆った後にマスキングテープ等を剥がすことにより、接触部142を露出させてよい。第2面142bは、撥水性を有する部材により覆われてよい。 The second surface 142b is covered by the water-repellent part 150. At least a portion of the third surface 142c is exposed from the water-repellent portion 150. For example, the water-repellent portion 150 may be provided by performing a water-repellent process of attaching (applying) a water-repellent agent to a part of the contact portion 142 using a water-repellent spray, a coating device, or the like. The member constituting the main body 132 of the inspection unit 130 may be impregnated with a water repellent. A portion to which the water repellent is not to be attached (for example, (a part of) the contact portion 142) may be covered with a masking tape or the like. After covering a part of the reaction section 140 (contact section 142) with the water-repellent section 150, the contact section 142 may be exposed by peeling off a masking tape or the like. The second surface 142b may be covered with a water-repellent member.
 撥水剤は、シリコン系撥水剤でもよく、フッ素系撥水剤でもよい。撥水剤(撥水部150)は、変色し難いものであることが好ましい。撥水剤(撥水部150)は、透過性又は半透過性を有するものであってよい。撥水剤(撥水部150)は、表示部144を覆う場合には、呈色を視認し易くするために、無色透明であるものを用いてよい。 水 The water repellent may be a silicone water repellent or a fluorine water repellent. It is preferable that the water repellent (water repellent portion 150) does not easily discolor. The water-repellent agent (water-repellent portion 150) may be permeable or semi-permeable. When the water repellent (the water repellent portion 150) covers the display portion 144, a colorless and transparent material may be used in order to make the coloration easily visible.
 接触部142の第2面142bは、本体部132に固定される第1面142aと反対側の面であるため、本体部132から露出している部分である。従って、接触部142の第2面142bは、着用者が触れ易い部分である。着用者が触れ易い部分を撥水部150で覆うことで、着用者が、接触部142に触れることを抑制でき、検査精度を向上できる。一方で、第1面142aと第2面142bとをつなぐ第3面142cは、着用者が触れ難い部分である。着用者が触れ難い部分を撥水部150から露出させることで、対象成分を接触部142に触れさせることができ、検査を行うことができる。 The second surface 142b of the contact portion 142 is a portion exposed from the main body 132 because it is a surface opposite to the first surface 142a fixed to the main body 132. Therefore, the second surface 142b of the contact portion 142 is a portion that the wearer can easily touch. By covering the portion that the wearer easily touches with the water-repellent portion 150, the wearer can be prevented from touching the contact portion 142, and the inspection accuracy can be improved. On the other hand, the third surface 142c connecting the first surface 142a and the second surface 142b is a portion that is difficult for the wearer to touch. By exposing a portion that is difficult for the wearer to touch from the water-repellent portion 150, the target component can be brought into contact with the contact portion 142, and an inspection can be performed.
 本実施の形態では、第3面142cの露出面は、本体部132の幅方向の外側縁側に位置してよい。第3面142cが撥水部150に覆われている非露出面は、本体部132の長手方向の端部側に位置してよい。 In the present embodiment, the exposed surface of the third surface 142c may be located on the outer edge side in the width direction of the main body 132. The non-exposed surface in which the third surface 142c is covered with the water-repellent portion 150 may be located on the longitudinal end side of the main body 132.
 なお、表示部144も、接触部142と同様に、第1面144aと、第2面144bと、第3面144cと、を有してよい。これにより、着用者が、表示部144に含まれる指示薬に直接触れることを抑制できる。これにより、指示薬が肌にダメージを与え得るものであっても、着用者の安全性を高めることができる。また、表示部144が、撥水部150に覆われている状態で、健康状態を示す指示薬による呈色を視認可能であってよい。これにより、表示部144が撥水部150に覆われていても、着用者は、指示薬による呈色を視認可能である。従って、着用者の安全性を高めつつ、表示部144が示す健康状態を容易に把握することができる。 Note that the display unit 144 may have a first surface 144a, a second surface 144b, and a third surface 144c, like the contact unit 142. Accordingly, it is possible to suppress the wearer from directly touching the indicator contained in the display unit 144. Thereby, even if the indicator can damage the skin, the safety of the wearer can be improved. Further, in a state where the display unit 144 is covered with the water-repellent unit 150, the coloration by the indicator indicating the health condition may be visible. Thereby, even if the display part 144 is covered with the water-repellent part 150, the wearer can visually recognize the coloring by the indicator. Therefore, it is possible to easily grasp the health status indicated by the display unit 144 while improving the safety of the wearer.
 (9)第8実施形態
 次に、第8実施形態に係る包装体100について、図14を用いて説明する。図14は、第8実施形態に係る検査部130の斜視図である。なお、上述の各実施形態と同様の部分は、説明を省略する。
(9) Eighth Embodiment Next, a package 100 according to an eighth embodiment will be described with reference to FIG. FIG. 14 is a perspective view of the inspection unit 130 according to the eighth embodiment. The description of the same parts as those in the above embodiments will be omitted.
 図14に示すように、第3面142cの露出面は、本体部132の幅方向Yの外側縁側だけでなく、本体部132の長手方向Xの端部側にも位置してよい。これにより、第3面142cの露出面積が増加するため、より短時間で検査を行うことができる。一方で、第2面142bは、撥水部150に覆われているため、着用者が、接触部142に触れることを抑制でき、検査精度を向上できる。 As shown in FIG. 14, the exposed surface of the third surface 142c may be located not only on the outer edge side in the width direction Y of the main body 132 but also on the end side in the longitudinal direction X of the main body 132. This increases the exposed area of the third surface 142c, so that the inspection can be performed in a shorter time. On the other hand, since the second surface 142b is covered with the water-repellent portion 150, the wearer can be prevented from touching the contact portion 142, and the inspection accuracy can be improved.
 (10)第9実施形態
 次に、第9実施形態に係る包装体100について、図15を用いて説明する。図15は、第9実施形態に係る検査部130の斜視図である。なお、上述の各実施形態と同様の部分は、説明を省略する。
(10) Ninth Embodiment Next, a package 100 according to a ninth embodiment will be described with reference to FIG. FIG. 15 is a perspective view of the inspection unit 130 according to the ninth embodiment. The description of the same parts as those in the above embodiments will be omitted.
 図15に示すように、第3面142cの露出面は、本体部132の長手方向Xの端部側に位置してよい。一方で、第3面142cが撥水部150に覆われている非露出面は、本体部132の幅方向Yの外側縁側に位置してよい。これにより、着用者が、検査部130(本体部132)の幅方向Yの外側縁を把持したとしても、着用者が、接触部142に触れることを抑制できるため、検査精度を向上できる。 露出 As shown in FIG. 15, the exposed surface of the third surface 142c may be located on the end side in the longitudinal direction X of the main body 132. On the other hand, the non-exposed surface in which the third surface 142c is covered with the water-repellent portion 150 may be located on the outer edge side in the width direction Y of the main body 132. Accordingly, even if the wearer grips the outer edge in the width direction Y of the inspection section 130 (the main body section 132), the wearer can be prevented from touching the contact section 142, so that the inspection accuracy can be improved.
 本体部132の長手方向Xの中心側に位置する反応部140の長手方向Xの端部は、撥水部150により覆われてもよく、覆われてなくてもよい。 端 The end in the longitudinal direction X of the reaction section 140 located on the center side in the longitudinal direction X of the main body section 132 may or may not be covered by the water-repellent section 150.
 (11)第10実施形態
 次に、第10実施形態に係る包装体100について、図16を用いて説明する。図16は、第10実施形態に係る包装体100の斜視図である。図16の上図は、包装体100が開封される前の状態を示し、図16の下図は、包装体100が開封された状態を示す。なお、上述の各実施形態と同様の部分は、説明を省略する。
(11) Tenth Embodiment Next, a package 100 according to a tenth embodiment will be described with reference to FIG. FIG. 16 is a perspective view of a package 100 according to the tenth embodiment. 16 shows a state before the package 100 is opened, and a lower diagram in FIG. 16 shows a state where the package 100 is opened. The description of the same parts as those in the above embodiments will be omitted.
 上述の実施形態では、検査部130は、包装シート120と固定されていた。本実施の形態では、検査部130は、包装シート120の一部である。従って、包装シート120が、反応部140(接触部142及び表示部144)を有する。 In the above embodiment, the inspection unit 130 is fixed to the packaging sheet 120. In the present embodiment, the inspection unit 130 is a part of the packaging sheet 120. Therefore, the packaging sheet 120 has the reaction section 140 (the contact section 142 and the display section 144).
 図16の上図に示すように、反応部140(接触部142及び表示部144)は、包装体100の開封前において、露出していない。一方で、図16の下図に示すように、反応部140は、包装体100の開封により露出する。これにより、反応部140が、検査前において他のものに接触することを抑制でき、検査精度を向上できる。また、検査前において指示薬が他のものに触れにくくなり、指示薬が他のものに付着し難くすることができる。従って、着用者の安全性を高めることができる。 反 応 As shown in the upper diagram of FIG. 16, the reaction section 140 (the contact section 142 and the display section 144) is not exposed before the package 100 is opened. On the other hand, as shown in the lower diagram of FIG. 16, the reaction section 140 is exposed by opening the package 100. Thus, it is possible to prevent the reaction section 140 from contacting other components before the inspection, and to improve the inspection accuracy. In addition, it is possible to make it difficult for the indicator to touch other things before the examination, and to make it harder for the indicator to adhere to other things. Therefore, the safety of the wearer can be improved.
 図16に示すように、包装シート120上に反応部140(検査部130)が設けられてもよい。従って、検査部130が、包装シート120の一部となっている。本実施の形態では、検査部130は、第1シート部分121の一部となってよい。開封前(包装状態)において第1シート部分121の露出していない面に検査部130が配置されてよい。 反 応 As shown in FIG. 16, a reaction section 140 (inspection section 130) may be provided on the packaging sheet 120. Therefore, the inspection unit 130 is a part of the packaging sheet 120. In the present embodiment, the inspection unit 130 may be a part of the first sheet part 121. Before opening (packaged state), the inspection unit 130 may be arranged on a surface of the first sheet portion 121 that is not exposed.
 反応部140は、開封前において、包装シート120(すなわち、第1シート部分121と第2シート部分122と)の間に挟まれるように配置されていてよい。これにより、吸収性物品110に指示薬が付着することを抑制でき、着用者の安全性を高めることができる。 The reaction section 140 may be arranged so as to be sandwiched between the packaging sheet 120 (that is, the first sheet portion 121 and the second sheet portion 122) before opening. Thereby, the indicator can be prevented from attaching to the absorbent article 110, and the safety of the wearer can be enhanced.
 なお、検査部130を包装シート120(本実施の形態では、第1シート部分121)の一部とするため、着用者の健康状態を表示するための指示薬を包装シート120に塗布してもよく、指示薬を構成する溶液に包装シート120を含浸してもよい。 In addition, since the inspection unit 130 is a part of the wrapping sheet 120 (the first sheet portion 121 in the present embodiment), an indicator for displaying the health condition of the wearer may be applied to the wrapping sheet 120. Alternatively, the packaging sheet 120 may be impregnated with a solution constituting the indicator.
 (12)第11実施形態
 次に、第11実施形態に係る包装体100について、図17を用いて説明する。図17は、第11実施形態に係る包装体100の斜視図である。図17は、包装体100が開封された状態を示す。なお、上述の各実施形態と同様の部分は、説明を省略する。
(12) Eleventh Embodiment Next, a package 100 according to an eleventh embodiment will be described with reference to FIG. FIG. 17 is a perspective view of a package 100 according to the eleventh embodiment. FIG. 17 shows a state where the package 100 is opened. The description of the same parts as those in the above embodiments will be omitted.
 図17に示すように、包装シート120には、包装シート120の一部を検査部130とするためのミシン目125が形成されてもよい。着用者は、ミシン目125を切断することにより、検査部130を取得できてもよい。 As shown in FIG. 17, perforations 125 for forming a part of the packaging sheet 120 as the inspection unit 130 may be formed on the packaging sheet 120. The wearer may be able to acquire the inspection unit 130 by cutting the perforations 125.
 反応部140は、吸収性物品110に対向せずに、包装シート120に対向するように配置されてもよい。本実施の形態では、検査部130は、第2シート部分122の一部となってよい。開封前(包装状態)において第2シート部分122の露出していない面に検査部130が配置されてよい。開封前において第1シート部分121の露出していない面に対向するように、検査部130が配置されてよい。これにより、吸収性物品110に指示薬が付着することを抑制でき、着用者の安全性を高めることができる。 The reaction section 140 may be arranged so as not to face the absorbent article 110 but to face the packaging sheet 120. In the present embodiment, the inspection unit 130 may be a part of the second sheet part 122. Before opening (packaged state), the inspection unit 130 may be arranged on a surface of the second sheet portion 122 that is not exposed. The inspection unit 130 may be arranged so as to face the unexposed surface of the first sheet portion 121 before opening. Thereby, the indicator can be prevented from attaching to the absorbent article 110, and the safety of the wearer can be enhanced.
 なお、図17(及び図16)では、包装体100は、リードテープを有しているが、包装体100は、リードテープを有さなくてよい。第1シート部分121の第1端縁121eを含む長手方向Xの端部は、例えば、接着剤又はヒートシールなどにより接合されてよい。これにより、包装体100の開封口は、封止されてよい。 In FIG. 17 (and FIG. 16), the package 100 has a lead tape, but the package 100 does not have to have a lead tape. The end of the first sheet portion 121 in the longitudinal direction X including the first edge 121e may be joined by, for example, an adhesive or heat sealing. Thereby, the opening of the package 100 may be sealed.
 (13)その他実施形態
 以上、上述の実施形態を用いて本発明について詳細に説明したが、当業者にとっては、本発明が本明細書中に説明した実施形態に限定されるものではないということは明らかである。本発明は、特許請求の範囲の記載により定まる本発明の趣旨及び範囲を逸脱することなく修正及び変更態様として実施することができる。したがって、本明細書の記載は、例示説明を目的とするものであり、本発明に対して何ら制限的な意味を有するものではない。
(13) Other Embodiments As described above, the present invention has been described in detail by using the above-described embodiment. However, for those skilled in the art, the present invention is not limited to the embodiment described in this specification. Is clear. The present invention can be embodied as modified and changed aspects without departing from the spirit and scope of the present invention defined by the description of the claims. Therefore, the description in this specification is for the purpose of illustrative explanation, and does not have any restrictive meaning to the present invention.
 上述の第2実施形態では、第1裏面側部材62は、第1表面側部材42よりも親水性又は繊維密度が高いシート(親水性シート)であってよかったが、これに限られない。第1裏面側部材62は、表面側部材40の全ての液透過性シートよりも親水性又は繊維密度が高くてよい。これにより、排泄物は、第1裏面側部材62の方へ引き込まれ、表面側部材40へ戻り難くなるため、排泄物に含まれる指示薬による着用者の肌への影響を抑制できる。 In the above-described second embodiment, the first back side member 62 may be a sheet (hydrophilic sheet) having a higher hydrophilicity or fiber density than the first front side member 42, but is not limited thereto. The first back side member 62 may be higher in hydrophilicity or fiber density than all the liquid permeable sheets of the front side member 40. As a result, the excrement is drawn toward the first back side member 62 and is difficult to return to the front side member 40, so that the influence of the indicator contained in the excrement on the wearer's skin can be suppressed.
 また、第1裏面側部材62は、第1表面側部材42よりも親水性又は繊維密度が高いシート(親水性シート)である場合、表面側部材40を構成する全てのシートが液透過性シートであってよい。表面側部材40が液不透過性シートを含む場合と比べて、排泄物が拡散により裏面側部材60にまで到達し易い。裏面側部材60にまで到達した排泄物は、第1裏面側部材62を拡散して接触部22へ到達できる。従って、検査時間の短縮及び検査精度の向上を図りつつ、着用者の肌触りの悪化及び指示薬による肌のダメージをより抑制できる。 When the first back side member 62 is a sheet (hydrophilic sheet) having higher hydrophilicity or fiber density than the first front side member 42, all the sheets constituting the front side member 40 are liquid permeable sheets. It may be. Excretion is more likely to reach the back side member 60 by diffusion than in the case where the front side member 40 includes a liquid impermeable sheet. The excrement that has reached the back side member 60 can diffuse through the first back side member 62 and reach the contact portion 22. Therefore, it is possible to further suppress the deterioration of the touch of the wearer and the damage to the skin due to the indicator while shortening the inspection time and improving the inspection accuracy.
 また、上述の第2実施形態において、表面側部材40には、表面側部材40を貫通する第2開孔452を有してよい。これにより、検査部材20を露出させずに、開孔45(第1開孔451及び第2開孔452)によって排泄物を接触部22へさらに到達し易くできる。 In addition, in the above-described second embodiment, the front side member 40 may have the second opening 452 penetrating the front side member 40. Thereby, the excrement can be more easily reached the contact portion 22 by the openings 45 (the first opening 451 and the second opening 452) without exposing the inspection member 20.
 上述の各実施形態では、第1表面側部材42は、1又は2のシートにより構成されていたが、これに限られない。第1表面側部材42は、3以上のシートにより構成されてよい。例えば、第1表面側部材42は、2つの液透過性シート(第1及び第3表面側部材)によって液不透過性シート(第2表面側部材)が厚さ方向Tにおいて挟まれた3層のシートにより構成されてよい。これにより、液不透過性シート(第2表面側部材)よりも非肌面側に配置されている液透過性シート(第3表面側部材)を排泄物が拡散する。検査部材20の肌面側T1からも排泄物が接触し易くなる。液不透過性シートにより排泄物に含まれる指示薬による着用者の肌へのダメージを抑制しつつ、短時間で検査に必要な排泄物(対象成分)を接触部22に到達させることができる。なお、表面側部材40が液不透過性シートを含む場合には、少なくとも液不透過性シートには、液不透過性シートよりも非肌面側T2へ排泄物を移動させるために開孔が形成されている。 In each of the above embodiments, the first surface-side member 42 is configured by one or two sheets, but is not limited thereto. The first surface side member 42 may be configured by three or more sheets. For example, the first front-side member 42 has three layers in which the liquid-impermeable sheet (second front-side member) is sandwiched in the thickness direction T by two liquid-permeable sheets (first and third front-side members). Sheet. Thereby, excrement is diffused in the liquid-permeable sheet (third surface-side member) disposed on the non-skin side with respect to the liquid-impermeable sheet (second surface-side member). The excrement easily comes into contact also from the skin surface side T1 of the inspection member 20. The liquid impermeable sheet allows the excrement (target component) required for the examination to reach the contact portion 22 in a short time while suppressing damage to the wearer's skin due to the indicator contained in the excrement. When the front-side member 40 includes a liquid-impermeable sheet, at least the liquid-impermeable sheet has an opening for moving excreta to the non-skin side T2 than the liquid-impermeable sheet. Is formed.
 また、表面側部材40と同様に、裏面側部材60は、3以上のシートにより構成されてよい。例えば、裏面側部材60が、表面側部材に含まれる液透過性シートよりも親水性又は繊維密度が高い親水性シートを含む場合、親水性シートは、検査部材20上に配置されてなくてよい。すなわち、親水性シートは、検査部材20と当接しなくてよい。厚さ方向Tにおいて当該親水性シートと検査部材20との間に液透過性シートが配置されていてもよい。親水性シートは、液透過性シートを介して排泄物を引き込むことにより、排泄物を表面側部材40へ戻り難くしてもよい。 Also, like the front side member 40, the back side member 60 may be configured by three or more sheets. For example, when the back side member 60 includes a hydrophilic sheet having a higher hydrophilicity or fiber density than the liquid-permeable sheet included in the front side member, the hydrophilic sheet may not be disposed on the inspection member 20. . That is, the hydrophilic sheet does not need to contact the inspection member 20. A liquid permeable sheet may be disposed between the hydrophilic sheet and the inspection member 20 in the thickness direction T. The hydrophilic sheet may make it difficult for the excrement to return to the front side member 40 by drawing the excrement through the liquid permeable sheet.
 上述の実施形態において、表面側部材40を裏面側部材60から剥離する場合、裏面側部材60を固定して表面側部材40を裏面側部材60から剥がしてよい。また、表面側部材40を固定して裏面側部材60を表面側部材40から剥がしてよい。結果として、表面側部材40を裏面側部材60から剥離することができる。 In the above embodiment, when the front side member 40 is peeled off from the back side member 60, the back side member 60 may be fixed and the front side member 40 may be peeled off from the back side member 60. Alternatively, the front side member 40 may be fixed and the back side member 60 may be peeled from the front side member 40. As a result, the front side member 40 can be separated from the back side member 60.
 上述の実施形態では、検査部材20は、直線状の板状であった。本実施形態では、検査部材20は、例えば、1以上の折り目を有してよい。従って、検査部材20は、例えば、2つ折り又は3つ折りの形状であってよい。検査部材20は、Z型に折り畳まれた部材により構成されてよい。これにより、検査部材20をコンパクトな状態で、吸収性物品1の内部へ配置することができる。検査部材20の面積が小さくなるため、検査部材20による着用者の肌触りの悪化を抑制し易くすることができる。 In the above embodiment, the inspection member 20 has a linear plate shape. In the present embodiment, the inspection member 20 may have, for example, one or more folds. Therefore, the inspection member 20 may have, for example, a two-fold or three-fold shape. The inspection member 20 may be configured by a member folded into a Z shape. Thereby, the inspection member 20 can be arranged inside the absorbent article 1 in a compact state. Since the area of the inspection member 20 is reduced, deterioration of the touch of the wearer due to the inspection member 20 can be easily suppressed.
 また、検査部材20は、接触部22が表面側部材40又は裏面側部材60の少なくとも一方に当接するように折られた状態で、配置されてよい。これにより、検査部材20が折られていても、接触部22に排泄物を到達し易くすることができる。 The inspection member 20 may be arranged in a state where the contact portion 22 is folded so as to contact at least one of the front surface member 40 and the rear surface member 60. This makes it easier for the excrement to reach the contact portion 22 even when the inspection member 20 is folded.
 また、検査部材20は、表示部22が表面側部材40又は裏面側部材60の少なくとも一方に当接するように折られた状態で、配置されてよい。これにより、検査部材20が折られていても、着用者は、表面側部材40を剥離するとすぐに表示部22を視認することができる。これにより、着用者は、健康状態を容易に確認することができる。 In addition, the inspection member 20 may be disposed in a state where the display unit 22 is folded such that the display unit 22 contacts at least one of the front surface member 40 and the rear surface member 60. Thus, even if the inspection member 20 is folded, the wearer can visually recognize the display unit 22 as soon as the front-side member 40 is peeled off. Thereby, the wearer can easily check the health condition.
 また、検査部材20は、粘着部を有する後処理テープ用のテープ部材が接触部22及び表示部24を有することにより構成されてよい。後処理テープ用のテープ部材としての検査部材20が有する粘着部により、使用後の吸収性物品1を、肌当接面が露出しないように丸めた状態で固定してよい。当該テープ部材としての検査部材20を用いることで、吸収性物品を衛生的に処分することができる。このように、着用者は、健康状態を検査した後に、検査部材20を後処理テープ用のテープ部材として使用することができ、検査部材20を有効活用できる。なお、後処理テープ用のテープ部材は、上述のようにZ型に折り畳まれた形状であってよい。 In addition, the inspection member 20 may be configured by a tape member for a post-processing tape having an adhesive portion having the contact portion 22 and the display portion 24. The used absorbent article 1 may be fixed in a rounded state so that the skin contact surface is not exposed by the adhesive portion of the inspection member 20 as the tape member for the post-treatment tape. By using the inspection member 20 as the tape member, the absorbent article can be sanitarily disposed. As described above, the wearer can use the inspection member 20 as a tape member for a post-processing tape after inspecting the health condition, and can effectively utilize the inspection member 20. Note that the tape member for the post-processing tape may have a shape folded into a Z shape as described above.
 なお、着用者は、表示部24の呈色を示す呈色情報(画像情報及び/又は映像情報)をネットワーク(管理サーバ)へ送ることで、検査情報を取得してもよい。例えば、着用者は、表面側部材40を裏面側部材60から剥離した後、露出した表示部24を、例えば、着用者(ユーザ)が所有する通信装置に内蔵されたカメラにより撮影することで呈色情報を取得してもよい。着用者は、呈色情報を通信装置を介して管理サーバへ送ることができる。着用者は、呈色情報と共に着用者の情報を示すユーザ情報を送ってもよい。ユーザ情報は、例えば、ユーザの識別子、通信装置の識別子、排泄物の種類を示す情報、吸収性物品1(検査部材20)の種類を示す情報、対象成分を特定する情報などの少なくともいずれかである。 Note that the wearer may acquire the examination information by sending color information (image information and / or video information) indicating the color of the display unit 24 to the network (management server). For example, after the wearer peels off the front-side member 40 from the back-side member 60, the wearer (user) presents the exposed display unit 24 by, for example, photographing the display unit 24 with a camera built in a communication device owned by the wearer (user). Color information may be acquired. The wearer can send the color information to the management server via the communication device. The wearer may send user information indicating the wearer's information together with the coloration information. The user information is, for example, at least one of a user identifier, a communication device identifier, information indicating the type of excrement, information indicating the type of the absorbent article 1 (the inspection member 20), information specifying the target component, and the like. is there.
 また、着用者は、検査部材20を含む吸収性物品1又は検査部材20そのものを、指示薬による呈色反応を検知可能である収容装置へ収容してよい。収容装置は、呈色反応を検知するために、可視光を表示部24へ照射してよい。収容装置は、可視光と異なる特殊な波長を有する特殊光(例えば、可視光よりも短い波長を有する紫外線)を照射することで指示薬による呈色を確認できる検査部材20に対して、当該特殊な波長を有する光を表示部24へ照射してよい。収容装置は、収容装置内において、可視光又は特殊光を照射しながら撮影することで呈色情報を取得してもよい。このように、収容装置内で、光を照射しながら表示部24を撮影することで、周囲の環境の影響を受けずに、正確に呈色を確認することができる。 着 用 Moreover, the wearer may house the absorbent article 1 including the inspection member 20 or the inspection member 20 itself in an accommodation device capable of detecting a color reaction by the indicator. The storage device may irradiate the display unit 24 with visible light in order to detect a color reaction. The storage device irradiates special light having a special wavelength different from visible light (for example, ultraviolet light having a shorter wavelength than visible light) to the inspection member 20 that can confirm coloration by the indicator by applying the special light. Light having a wavelength may be applied to the display unit 24. The accommodation device may acquire color information by photographing while irradiating visible light or special light in the accommodation device. As described above, by photographing the display unit 24 while irradiating light in the storage device, it is possible to accurately confirm the coloration without being affected by the surrounding environment.
 収容装置は、表示部24を撮影することにより取得した呈色情報をネットワーク(管理サーバ)へ送ってもよい。この場合、収容装置は、ユーザ情報として、収容装置の識別子を含めてもよい。また、収容装置は、取得した呈色情報を着用者が所有する通信装置へ送ってもよい。着用者は、表示部24を通信装置へ表示することによって、呈色の有無を判定してもよい。これにより、着用者は、より正確に健康状態を確認できる。なお、着用者は、上述と同様に、収容装置から取得した呈色情報を通信装置を介してネットワークへ送ってもよい。 The accommodation device may send the color information acquired by photographing the display unit 24 to a network (management server). In this case, the accommodation device may include the identifier of the accommodation device as the user information. Further, the housing device may send the acquired color information to the communication device owned by the wearer. The wearer may determine the presence or absence of coloration by displaying the display unit 24 on the communication device. Thereby, the wearer can check the health condition more accurately. Note that the wearer may send the color information acquired from the housing device to the network via the communication device, as described above.
 管理サーバは、呈色情報(及びユーザ情報)に基づいて、着用者(ユーザ)の健康状態を判定することができる。管理サーバは、判定結果を示す情報を呈色情報の送信元である通信装置へ送信してもよい。管理サーバは、判定結果を示す判定情報と共に、判定結果に基づくアドバイスを示すアドバイス情報を当該通信装置へ送信してもよい。管理サーバは、収容装置から呈色情報を受け取った場合であっても、収容装置の識別子と関連付けられている通信装置の識別子(ユーザの識別子)に基づいて、関連付けられている通信装置(すなわち、ユーザが所有する通信装置)へ判定情報(及びアドバイス情報)を送信してもよい。 The management server can determine the health condition of the wearer (user) based on the coloration information (and the user information). The management server may transmit the information indicating the determination result to the communication device that is the source of the color information. The management server may transmit the advice information indicating the advice based on the determination result to the communication device together with the determination information indicating the determination result. Even when the management server receives the color information from the accommodation device, the management server determines the associated communication device based on the identifier (user identifier) of the communication device associated with the accommodation device identifier (ie, The determination information (and the advice information) may be transmitted to a communication device owned by the user.
 通信装置は、通信装置により受信した判定情報に基づいて、判定結果を表示してよい。これにより、着用者は、表示された判定結果によって健康状態を把握することができる。着用者は、着用者自身の判定によるものではなく、客観的な判定結果を取得できる。また、通信装置は、アドバイス情報を受信した場合には、アドバイスを表示してよい。これにより、着用者は、アドバイスを把握することができる。 The communication device may display the determination result based on the determination information received by the communication device. Thereby, the wearer can grasp the health condition based on the displayed determination result. The wearer can obtain an objective determination result, not based on the wearer's own determination. In addition, when the communication device receives the advice information, the communication device may display the advice. Thereby, the wearer can grasp the advice.
 通信装置は、上述した各種の処理を実行するためのプログラムを有する。通信装置は、プログラムを記憶するメモリ及びメモリに記憶されたプログラムを実行するプロセッサを有する。プログラムは、ネットワーク(例えば、管理サーバ)から取得可能であってよい。 The communication device has a program for executing the above-described various processes. The communication device has a memory for storing a program and a processor for executing the program stored in the memory. The program may be obtainable from a network (for example, a management server).
 上述の実施の形態では、吸収性物品1は、生理用ナプキンであったが、これに限られない。吸収性物品1は、例えば、テープ型又はパンツ型の使い捨ておむつであってよい。 で は In the above-described embodiment, the absorbent article 1 is a sanitary napkin, but is not limited thereto. The absorbent article 1 may be a tape-type or pants-type disposable diaper, for example.
 上述の実施の形態では、検査部材20は、後側域S2と中央域S3とに跨がって配置されていた。検査部材20は、前側域S1、後側域S2、中央域S3のいずれかにのみ配置されてよい。これにより、検査部材20が配置される領域を低減することで、着用者の肌触りの悪化を抑制してもよい。 In the above-described embodiment, the inspection member 20 is disposed so as to straddle the rear side area S2 and the central area S3. The inspection member 20 may be arranged only in one of the front area S1, the rear area S2, and the central area S3. Thereby, the deterioration of the touch of the wearer may be suppressed by reducing the region where the inspection member 20 is arranged.
 上述の実施形態において、中央域S3は、着用者の脚回りに配置される脚回り開口部が設けられた領域であってよい。脚回り開口部は、幅方向の内側に向かうにつれ、吸収性物品の外側縁から幅方向の内側に凹む部分である。或いは、吸収性物品1が、吸収コアを含む場合、中央域S3は、幅方向の内側に向かうにつれ、吸収コアの外側縁から幅方向の内側に凹む部分が設けられる領域であってよい。或いは、中央域S3は、周囲の吸収コアよりも厚い領域である中高部が配置されている領域であってよい。或いは、中央域S3は、吸収性物品1を下着へ止めるウイングが設けられる場合、ウイングが設けられる領域であってよい。 In the above-described embodiment, the central region S3 may be a region where a leg opening is provided around the wearer's leg. The leg opening is a portion that is recessed inward in the width direction from the outer edge of the absorbent article toward the inside in the width direction. Alternatively, when the absorbent article 1 includes an absorbent core, the central region S3 may be a region in which a portion that is recessed inward in the width direction from the outer edge of the absorbent core is provided toward the inside in the width direction. Alternatively, the central region S3 may be a region where the middle and high portions, which are regions thicker than the surrounding absorbent cores, are arranged. Alternatively, when a wing for stopping the absorbent article 1 to the underwear is provided, the central area S3 may be an area where the wing is provided.
 上述において、反応部140(接触部142及び/又は表示部144)の一部が撥水部150により覆われていたが、これに限られない。反応部140は、例えば、着用者の指が、接触部142に触れたり、指示薬に触れたりすることを抑制できる部材であればよく、撥水性を有さない他の部材により覆われていてもよい。 In the above description, a part of the reaction part 140 (the contact part 142 and / or the display part 144) is covered with the water-repellent part 150, but is not limited thereto. The reaction section 140 may be any member that can suppress the wearer's finger from touching the contact section 142 or the indicator, for example, and may be covered with another member that does not have water repellency. Good.
 上述の第4から第9実施形態では、検査部130がリードテープとしての機能を有していたがこれに限られない。検査部130は、リードテープと異なるものであってよい。検査部130は、包装シート120(すなわち、第1シート部分121)の第1端縁121eを跨がないように配置されてよい。例えば、検査部130は、厚さ方向Zにおいて、包装シート120の一方側に露出している第1シート部分121上のみに配置(固定)されてよい。これにより、着用者は、包装体100を開封する前に、検査部130を容易に把握することができる。 In the fourth to ninth embodiments, the inspection unit 130 has a function as a lead tape, but is not limited to this. The inspection unit 130 may be different from a lead tape. The inspection unit 130 may be arranged so as not to straddle the first edge 121e of the packaging sheet 120 (that is, the first sheet portion 121). For example, the inspection unit 130 may be arranged (fixed) only on the first sheet portion 121 exposed on one side of the packaging sheet 120 in the thickness direction Z. Thereby, the wearer can easily grasp the inspection unit 130 before opening the package 100.
 また、例えば、検査部130は、包装シート120と別の部材である場合であっても、第10実施形態と同様に、包装状態において、検査部130は、第1シート部分121の露出していない面上に配置(固定)されてよい。第11実施形態と同様に、包装状態において、検査部130は、第1シート部分121の露出していない面に対向するように、第2シート部分122の露出していない面に配置(固定)されてよい。これにより、検査前において指示薬が他のものに触れにくくなり、指示薬が他のものに付着し難くすることができる。従って、着用者の安全性を高めることができる。また、検査部130も汚れが付着し難くなり、検査精度を向上できる。 Further, for example, even when the inspection unit 130 is a member different from the packaging sheet 120, the inspection unit 130 exposes the first sheet portion 121 in the packaged state, as in the tenth embodiment. It may be placed (fixed) on a surface that does not. As in the eleventh embodiment, in the packaged state, the inspection unit 130 is arranged (fixed) on the unexposed surface of the second sheet portion 122 so as to face the unexposed surface of the first sheet portion 121. May be. This makes it difficult for the indicator to touch other things before the test, and makes it difficult for the indicator to adhere to other things. Therefore, the safety of the wearer can be improved. In addition, the inspection unit 130 is also less likely to be stained, and the inspection accuracy can be improved.
 上述では、検査部130は、直線状の板状であった。本実施形態では、検査部130は、例えば、1以上の折り目を有してよい。従って、検査部130は、例えば、2つ折り又は3つ折りの形状であってよい。検査部130は、Z型に折り畳まれた部材により構成されてよい。これにより、検査部130をコンパクトな状態で、包装シート120へ固定することができる。 で は In the above description, the inspection unit 130 has a linear plate shape. In the present embodiment, the inspection unit 130 may have, for example, one or more folds. Therefore, the inspection unit 130 may have, for example, a two-fold or three-fold shape. The inspection unit 130 may be configured by a member folded in a Z shape. Thereby, the inspection unit 130 can be fixed to the packaging sheet 120 in a compact state.
 また、検査部130は、反応部140が露出しないように折られた状態で、包装シート120に固定されてよい。これにより、使用前に排泄物E以外のものが、接触部142に触れることを抑制でき、検査精度を向上できる。また、検査部材が折られている場合、使用前において、折られた検査部材を伸ばす(広げる)ことができる。これにより、着用者が検査部130を把持する位置を、排泄物Eから遠ざけた状態で、検査部130を排泄物Eに接触させることができる。着用者に排泄物Eが付着し難くなり、着用者は、衛生的に健康状態を検査することができる。 The inspection unit 130 may be fixed to the packaging sheet 120 in a state where the inspection unit 130 is folded so that the reaction unit 140 is not exposed. Thereby, it is possible to suppress the thing other than the excrement E from touching the contact portion 142 before use, and it is possible to improve the inspection accuracy. When the inspection member is folded, the folded inspection member can be extended (spread) before use. Thereby, the inspection unit 130 can be brought into contact with the excrement E while the position where the wearer grips the inspection unit 130 is kept away from the excrement E. The excrement E hardly adheres to the wearer, and the wearer can hygienically inspect the health condition.
 また、検査部130は、粘着部を有する後処理テープ用のテープ部材が反応部140を有することにより構成されてよい。後処理テープ用のテープ部材としての検査部130が有する粘着部により、使用後の吸収性物品を、肌当接面が露出しないように丸めた状態で固定してよい。当該テープ部材としての検査部130を用いることで、吸収性物品を衛生的に処分することができる。このように、着用者は、健康状態を検査した後に、検査部130を後処理テープ用のテープ部材として使用することができ、検査部130を有効活用できる。なお、後処理テープ用のテープ部材は、上述のようにZ型に折り畳まれた形状であってよい。 The inspection unit 130 may be configured by a tape member for a post-processing tape having an adhesive unit having the reaction unit 140. The used absorbent article may be fixed in a rounded state so that the skin contact surface is not exposed by the adhesive portion of the inspection unit 130 as a tape member for the post-treatment tape. By using the inspection unit 130 as the tape member, the absorbent article can be sanitarily disposed. In this manner, the wearer can use the inspection unit 130 as a tape member for a post-processing tape after inspecting the health condition, and the inspection unit 130 can be effectively used. Note that the tape member for the post-processing tape may have a shape folded into a Z shape as described above.
 なお、着用者は、表示部144の呈色を示す呈色情報(画像情報及び/又は映像情報)をネットワーク(管理サーバ)へ送ることで、検査情報を取得してもよい。例えば、着用者は、排泄物Eへ付着させることにより呈色した検査部130(表示部144)を、例えば、着用者(ユーザ)が所有する通信装置に内蔵されたカメラにより撮影することで呈色情報を取得してもよい。着用者は、呈色情報を通信装置を介して管理サーバへ送ることができる。着用者は、呈色情報と共に着用者の情報を示すユーザ情報を送ってもよい。ユーザ情報は、例えば、ユーザの識別子、通信装置の識別子、排泄物の種類を示す情報、吸収性物品110(検査部130)の種類を示す情報、対象成分を特定する情報などの少なくともいずれかである。 Note that the wearer may acquire the test information by sending color information (image information and / or video information) indicating the color of the display unit 144 to the network (management server). For example, the wearer presents the inspection unit 130 (display unit 144) colored by attaching to the excrement E by, for example, photographing with a camera built in a communication device owned by the wearer (user). Color information may be acquired. The wearer can send the color information to the management server via the communication device. The wearer may send user information indicating the wearer's information together with the coloration information. The user information is, for example, at least one of an identifier of the user, an identifier of the communication device, information indicating the type of excrement, information indicating the type of the absorbent article 110 (inspection unit 130), information specifying the target component, and the like. is there.
 また、着用者は、検査部130を、指示薬による呈色反応を検知可能である収容装置へ収容してよい。収容装置は、呈色反応を検知するために、可視光を表示部144へ照射してよい。収容装置は、可視光と異なる特殊な波長を有する特殊光(例えば、可視光よりも短い波長を有する紫外線)を照射することで指示薬による呈色を確認できる検査部130に対して、当該特殊な波長を有する光を表示部144へ照射してよい。収容装置は、収容装置内において、可視光又は特殊光を照射しながら撮影することで呈色情報を取得してもよい。このように、収容装置内で、光を照射しながら表示部144を撮影することで、周囲の環境の影響を受けずに、正確に呈色を確認することができる。 着 用 Further, the wearer may house the inspection unit 130 in a housing device capable of detecting a color reaction by the indicator. The storage device may irradiate the display unit 144 with visible light to detect a color reaction. The storage device irradiates special light having a special wavelength different from visible light (for example, ultraviolet light having a shorter wavelength than visible light) to the inspection unit 130 that can confirm coloring by the indicator. The display 144 may be irradiated with light having a wavelength. The accommodation device may acquire color information by photographing while irradiating visible light or special light in the accommodation device. As described above, by photographing the display unit 144 while irradiating light in the storage device, it is possible to accurately confirm coloration without being affected by the surrounding environment.
 収容装置は、表示部144を撮影することにより取得した呈色情報をネットワーク(管理サーバ)へ送ってもよい。この場合、収容装置は、ユーザ情報として、収容装置の識別子を含めてもよい。また、収容装置は、取得した呈色情報を着用者が所有する通信装置へ送ってもよい。着用者は、呈色情報により示される表示部144を通信装置へ表示することによって、呈色の有無を判定してもよい。これにより、着用者は、より正確に健康状態を確認できる。なお、着用者は、上述と同様に、収容装置から取得した呈色情報を通信装置を介してネットワークへ送ってもよい。 The accommodation device may send the color information acquired by photographing the display unit 144 to the network (management server). In this case, the accommodation device may include the identifier of the accommodation device as the user information. Further, the housing device may send the acquired color information to the communication device owned by the wearer. The wearer may determine the presence or absence of color by displaying the display unit 144 indicated by the color information on the communication device. Thereby, the wearer can check the health condition more accurately. Note that the wearer may send the color information acquired from the housing device to the network via the communication device, as described above.
 管理サーバは、呈色情報(及びユーザ情報)に基づいて、着用者(ユーザ)の健康状態を判定することができる。管理サーバは、判定結果を示す情報を呈色情報の送信元である通信装置へ送信してもよい。管理サーバは、判定結果を示す判定情報と共に、判定結果に基づくアドバイスを示すアドバイス情報を当該通信装置へ送信してもよい。管理サーバは、収容装置から呈色情報を受け取った場合であっても、収容装置の識別子と関連付けられている通信装置の識別子(ユーザの識別子)に基づいて、関連付けられている通信装置(すなわち、ユーザが所有する通信装置)へ判定情報(及びアドバイス情報)を送信してもよい。 The management server can determine the health condition of the wearer (user) based on the coloration information (and the user information). The management server may transmit the information indicating the determination result to the communication device that is the source of the color information. The management server may transmit the advice information indicating the advice based on the determination result to the communication device together with the determination information indicating the determination result. Even when the management server receives the color information from the accommodation device, the management server determines the associated communication device based on the identifier (user identifier) of the communication device associated with the accommodation device identifier (ie, The determination information (and the advice information) may be transmitted to a communication device owned by the user.
 通信装置は、通信装置により受信した判定情報に基づいて、判定結果を表示してよい。これにより、着用者は、表示された判定結果によって健康状態を把握することができる。着用者は、着用者自身の判定によるものではなく、客観的な判定結果を取得できる。また、通信装置は、アドバイス情報を受信した場合には、アドバイスを表示してよい。これにより、着用者は、アドバイスを把握することができる。 The communication device may display the determination result based on the determination information received by the communication device. Thereby, the wearer can grasp the health condition based on the displayed determination result. The wearer can obtain an objective determination result, not based on the wearer's own determination. In addition, when the communication device receives the advice information, the communication device may display the advice. Thereby, the wearer can grasp the advice.
 通信装置は、上述した各種の処理を実行するためのプログラムを有する。通信装置は、プログラムを記憶するメモリ及びメモリに記憶されたプログラムを実行するプロセッサを有する。プログラムは、ネットワーク(例えば、管理サーバ)から取得可能であってよい。 The communication device has a program for executing the above-described various processes. The communication device has a memory for storing a program and a processor for executing the program stored in the memory. The program may be obtainable from a network (for example, a management server).
 上述において、各実施形態は、適宜組み合わされてよい。 に お い て In the above description, each embodiment may be appropriately combined.
 なお、日本国特許出願第2018-125581号(2018年6月29日出願)及び日本国特許出願第2018-125605号(2018年6月29日出願)の全内容が、参照により、本願明細書に組み込まれている。 The entire contents of Japanese Patent Application No. 2018-125581 (filed on June 29, 2018) and Japanese Patent Application No. 2018-125605 (filed on June 29, 2018) are incorporated herein by reference. Built in.

Claims (16)

  1.  吸収性物品であって、
     着用者の健康状態を検査するための検査部材と、
     液透過性のトップシートを少なくとも含み、かつ前記検査部材よりも肌面側に配置されている表面側部材と、
     液不透過性のバックシートを少なくとも含み、かつ前記検査部材よりも肌面側に配置されている裏面側部材と、を備え、
     前記検査部材は、
      前記表面側部材を通過した排泄物を接触させる接触部と、
      前記排泄物に含まれる対象成分に応じて前記着用者の健康状態を指示薬により表示する表示部と、を有し、
     前記表面側部材は、前記表示部の少なくとも一部を覆っており、
     前記表面側部材は、前記表示部が視認可能になるように前記裏面側部材から剥離可能である、吸収性物品。
    An absorbent article,
    Inspection members for inspecting the health condition of the wearer,
    A surface-side member that includes at least a liquid-permeable top sheet, and is disposed on the skin side with respect to the inspection member,
    A back side member that includes at least a liquid impermeable back sheet, and is disposed on the skin side with respect to the inspection member,
    The inspection member,
    A contact portion that contacts the excrement that has passed through the surface-side member;
    A display unit that displays the health condition of the wearer with an indicator according to the target component included in the excrement,
    The front side member covers at least a part of the display unit,
    The absorbent article, wherein the front-side member is peelable from the rear-side member so that the display unit can be viewed.
  2.  前記表面側部材には、厚さ方向において前記接触部と重なる開孔が形成されている請求項1に記載の吸収性物品。 2. The absorbent article according to claim 1, wherein an opening is formed in the front side member so as to overlap the contact portion in a thickness direction.
  3.  前記表面側部材は、前記トップシートを含む複数のシートにより構成され、
     前記開孔は、前記複数のシートのうち一部のシートにのみ形成されている請求項2に記載の吸収性物品。
    The front side member is configured by a plurality of sheets including the top sheet,
    The absorbent article according to claim 2, wherein the aperture is formed only in some of the plurality of sheets.
  4.  前記接触部と前記表示部とは、異なる位置に配置されており、
     前記表示部は、前記厚さ方向において前記開孔と重ならない請求項2又は3に記載の吸収性物品。
    The contact unit and the display unit are arranged at different positions,
    The absorbent article according to claim 2, wherein the display section does not overlap the opening in the thickness direction.
  5.  前記表面側部材は、前記トップシートよりも非肌面側に配置される液不透過性シートを含み、
     前記開孔は、少なくとも前記液不透過性シートに形成されている請求項2から4のいずれか1項に記載の吸収性物品。
    The front-side member includes a liquid-impermeable sheet disposed on the non-skin side than the top sheet,
    The absorbent article according to any one of claims 2 to 4, wherein the aperture is formed at least in the liquid impermeable sheet.
  6.  前記開孔は、前記表面側部材を貫通する貫通孔である請求項2に記載の吸収性物品。 The absorbent article according to claim 2, wherein the opening is a through-hole penetrating the surface-side member.
  7.  前記裏面側部材は、前記表面側部材に含まれる液透過性シートよりも親水性又は繊維密度が高い親水性シートを含み、
     前記検査部材は、前記親水性シート上に配置されている請求項1から6に記載の吸収性物品。
    The back side member includes a hydrophilic sheet having a higher hydrophilicity or fiber density than the liquid permeable sheet included in the front side member,
    The absorbent article according to claim 1, wherein the inspection member is disposed on the hydrophilic sheet.
  8.  包装体であって、
     吸収性物品と、
     前記吸収性物品を個別に包装する包装シートと、
     着用者の健康状態を検査するための検査部と、を有し、
     前記検査部は、着用者の排泄物に含まれる対象成分に応じて前記着用者の健康状態を表示し、
     前記検査部は、前記包装シートと固定されている又は前記包装シートの一部である、包装体。
    A package,
    An absorbent article;
    A packaging sheet for individually packaging the absorbent articles,
    Having an inspection unit for inspecting the health condition of the wearer,
    The inspection unit displays a health condition of the wearer according to a target component included in the excrement of the wearer,
    The package wherein the inspection unit is fixed to the packaging sheet or is a part of the packaging sheet.
  9.  前記検査部は、前記健康状態を表示させるために前記排泄物を接触させる接触部を有し、
     前記接触部は、前記包装シートと厚さ方向で重なっている請求項8に記載の包装体。
    The inspection unit has a contact unit that contacts the excrement to display the health condition,
    The package according to claim 8, wherein the contact portion overlaps the packaging sheet in a thickness direction.
  10.  前記検査部は、前記健康状態を表示させるために前記排泄物を接触させる接触部を有し、
     前記検査部は、前記包装シートの端縁を跨ぐように配置されており、
     前記検査部は、前記包装体が開封された状態において前記包装シートの外側へ前記端縁から延出する延出部を有し、
     前記接触部は、前記延出部に配置されている請求項8又は9に記載の包装体。
    The inspection unit has a contact unit that contacts the excrement to display the health condition,
    The inspection unit is disposed so as to straddle the edge of the packaging sheet,
    The inspection unit has an extending portion extending from the edge to the outside of the packaging sheet in a state where the package is opened,
    The package according to claim 8, wherein the contact portion is arranged on the extension portion.
  11.  前記検査部は、前記包装体を開封するために前記包装シートから剥がされるリードテープである請求項8から10のいずれか1項に記載の包装体。 The package according to any one of claims 8 to 10, wherein the inspection unit is a lead tape that is peeled off from the packaging sheet to open the package.
  12.  前記検査部は、指示薬を含み、かつ前記排泄物に含まれる対象成分に応じて前記着用者の健康状態を前記指示薬により表示する表示部を有し、
     前記表示部の少なくとも一部は、撥水性を有する撥水部に覆われている請求項8から11のいずれか1項に記載の包装体。
    The inspection unit includes an indicator, and has a display unit that displays the health condition of the wearer with the indicator according to a target component included in the excrement,
    The package according to any one of claims 8 to 11, wherein at least a part of the display unit is covered with a water-repellent portion having water repellency.
  13.  前記表示部が前記撥水部に覆われている状態で、前記健康状態を示す前記指示薬による呈色を視認可能である請求項12に記載の包装体。 The package according to claim 12, wherein, in a state where the display section is covered with the water-repellent section, the coloring by the indicator indicating the health condition can be visually recognized.
  14.  前記検査部は、前記健康状態を表示させるために前記排泄物を接触させる接触部を有し、
     前記接触部の一部は、撥水性を有する撥水部に覆われている請求項8から13のいずれか1項に記載の包装体。
    The inspection unit has a contact unit that contacts the excrement to display the health condition,
    The package according to any one of claims 8 to 13, wherein a part of the contact portion is covered with a water-repellent portion having water repellency.
  15.  前記検査部は、前記接触部が固定されている本体部を有し、
     前記接触部は、前記本体部に固定される第1面と、前記第1面と反対側の面である第2面と、前記第1面と前記第2面とをつなぐ第3面と、を有し、
     前記第2面は、前記撥水部により覆われており、前記第3面の少なくとも一部は、前記撥水部から露出している請求項14に記載の包装体。
    The inspection unit has a main body to which the contact unit is fixed,
    A first surface fixed to the main body, a second surface opposite to the first surface, a third surface connecting the first surface and the second surface, Has,
    The package according to claim 14, wherein the second surface is covered by the water-repellent portion, and at least a part of the third surface is exposed from the water-repellent portion.
  16.  前記検査部は、前記包装シートの一部であり、
     前記包装シートは、
      前記健康状態を表示させるために前記排泄物を接触させる接触部と、
      前記排泄物に含まれる対象成分に応じて前記着用者の健康状態を表示する表示部と、を有し、
     前記接触部及び前記表示部は、前記包装体の開封前において露出しておらず、かつ、前記包装体の開封により露出する請求項8に記載の包装体。
    The inspection unit is a part of the packaging sheet,
    The packaging sheet,
    A contact portion for contacting the excrement to display the health condition;
    A display unit that displays the health condition of the wearer according to the target component included in the excrement,
    The package according to claim 8, wherein the contact portion and the display portion are not exposed before the package is opened, and are exposed when the package is opened.
PCT/JP2019/024485 2018-06-29 2019-06-20 Absorbent article, and package WO2020004218A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201980042377.4A CN112334102B (en) 2018-06-29 2019-06-20 Absorbent article and package

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018-125581 2018-06-29
JP2018125605A JP6920252B2 (en) 2018-06-29 2018-06-29 Package
JP2018-125605 2018-06-29
JP2018125581A JP6905959B2 (en) 2018-06-29 2018-06-29 Absorbent article

Publications (1)

Publication Number Publication Date
WO2020004218A1 true WO2020004218A1 (en) 2020-01-02

Family

ID=68987181

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/024485 WO2020004218A1 (en) 2018-06-29 2019-06-20 Absorbent article, and package

Country Status (2)

Country Link
CN (1) CN112334102B (en)
WO (1) WO2020004218A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788128A (en) * 1993-07-30 1995-04-04 Kobayashi Pharmaceut Co Ltd Pad material for body fluid absorption
JP2003501216A (en) * 1999-06-11 2003-01-14 エスシーエー・ハイジーン・プロダクツ・アーベー Absorbent articles containing active additives and use of visual indicators in absorbent articles
JP2004245818A (en) * 2002-07-12 2004-09-02 Sanyo Chem Ind Ltd Absorber for diagnosis and absorbent article
KR20080019264A (en) * 2008-02-11 2008-03-03 이동현 A physiological pad for self diagonosis of cancers and geriatric diseases
JP2016501613A (en) * 2012-12-21 2016-01-21 エスセーアー・ハイジーン・プロダクツ・アーベー Absorbent article body fluid testing device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062764A1 (en) * 2007-08-30 2009-03-05 Kimberly-Clark Worldwide, Inc. Zoned application of decolorizing composition for use in absorbent articles
CN103099711A (en) * 2013-01-31 2013-05-15 陈维京 Paper diaper with function of detect inflammation
CN106983603A (en) * 2017-05-14 2017-07-28 郭宝煊 Intelligent sanitary napkins
CN107028704A (en) * 2017-05-18 2017-08-11 肇庆学院 A kind of intelligent nappy and application method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788128A (en) * 1993-07-30 1995-04-04 Kobayashi Pharmaceut Co Ltd Pad material for body fluid absorption
JP2003501216A (en) * 1999-06-11 2003-01-14 エスシーエー・ハイジーン・プロダクツ・アーベー Absorbent articles containing active additives and use of visual indicators in absorbent articles
JP2004245818A (en) * 2002-07-12 2004-09-02 Sanyo Chem Ind Ltd Absorber for diagnosis and absorbent article
KR20080019264A (en) * 2008-02-11 2008-03-03 이동현 A physiological pad for self diagonosis of cancers and geriatric diseases
JP2016501613A (en) * 2012-12-21 2016-01-21 エスセーアー・ハイジーン・プロダクツ・アーベー Absorbent article body fluid testing device

Also Published As

Publication number Publication date
CN112334102B (en) 2022-08-30
CN112334102A (en) 2021-02-05

Similar Documents

Publication Publication Date Title
US20240325211A1 (en) Disposable hygienic article with means for diagnostic testing
JP7499303B2 (en) Absorbent articles
AU2009228014B2 (en) Cotton thread as a low-cost multi-assay diagnostic platform
CN103052371B (en) Disposable wearing article
JP5260543B2 (en) Lateral flow assay device and absorbent article containing the device
JP5624801B2 (en) Absorbent articles
KR20100101103A (en) Multi-layered devices for analyte detection
CN112512471B (en) Absorbent article
EP3443345B1 (en) On-diaper body fluid screening device
JP4163600B2 (en) Diapers with health indicators
CN107407676A (en) Check external member
CN114845674A (en) Absorbent article and absorbent article package
JP6905959B2 (en) Absorbent article
TWI558386B (en) Dispose of items with disposable dessert
WO2020004218A1 (en) Absorbent article, and package
JP5624800B2 (en) Absorbent articles
JP7245624B2 (en) absorbent article
JP7064992B2 (en) Absorbent article
JP2020003434A (en) Packaged article
WO2016158733A1 (en) Adhesive plaster for use in collection of blood
EP4180016A1 (en) Absorbent article
JP2024018954A (en) Absorbent article
WO2024084726A1 (en) Absorbent article with test strip for vaginal discharge, and test strip for vaginal discharge for use in absorbent article
WO2017168388A1 (en) Diaper for collecting biological samples
JP2022052567A (en) Urinalysis tool

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19827563

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19827563

Country of ref document: EP

Kind code of ref document: A1